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  “Das	  Leben	  is	  wert	  gelebt	  zu	  werden,	  sagt	  die	  Kunst,	  die	  Schönste	  aller	  Verführerin;	  das	  Leben	  ist	  wert,	  erkannt	  zu	  werden,	  sagt	  die	  Wissenschaft.”	  	  
	  





The	  human	  fungal	  pathogens	  Cryptococcus	  neoformans	  and	  C.	  gattii	  cause	  life-­‐threatening	  infections	  of	   the	  central	  nervous	  system.	  One	  of	   the	  major	  characteristics	  of	  cryptococcal	  disease	  is	  the	  ability	  of	  the	  pathogen	  to	  parasitise	  upon	  phagocytic	   immune	  effector	  cells.	  
Cryptococcus	   can	   survive	   and	   proliferate	  within	  macrophages,	   and	   is	   also	   able	   to	   escape	  into	   the	   extracellular	   environment	   via	   a	   non-­‐lytic	   mechanism	   (‘expulsion’)	   and	   can	   be	  transferred	  directly	  from	  one	  cell	  to	  another	  (lateral	  transfer).	  	  It	   is	  well	   established	   that	   the	  host’s	   cytokine	  profile	  dramatically	   affects	   the	  outcome	  of	  cryptococcal	  infections.	  Patients	  exhibiting	  a	  so-­‐called	  ‘Th1’	  response	  have	  a	  significantly	  better	   clinical	   prognosis	   than	   those	   exhibiting	   a	   ‘Th2’	   response.	   In	   the	   first	   part	   of	   this	  thesis,	  it	  is	  demonstrated	  that	  enhanced	  Th2,	  but	  not	  Th1,	  cytokine	  levels	  lead	  to	  increased	  intracellular	   cryptococcal	   proliferation	   but	   lower	   levels	   of	   cryptococcal	   expulsion.	   Thus,	  Th2	  responses	  favor	  cryptococcal	  survival	  and	  dissemination	  leading	  to	  fatal	  infections	  of	  the	   central	   nervous	   system.	   These	   results	   help	   to	   explain	   the	   observed	   poor	   prognosis	  associated	  with	  the	  dominant	  Th2	  cytokine	  profile	  (e.g.	  in	  HIV-­‐infected	  patients).	  	  Despite	   the	   importance	   of	   phagocyte/Cryptococcus	   interactions	   to	   disease	   progression,	  current	   methods	   for	   assaying	   virulence	   in	   the	   macrophage	   system	   are	   both	   time	  consuming	  and	  low	  throughput.	  In	  the	  second	  part	  of	  the	  thesis,	  the	  first	  stable	  and	  fully	  characterised	   GFP-­‐expressing	   derivates	   of	   two	   widely	   used	   cryptococcal	   strains:	  
C.	  neoformans	   serotype	   A	   type	   strain	  H99	   and	  C.	   gattii	   serotype	   B	   type	   strain	   R265	   are	  introduced	   and	   their	   use	   in	   the	   development	   of	   a	   method	   to	   effectively	   and	   rapidly	  investigate	   macrophage	   parasitism	   by	   flow	   cytometry,	   a	   technique	   that	   preserves	   the	  accuracy	  of	  current	  approaches	  but	  offers	  four-­‐fold	  improvement	  in	  speed,	  is	  reported.	  	  In	  addition,	  work	  to	  examine	  how	  Cryptococcus-­‐macrophage	  interaction	  relates	  to	  a	  novel	  outbreak	  of	  cryptococcosis	   in	   immunocompetent	   individuals	  has	  been	  extended.	   Isolates	  from	   an	   ongoing	   outbreak	   on	   Vancouver	   Island,	   Canada,	   share	   an	   increased	   ability	   to	  proliferate	  within	  macrophages	   that	  correlates	  with	  a	  characteristic	   tubular	  morphology	  of	   cryptococcal	   mitochondria.	   The	   third	   part	   of	   the	   thesis	   dissects	   cellular	   conditions	  within	   the	   host	   as	   inducer	   of	   tubular	   morphology,	   describes	   the	   early	   onset	   of	  mitochondrial	  tubularisation	  upon	  encounter	  of	  the	  intracellular	  niche	  in	  a	  hypervirulent	  isolate	   and	   the	   first	   steps	   towards	   a	   comparative	   mitochondrial	   genome	   sequencing	  approach	  to	  identify	  molecular	  mechanisms.	  	  
Acknowledgements	  
There	   are	   so	  many	   people	  who	   have	   contributed	   to	   this	   piece	   of	  work,	  many	   of	  them	  might	  not	  even	  be	  aware	  of	  how	  much	  support	  they	  provided.	  I	  would	  like	  to	  thank	  everyone	  around	  me	  for	  his	  or	  her	  contribution	  in	  the	  last	  three	  years	  and	  would	  like	  to	  take	  this	  chance	  to	  acknowledge	  several	  people	  who	  had	  a	  particular	  strong	  impact	  during	  my	  PhD	  studies	  in	  the	  next	  few	  lines.	  	  	  First	  of	  all,	  I	  would	  like	  to	  express	  my	  deep	  gratitude	  to	  my	  supervisor	  Robin	  May.	  Robin,	  you	  have	  provided	  fantastic	  support	  and	  guidance	  throughout	  the	  last	  three	  years	  and	   I	  believe	   I	   can	   say	   I	   could	  have	  not	  asked	   for	  a	  better	   supervisor.	  You	  supported	  me	  in	  my	  development	  as	  an	  independent	  researcher	  by	  believing	  in	  me	  and	  giving	  me	  the	  freedom	  to	  follow	  my	  own	  ideas	  whilst	  making	  sure	  that	  I	  stayed	  on	  track.	  Your	  door	  was	  always	  open	  to	  come	  in	  for	  a	  chat.	  Thank	  you	  for	  giving	  me	  the	  chance	  to	  do	  my	  PhD	  in	  your	  lab	  and	  for	  the	  continuing	  support	  you	  have	  been	  offering.	  	  	  On	  my	  scientific	  way,	  I	  encountered	  many	  challenges	  and	  many	  people	  helped	  me	  to	  live	  up	  to	  these:	  Tony	  Lammas	  who	  showed	  me	  how	  to	  master	  primary	  human	  macrophages	  helping	  me	  to	  publish	  my	   first	  paper,	   Julian	  Rutherford	  and	  Robert	  Panting	   who	   hosted	   me	   for	   two	   months	   in	   Newcastle	   and	   taught	   me	   biolistic	  transformation	   laying	  the	  foundation	  of	  a	  second	  publication	  and	  Teun	  Boekhout	  and	  Ferry	  Hagen	  who	  gave	  me	  the	  opportunity	  to	  work	  with	  them	  for	  three	  weeks	  at	   the	   CBS	   in	   the	   Netherlands	   helping	   me	   to	   extract	   DNA	   and	   to	   beat	   DNA	  contaminations	  I	  had	  been	  struggling	  with	  for	  a	  long	  time.	  I	  would	  like	  to	  thank	  all	  of	  you	  for	  your	  help.	  	  	  Not	  only	  Robin,	  the	  whole	  May-­‐lab:	  Elizabeth,	  Nicola,	  Hansong,	  Rhiannon,	  Leanne	  and	  Simon	  offered	  me	  constant	  support.	  It	  has	  been	  an	  honour	  working	  with	  you	  and	  you	  guys	  are	  not	  only	  colleagues	  –	  you	  have	  become	  friends.	  Simon,	  thanks	  for	  all	   your	  patience	  when	   I	   couldn’t	   figure	  out	  how	   to	  use	   the	  microscopes	  and	   the	  great	  GFP	  project	  we	  did	  together	  –	  it	  was	  great	  fun.	  	  	  
Acknowledgements	  
I	  have	  been	  incredibly	  fortunate	  to	  have	  a	  great	  circle	  of	  friends	  around	  that	  stood	  by	  me.	   I	  want	  to	  mention	  Elizabeth	  and	  Nicola,	   together	  with	  my	  dear	  neighbour	  Femy,	  who	   helped	  me	   through	   a	   very	   difficult	   personal	   time	   and	   always	   had	   an	  open	  ear	  and	  dried	  many	  tears.	  I	  hope	  you	  know	  how	  much	  you	  helped	  me	  to	  enjoy	  and	   love	   life	   again.	   I	   would	   also	   like	   to	   mention	   my	   wonderful	   and	   dearest	  housemates	  Angela	   Joyce	  and	  Lu	  Chen	  who	  patiently	  dealt	  with	  a	   lot	  of	  stressing	  out	   and	   self-­‐doubt	   on	   my	   side	   but	   always	   encouraged	   me	   to	   keep	   going	   when	  things	   seemed	   tough.	   Last	   but	   not	   least,	   I	  want	   to	   thank	  Phil,	   Charlie,	   Cathy	   and	  Serena	  for	  keeping	  the	  ropes	  together	  in	  the	  last	  year.	  I	  love	  our	  little	  adventures	  together	  and	  hope	  they	  keep	  coming.	  	  	  	  Die	  letzten	  Zeilen	  möchte	  ich	  zwei	  besonderen	  Menschen	  widmen	  –	  meinen	  Eltern.	  Ein	  besonderer	  Dank	  kommt	  Euch	  zu	  teil:	  schweren	  Herzen	  habt	  ihr	  mich	  ziehen	  lassen	   um	   meinen	   akademischen	   Traum	   des	   Doktortitels	   zu	   erfüllen.	   Obwohl	  keiner	   von	   euch	   beiden	   die	   Erfahrung	   einer	   universitären	   Ausbildung	   machen	  konnte,	  habt	   ihr	  mich	  auf	  meinem	  Weg	  unterstützt	  und	  standet	  hinter	  mir	  selbst	  wenn	  ihr	  meine	  Entscheidungen	  nicht	  immer	  verstanden	  habt.	  Vielen	  Dank!	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Thesis	  Overview	  
Opportunistic	  pathogens	  have	  become	  of	   increasing	  medical	   importance	  over	  the	   last	  decade	  due	  to	  the	  AIDS	  pandemic.	  Cryptococcosis	  is	  not	  only	  the	  fourth	  most	  common	  fatal	   infectious	   disease	   in	   sub-­‐Saharan	   Africa,	   but	   Cryptococcus	   is	   also	   an	   emerging	  pathogen	   of	   immunocompetent	   individuals.	   The	   interaction	   between	   the	   yeast	   and	  macrophages,	  specialized	  cells	  of	  the	  host’s	  immune	  system,	  is	  a	  major	  determinant	  for	  the	  outcome	  of	  disease.	  Cryptococcus	  can	  survive	  and	  proliferate	  within	  these	  cells,	  and	  is	   also	   able	   to	   escape	   into	   the	   extracellular	   environment	   via	   a	   non-­‐lytic	   mechanism	  (‘expulsion’)	  and	  can	  be	  transferred	  directly	  from	  one	  cell	  to	  another	  (lateral	  transfer).	  Further	   definition	   of	   cryptococcal	   interaction	   with	   macrophages	   may	   improve	  cryptococcosis	  treatment	  by	  highlighting	  potentially	  novel	  therapeutic	  approaches.	  This	   thesis	  was	  written	   in	   a	   traditional	   style	  with	   introduction	   (chapter	   1),	  material	  and	   methods	   (chapter	   2),	   results	   and	   discussion	   (chapter	   3-­‐6).	   	   As	   three	   different	  projects	  are	  presented	  in	  this	  thesis,	  the	  discussion	  of	  each	  project	  immediately	  follows	  the	  results	  to	  better	  explain	  the	  data.	  	  Chapter	   3	   analyses	   the	   effect	   of	   cytokine	   signaling	   on	   the	   outcome	   of	   macrophage	  parasitism	  by	  Cryptococcus	  neoformans.	  It	  is	  demonstrated	  that	  enhanced	  Th2,	  but	  not	  Th1,	   cytokine	   levels	   lead	   to	   increased	   intracellular	   cryptococcal	   proliferation	   but	  lower	  levels	  of	  cryptococcal	  expulsion.	  Chapter	   4	   is	   a	   technical	   chapter	   describing	   the	   production	   and	   characterisation	   of	  GFP-­‐tagged	   cryptococcal	   strains	   and	   subsequent	   development	   of	   a	   flow	   cytometry	  based	  approach	  for	  accurate	  and	  high	  throughput	  quantification	  of	  parameters	  such	  as	  cryptococcal	   phagocytosis	   and	   intracellular	   proliferation	   to	   describe	   macrophage	  parasitism.	  	  Chapter	   5	   analyses	   the	   involvement	   of	   mitochondria	   in	   enhanced	   macrophage	  parasitism	   in	   isolates	   causing	   cryptococcosis	   in	   immunocompetent	   individuals.	   It	  describes	   the	   effect	   of	   different	   stress	   conditions	   encountered	   within	   the	   host	   and	  environment	   on	   mitochondrial	   morphology	   and	   the	   preliminary	   work	   for	   a	  comparative	  mitochondrial	  genome	  sequencing	  approach	   to	  decipher	   the	  underlying	  mechanism	  of	  the	  increased	  virulence.	  This	  is	  a	  currently	  ongoing	  project.	  Chapter	  6	  describes	  an	  attempt	   to	  decipher	   the	   role	  of	  a	   sterol	   signaling	  pathway	   in	  cryptococcal	  adaptation	  to	  low	  oxygen	  conditions.	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1.1	   THE	  CRYPTOCOCCUS	  SPECIES	  COMPLEX	  
	  Opportunistic	  pathogens	  have	  become	  of	   increasing	  medical	   importance	  over	  the	  last	  decade	  due	  to	  the	  AIDS	  pandemic.	  Cryptococcosis	  is	  not	  only	  the	  fourth	  most	  common	  fatal	  infectious	  disease	  in	  sub-­‐Saharan	  Africa,	  but	  Cryptococcus	  is	  also	  an	  emerging	   pathogen	   of	   immunocompetent	   individuals.	   The	   following	   section	  will	  give	   an	   introduction	   to	   the	   genus	   Cryptococcus	   and	   the	   related	   disease	  cryptococcosis.	  	  	  
1.1.1	   CRYPTOCOCCUS	  SP.	  The	   basidiomycetous	   genus	  Cryptococcus	   includes	  more	   than	   70	   species.	   	   In	   the	  1890s,	   Buschke	   and	   Busse	   first	   indentified	   C.	   neoformans	   as	   human	   pathogen	  (Busse,	   1894,	   Buschke,	   1895)	   and	   to	   date,	   two	   species	   are	   predominantly	  considered	   as	   causative	   agents	   of	   cryptococcosis:	   C.	   neoformans	   and	   C.	   gattii	  (Casadevall	  et	  al.,	  1998).	  Clinical	  isolates	  appear	  predominantly	  in	  their	  vegetative	  haploid	   form	   as	   spherical	   yeast	   with	   a	   characteristic	   polysaccharide	   capsule	  (Figure	  1)	  (Mitchell	  et	  al.,	  1995).	  Due	  to	  the	  varying	  size	  of	  the	  yeast	  capsule,	  cell	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diameter	  can	  vary	  from	  2	  µm	  in	  poorly	  encapsulated	  strains	  up	  to	  80	  µm	  in	  heavily	  encapsulated	  strains	  (Casadevall	  et	  al.,	  1998).	  	  Based	  on	  differential	  antibody	  recognition	  of	   the	  capsule	  polysaccharide,	   the	  two	  medically	   important	   species	   are	   classified	   into	   C.	   neoformans	   serotypes	   A	  (C.	  neoformans	   var.	   grubii),	   D	   (C.	   neoformans	   var.	   neoformans)	   and	   A/D,	   and	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Figure	  1:	  Cryptococcal	  capsule	  after	  India	  ink	  staining.	  Images	  were	  taken	  (A)	  under	  light	   microscope	   and	   (B)	   scanning	   electron	   microscope.	   (Taken	   and	   modified	   from	  Zaragoza	  et	  al.	  2010	  (Zaragoza	  et	  al.,	  2010))	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Figure	  2:	  Schematic	  phylogeny	  of	  the	  Cryptococcus	  species	  complex.	  Diagram	  includes	  species,	   serotype,	  molecular	   type	   and	   reference	   strains.	  The	   species	   complex	   consists	   of	  two	  species;	  C.	  neoformans	  and	  C.	  gattii.	  C.	  Neoformans	  is	  further	  divided	  into	  the	  serotype	  a	  variety	  grubii	  with	  the	  molecular	  types	  VNI,	  VNII,	  VNB,	   the	  AD	  hybrids	  (VNIII)	  and	  the	  serotype	   D	   variety	   neoformans	   molecular	   type	   VNIV.	   The	   second	   species	   C.	   gattii	  comprises	   the	   serotypes	   B	   and	   C	   with	   the	   molecular	   types	   VGI,	   VGII,	   VGIII	   and	   VGIV	  (Bovers	  et	  al.,	  2008,	  Lin	  et	  al.,	  2006,	  Meyer	  et	  al.,	  2003,	  Findley	  et	  al.,	  2009).	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1.1.1.1	   CRYPTOCOCCUS	  NEOFORMANS	  AND	  CRYPTOCOCCUS	  GATTII	  Historically,	   all	   pathogenic	   serotypes	   used	   to	   be	   considered	   as	   varieties	   of	   the	  species	   C.	   neoformans.	   However,	   due	   to	   their	   genetic	   variability	   and	   the	   lack	   of	  evidence	  for	  sexual	  recombination	  between	  C.	  neoformans	  and	  C.	  gattii,	  the	  latter	  is	  now	   regarded	   as	   an	   individual	   species	   (Kwon-­‐Chung	   et	   al.,	   2002).	   Further	  differences	  between	  both	  species	  can	  be	   found	   in	  their	  geographical	  distribution,	  epidemiology	  and	  clinical	  manifestation	  (Casadevall	  et	  al.,	  1998).	  	  
C.	   neoformans	   is	   globally	   distributed	   and	   has	   been	   isolated	   from	  various	   natural	  sources	  with	   particularly	   high	   concentrations	   in	   avian	   guano,	   rotting	   vegetables	  and	   soil.	   In	   contrast,	   C.	   gattii,	   besides	   also	   being	   distributed	   worldwide,	   shows	  geographical	   hot	   spots	   in	   tropical	   and	   subtropical	   regions,	   with	   the	   notable	  exception	  of	  British	  Columbia.	  In	  tropical	  and	  subtropical	  regions	  it	  has	  been	  found	  to	   be	   associated	   with	   the	   eucalyptus	   tree	   species	   Eucalyptus	   camaldulensis,	  
E.	  tereticornis,	  E.	  rudis	  and	  E.	  gomphocephala	  (Sorrell	  et	  al.,	  1997,	  Harrison,	  2000,	  Ellis	  et	  al.,	  1990b,	  Pfeiffer	  et	  al.,	  1992).	  	  
C.	   neoformans	   mainly	   causes	   opportunistic	   infections	   of	   immunocompromised	  patients	  with	   underlying	   conditions	   such	   as	  HIV,	   leukemia	   and	   other	   cancers	   or	  those	   taking	   corticosteroid	   medication	   (Mitchell	   et	   al.,	   1995).	   Serotype	   A	   is	  responsible	   for	   the	   majority	   (95	   %)	   of	   cryptococcosis	   cases	   in	   the	  immunocompromised	   host	   (Hull	   et	   al.,	   2002).	   C.	   gattii	   mainly	   affects	  immunocompetent	   individuals.	   Although	   it	   only	   causes	   0.94	   cases	   per	   million	  population	   per	   year	   even	   in	   endemic	   areas	   such	   as	   Australia	   (Chen	   et	   al.,	   2000,	  Sorrell,	  2001),	  a	  recent	  and	  ongoing	  cryptococcosis	  outbreak	  in	  healthy	  individuals	  on	   Vancouver	   Island,	   British	   Columbia,	   Canada	   has	   highlighted	   the	   potential	   of	  
C.	  gattii	   to	   act	   as	   an	   emerging	   pathogen	   (Kidd	   et	   al.,	   2007,	   Kidd	   et	   al.,	   2004,	  MacDougall	  et	  al.,	  2007).	  The	  outbreak	  started	  in	  1999	  showing	  incidence	  rates	  of	  up	  to	  36	  cases	  per	  million	  population	  per	  year	  on	  Vancouver	  Island	  during	  2002-­‐2005	  (MacDougall	  et	  al.,	  2007).	  Moreover,	  there	  is	  evidence	  that	  the	  outbreak	  has	  since	  spread	  to	  mainland	  British	  Columbia	  and	  the	  Pacific	  Northwest	  (Byrnes	  et	  al.,	  2009a,	  Byrnes	  et	  al.,	  2009c,	  Byrnes	  et	  al.,	  2009b,	  Datta	  et	  al.,	  2009,	  Bartlett	  et	  al.,	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2008,	  MacDougall	   et	   al.,	   2007).	   Interestingly,	  most	   clinical	   isolates	   belong	   to	   the	  
C.	  gattii	  genotype	  VGII	   (Kidd	   et	   al.,	   2004).	   Isolates	   from	   this	   genotype	  have	  been	  separated	   into	   three	   subtypes:	   a	   VGIIa	   cluster	   containing	   hypervirulent	   clinical	  isolates,	   a	   VGIIb	   cluster	   containing	   mainly	   environmental	   isolates	   and	   a	   VGIIc	  cluster	   containing	   hypervirulent	   isolates	   recovered	   in	  Oregon	   (Kidd	   et	   al.,	   2005,	  Kidd	  et	  al.,	  2004,	  Byrnes	  et	  al.,	  2009a).	  In	   addition,	   other	   non-­‐neoformans/non-­‐gattii	   species,	   such	   as	   C.	   laurentii	   and	  
C.	  albidus	  have	  recently	  started	  to	  emerge	  as	  potential	  human	  pathogens.	  However,	  as	  most	  of	  the	  non-­‐neoformans/non-­‐gattii	  species	  are	  not	  able	  to	  survive	  at	  human	  body	   temperature,	   infections	  are	  generally	   rare.	  Twenty	   cases	  of	  C.	   laurentii	  and	  18	  cases	  of	  C.	  albidus	  induced	  cryptococcosis	  have	  been	  reported	  to	  date	  (reviewed	  in	  (Khawcharoenporn	  et	  al.,	  2007)).	  	  	  
1.1.1.2	   THE	  CRYPTOCOCCAL	  LIFE	  CYCLE	  Although	  Cryptococcus	  is	  predominantly	  found	  as	  budding	  yeast	  in	  patients	  and	  in	  the	   environment	   it	   can	   also	   appear	   in	   its	   filamentous	   form	   during	   mating	   and	  monokaryotic	   fruiting.	  During	  sexual	  reproduction,	  haploid	  yeast	  cells	  of	   the	   two	  opposite	  mating	  types	  a	  and	  α	   fuse	  and	  produce	  dikaryotic	  filaments.	  A	  basidium	  develops	   after	   migration	   of	   the	   parental	   nuclei	   to	   the	   ultimate	   hyphal	   cell.	   The	  nuclei	   fuse	   and	   undergo	  meiosis	   followed	   by	  mitosis	   and	   production	   of	   haploid	  basidiospores	   by	   budding	   on	   four	   characteristic	   chains.	   Cryptococcus	   can	   also	  respond	   to	   nutrient	   limitation	   by	   monokaryotic	   fruiting.	   Diploid	   monokaryotic	  hyphae	  result	  from	  endoduplication	  or	  cell	  and	  nuclear	  fusion	  of	  yeast	  cells	  of	  the	  same	   mating	   type.	   Meiosis	   occurs	   during	   basidium	   development,	   haploid	  basidiospores	   are	   produced	   shortly	   afterwards.	   Mature	   basidiospores	   are	  dispersed	   in	   the	   environment	   and	   germinate	   to	   haploid	   yeast	   cells	   (Figure	   3)	  (Idnurm	  et	  al.,	  2005,	  Hull	  et	  al.,	  2002).	  	  	  	  
Chapter	  1:	  Introduction	  
	   8	  
	  
Figure	  3:	  Schematic	  life	  cycle	  of	  Cryptococcus	  neoformans.	  Nutrient	  limitation	  can	  lead	  to	   mating	   and	   monokaryotic	   fruiting.	   During	   sexual	   reproduction,	   opposite	   mating	  partners	   fuse	   to	  a	  dikaryotic	   filament.	  After	   formation	  of	  a	  basidium,	  nuclear	   fusion	  and	  meiosis/mitosis	   occur	   eventually	   resulting	   in	   production	   of	   basidiospores	   by	   budding.	  During	  monokaryotic	   fruiting,	   yeast	   cells	   of	   one	  mating	   type	   form	  monokaryotic	  diploid	  hyphae	  that	  develop	  into	  basidia	  and	  sporulate	  following	  meiosis	  and	  mitosis.	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1.1.1.3	   THE	  CRYPTOCOCCUS	  GENOME	  SEQUENCING	  PROJECT	  To	   date,	   seven	   cryptococcal	   genomes	   have	   been	   sequenced:	   C.	   neoformans	  serotype	  A	   strain	  H99;	  C.	   neoformans	   serotype	  D	   strains	   JEC21	   and	  B3501A	  and	  
C.	  gattii	   serotype	   B	   strains	   R265,	   CBS7750,	   WM276	   and	   R272	   (genome	  information	   summarized	   in	   table	   1).	   The	   JEC21	   genome	   project	   yielded	  19	  megabases	  (Mb)	  of	  sequence	  information	  organized	  in	  14	  chromosomes	  that	  is	  predicted	   to	   encode	   6,572	   protein-­‐like	   genes	   rich	   in	   alternatively	   spliced	   and	  antisense	  messages.	  Genes	  have	  on	  average	  6.3	  exons	  of	  255	  base	  pairs	  (bp)	  and	  5.3	   introns	  of	  67	  bp	  length;	  the	  average	  transcript	   is	  1.9	  kilo	  bases	  (kb)	   long	  and	  contains	  15	  %	  noncoding	  sequence	  (Loftus	  et	  al.,	  2005).	  Furthermore,	  the	  genome	  data	  indicates	  karyotype	  instability	  and	  phenotypic	  variation	  due	  to	  its	  richness	  in	  repetitive	   elements;	   5	   %	   of	   the	   JEC21	   genome	   has	   been	   identified	   to	   be	  transposons	  that	  cluster	  in	  centromere-­‐like	  regions	  (Loftus	  et	  al.,	  2005).	  	  The	   availability	   of	   sequence	   data	   within	   the	   genus	   Cryptococcus	   enables	  comparative	   genome	   studies	   and	  microarray	   studies	   to	   explore	   virulence	   genes	  and	   understand	   the	   molecular	   basis	   of	   pathogenicity	   mechanisms	   during	  cryptococcal	   disease	   (Fan	   et	   al.,	   2005,	   Kraus	   et	   al.,	   2004,	   Ma	   et	   al.,	   2009a).	  Alternative	  splicing	  and	  antisense	  mechanisms	  have	  been	  identified	  for	  277	  and	  53	  genes,	   respectively,	   indicating	   both	   being	   widespread	   and	   regulatory	   in	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1.1.2	   CRYPTOCOCCOSIS	  Cryptococcal	  infection	  can	  be	  asymptomatic,	  chronic	  or	  acute.	  Typically,	  an	  initial	  pulmonary	  infection	  can	  spread	  systemically,	  with	  a	  particular	  predilection	  for	  the	  central	   nervous	   system	   (CNS).	   Pulmonary	   infections	   are	   in	   most	   cases	  asymptomatic.	   However,	   they	   can	   involve	   coughing,	   pleuritic	   chest	   pain,	   fever,	  dyspnoea,	   weight	   loss	   and	   malaise.	   Pneumonia	   and	   acute	   respiratory	   distress	  syndrome	  have	  mainly	  been	  reported	  for	  immunocompromised	  patients	  (Nadrous	  
et	   al.,	   2003,	   Campbell,	   1966).	   Cryptococcosis	   of	   the	   CNS	   is	   life	   threatening	   and	  presents	  as	  meningitis	  or	  meningo-­‐encephalitis	  with	  symptoms	  such	  as	  headache,	  increased	   intracranial	   pressure,	   fever,	   lethargy,	   coma,	   personality	   changes	   and	  memory	   loss.	   Less	   common	   are	   secondary	   infections	   of	   the	   skin,	   lungs,	   prostate	  and	  the	  eye	  (Mitchell	  et	  al.,	  1995).	  A	  recent	  publication	  estimated	  957,900	  cases	  of	  cryptococcal	  meningitis	  resulting	  in	  624,700	  deaths	  globally	  each	  year	  (Park	  et	  al.,	  2009).	  Cryptococcosis	   is	   an	   important	   cause	  of	  death	   in	  HIV	   infected	   individuals	  with	   an	   incidence	   of	   15	  %	   and	   a	   mortality	   of	   30-­‐60	   %.	   The	   mortality	   rate	   in	  transplant	   patients	   is	   even	   higher	   at	   20-­‐100	  %	   (Centre	   for	   Disease	   Control	   and	  Prevention)(Mitchell	  et	  al.,	  1995).	  	  Initial	  infection	  with	  Cryptococcus	  occurs	  via	  inhalation	  of	  airborne	  propagules	  and	  subsequent	   colonization	   of	   the	   respiratory	   tract	   (Casadevall	   et	   al.,	   1998).	   It	   is	  believed	  that	  yeast	  cells	  with	  a	  diameter	  of	  4-­‐10	  µm	  and	  additional	  polysaccharide	  capsule	  are	  too	  big	  to	  be	  the	  infectious	  particle.	  Instead,	  small	  basidiospores	  (1-­‐2	  
µm),	   produced	  during	  mating	   or	  monokaryotic	   fruiting,	   or	   desiccated	   yeast	   cells	  are	  rather	  thought	  to	  be	  the	  infectious	  propagule	  (Ellis	  et	  al.,	  1990a,	  Velagapudi	  et	  
al.,	   2009).	   In	   mouse	   and	   rat	   model	   systems,	   C.	   neoformans	   is	   internalized	   by	  alveolar	  macrophages	  shortly	  after	  inhalation	  (Diamond	  et	  al.,	  1973a,	  Bulmer	  et	  al.,	  1975,	  Goldman	  et	  al.,	  2000,	  Feldmesser	  et	  al.,	  2000,	  Swenson	  et	  al.,	  1978,	  Mitchell	  
et	  al.,	  1972).	  RFLP	  analyses	  suggests	  that	  initial	  infection	  with	  C.	  neoformans	  often	  occurs	  in	  early	  childhood	  and	  can	  be	  followed	  by	  a	  long	  latent	  phase,	  most	  likely	  in	  macrophages,	   in	   immunocompetent	   individuals	   (Garcia-­‐Hermoso	   et	  al.,	   1999).	   In	  this	   context,	   two	   recent	   publications	   suggest	   a	   specific	   giant	   cell	   form	   of	  
Cryptococcus	  as	  the	  dormant	  form	  within	  the	  human	  body	  (Okagaki	  et	  al.,	  Zaragoza	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Figure	   4:	   Schematic	   pathogenesis	   of	   cryptococcal	   disease.	   Infection	   is	   believed	   to	  occur	   by	   inhalation	   of	   basidiospores	   establishing	   a	   primary	   infection	   in	   the	   lungs.	  
Cryptococcus	  cells	   are	   taken	  up	  by	   alveolar	  macrophages	   and	   can	  either	   go	   into	   a	   latent	  phase,	  likely	  within	  macrophages,	  but	  can	  also	  be	  reactivated	  and	  disseminate	  within	  the	  human	  body,	  in	  particular	  to	  the	  central	  nervous	  system	  but	  also	  to	  other	  organs	  such	  as	  the	  skin,	  kidneys,	  liver	  or	  bones.	  	  	  	  	  	  	  	  	   Images	  were	  taken	  and	  modified	  from:	  http://naturescrusaders.files.wordpress.com/2008/11/eucalyptus_tree_2_220.jpg	  http://naturescrusaders.files.wordpress.com/2008/11/eucalyptus_tree_2_220.jpg	  http://www.depiazzi.com.au/images/soil_mixes/soil_mixes_big/lawn_mix.jpg	  http://www.aurorahealthcare.org/healthgate/images/lung_aspiration.jpg	  http://fc03.deviantart.net/fs48/f/2009/196/2/3/Centrinova_Human_Body_System_by_Pegahoul.jpg	  http://www.hivandhepatitis.com/0_images_2008/kidney2.jpg	  http://www.nlm.nih.gov.ezproxyd.bham.ac.uk/medlineplus/ency/images/ency/fullsize/9734.jpg	  http://www.epidemic.org/theFacts/essentials/images/liverDiagram1.jpg	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1.1.2.1	   ANTICRYPTOCOCCAL	  THERAPY	  Cryptococcal	  meningitis	  is	  uniformly	  fatal	  without	  clinical	  intervention	  (Mwaba	  et	  
al.,	   2001).	   Standard	   therapy	   consists	   of	   amphotericin	   B,	   flucytosine	   and	  fluconazole.	   Amphotericin	   B	   and	   the	   triazole	   fluconazole	   both	   target	   the	   fungal	  membrane	  and	  disturb	  membrane	  integrity.	  The	  former	  associates	  with	  ergosterol,	  an	   essential	   component	   of	   the	   fungal	   plasma	  membrane,	   leading	   to	   formation	  of	  pores	  and	  increased	  permeability	  for	  protons	  and	  cations	  (Brajtburg	  et	  al.,	  1990).	  The	   latter	   inhibits	   the	   cytochrome	   P450	   enzyme	   14α-­‐demethylase	   and	   thus	   the	  conversion	   of	   lanosterol	   to	   ergosterol	   during	  membrane	   synthesis	   (Pasko	   et	   al.,	  1990).	   Flucytosine,	   after	   conversion	   to	   5-­‐fluorouracil,	   functions	   as	   pyrimidine	  antagonist	  inhibiting	  RNA	  biosynthesis	  (Reviewed	  in	  Vermes	  et	  al.,	  2000).	  Treatment	   regimes,	   however,	   are	   dependent	   on	   the	   patient	   cohort	   and	  comprehensive	   guidelines	   have	   been	   published	   recently	   in	   Perfect	   et	   al.	   2010	  (Perfect	   et	   al.,	   2010).	   For	   HIV-­‐infected	   individuals	   with	   cryptococcal	  meningoencephalitis	   it	   is	  recommended	  to	  initiate	  therapy	  with	  a	  combination	  of	  0.7-­‐1.0	  mg/kg	  of	  Amphotericin	  B	  per	  day	  intravenously	  and	  100	  mg/kg	  flucytosine	  per	  day	  orally	   for	  a	  minimum	  of	   two	  weeks,	   followed	  by	  400	  mg	   fluconazole	  per	  day	   orally	   for	   at	   least	   eight	   weeks	   (Perfect	   et	   al.,	   2010).	   The	   length	   of	   primary	  therapy	  with	   amphotericin	   B	   and	   flucytosine	   is	   suggested	   to	   be	   prolonged	   to	   at	  least	  four	  to	  six	  weeks	  in	  non-­‐HIV/non-­‐transplant	  patients	  (Perfect	  et	  al.,	  2010).	  	  To	   date,	   treatment	   of	   cryptococcosis	   remains	   a	   challenge.	   Even	  with	   immediate	  treatment,	  patients	  show	  high	  mortality	  rates	  and	  therapy	  is	  associated	  with	  toxic	  side	   effects	   and	   low	   cost-­‐effiency	   (Centre	   for	   Disease	   Control	   and	   Prevention).	  Especially	   in	   developing	   countries,	   amphotericin	   B,	   the	   most	   effective	  anticryptococcal	   medication,	   is	   too	   expensive	   and	   requires	   intravenous	  administration.	   Hence,	   treatment	   is	   focused	   on	   the	   cheaper	   and	   orally	   taken	  antifungal	   fluconazole	  (Jarvis	  et	  al.,	  2007)	  which	   is	  better	  suited	  for	  maintenance	  therapy	   but	   less	   effective	   for	   initial	   treatment	   (Powderly,	   1992,	   Bozzette	   et	   al.,	  1991).	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Although	   antifungal	   resistance	   does	   not	   seem	   to	   be	   a	   clinical	   problem	   currently	  (Witt	   et	   al.,	   1996,	   Aller	   et	   al.,	   2000),	   there	   have	   been	   recent	   concerns	   about	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1.2	   CRYPTOCOCCAL	   INTERACTIONS	   WITH	   THE	   HOST	   IMMUNE	  
SYSTEM	  
	  The	   dramatic	   course	   of	   Cryptococcus	   infections	   in	   immunocompromised	  individuals	  shows	  the	  importance	  of	  an	  intact	   immune	  response	  to	  the	  pathogen.	  This	  section	  will	  consider	  both	  the	  host’s	  innate	  and	  adaptive	  immune	  response	  to	  
C.	  neoformans	  and	  C.	  gattii	  together	  with	  how	  current	  knowledge	  might	  be	  applied	  in	  improving	  anticryptococcal	  therapy.	  	  	  	  
1.2.1	   THE	  INNATE	  IMMUNE	  RESPONSE	  TO	  CRYPTOCOCCUS	  	  A	   variety	   of	   innate	   factors	   interfere	   with	   the	   establishment	   of	   cryptococcal	  infection.	   Beside	   physical	   barriers	   such	   as	   the	   skin	   and	   the	   nasal	   mucosa,	   the	  anticryptococcal	  activity	  of	  human	  serum	  and	  saliva	  has	  been	  described	  repeatedly	  (Szilagyi	  et	  al.,	  1966,	  Nassar	  et	  al.,	  1995,	  Igel	  et	  al.,	  1966,	  Hendry	  et	  al.,	  1969,	  Baum	  
et	   al.,	   1961a,	   Baum	   et	   al.,	   1961b,	   Baum	   et	   al.,	   1963).	   However,	   the	   complement	  system	  and	  phagocytic	  effector	  cells	  are	  the	  major	  players	  in	  the	  non-­‐specific	  host	  immune	  response	  to	  Cryptococcus.	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1.2.1.1	   THE	  COMPLEMENT	  RESPONSE	  TO	  CRYPTOCOCCUS	  	  The	  complement	  system	  is	  an	  anti-­‐pathogen	  cascade	  of	  serum	  proteins	  that	  can	  be	  activated	   by	   the	   classical	   (antibody	   mediated),	   lectin	   or	   alternative	   (microbial	  surface	  mediated)	  pathway.	  All	  pathways	  eventually	  converge	  in	  the	  formation	  of	  the	   C3-­‐convertase	   and	   cleavage	   of	   C3	   into	   C3a	   and	   C3b.	   C3b	   either	   facilitates	  pathogen	   opsonization	   and	   thus	   enhances	   uptake	   by	   phagocytic	   cells	   or	   enables	  cleavage	  of	  C5	  into	  C5a	  and	  C5b.	  C5a	  functions,	  together	  with	  C3a,	  as	  a	  mediator	  of	  inflammatory	   responses	   and	   attracts	   phagocytic	   effector	   cells,	   whereas	   C5b	  initiates	   the	   formation	   of	   the	   membrane	   attack	   complex	   (C5b,	   C6,	   C7,	   C8,	   C9)	  (Janeway	  et	  al.,	  2001).	  	  Observations	   from	   animal	   model	   systems	   and	   human	   patients	   have	   repeatedly	  shown	   the	   importance	   of	   complement	   system	   during	   cryptococcal	   infections	  (Figure	   5).	   The	   survival	   time	   of	   C.	   neoformans-­‐infected	   guinea	   pigs	   and	   mice	  treated	  with	   cobra	   venom	   to	  deplete	   late	   complement	   components	   (C3	   to	  C9)	   is	  shortened	   and	   the	   ability	   to	   clear	  C.	   neoformans	   from	   extraneural	   sites	   reduced	  (Diamond	  et	  al.,	  1973b).	  Mice	  deficient	  in	  C5	  are	  more	  susceptible	  to	  intravenously	  injected	  C.	  neoformans	  and	  succumb	  three	  times	  quicker	  than	  C5	  positive	  mice	  due	  to	   acute	   and	   fatal	   pneumonia	   (Rhodes,	   1985,	   Rhodes	   et	   al.,	   1980).	   Furthermore,	  patients	   presenting	  with	   cryptococcal	   fungaemia	   show	   reduced	   levels	   of	   C3	   and	  alternative	   complement	   factor	   B	   (Macher	   et	   al.,	   1978)	   and	   brain	   sections	   from	  patients	   with	   cryptococcal	   meningitis	   do	   not	   show	   C3	   binding	   to	   the	   yeast	  (Truelsen	   et	   al.,	   1992).	   In	   contrast,	   however,	   C4-­‐deficient	   guinea	   pigs	   are	   not	  altered	  in	  their	  survival	  time	  after	  infection	  with	  C.	  neoformans,	  indicating	  that	  the	  alternative	   activation	   pathway	   is	   the	   major	   protective	   complement	   pathway	  during	  infections	  with	  C.	  neoformans	  (Diamond	  et	  al.,	  1973b).	  	  This	   finding	   is	   supported	   by	   results	   from	   in	   vitro	   analysis	   of	   the	   complement	  binding	  dynamics	  of	  C.	  neoformans.	  Diamond	  et	  al.	  (Diamond	  et	  al.,	  1974)	  reported	  the	   consumption	   of	   complement	   components	   by	   C.	   neoformans	  when	   incubated	  with	   normal	   or	   C4-­‐deficient	   guinea	   pig	   serum,	   whilst	   C.	   neoformans	   dependent	  activation	   of	   the	   complement	   cascade	   can	   be	   reconstituted	   from	   six	   proteins	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(factor	  D,	  factor	  B,	  factor	  H,	  factor	  I,	  C3	  and	  properdin)	  belonging	  to	  the	  alternative	  pathway	   (Kozel	   et	   al.,	   1989).	   It	  was	   estimated	   that	   approximately	   107	   to	   108	   C3	  fragments	  bind	  to	  an	  encapsulated	  cryptococcal	  cell	  and,	  dependent	  on	  the	  source	  of	   serum,	   localize	   inside	  and	  at	   the	  outer	  edge	  of	   the	   capsule	   (Gates	   et	  al.,	   2006,	  Zaragoza	   et	   al.,	   2003,	   Kozel	   et	   al.,	   1988,	   Kozel,	   1993a).	   The	   binding	   of	   C3	   starts	  characteristically	   with	   a	   lag	   phase	   of	   four	   to	   six	   minutes	   followed	   by	   rapid	  accumulation	   of	   C3	   fragments	   to	   the	   encapsulated	   yeast	   cell	   when	   incubated	   in	  normal	   human	   serum	   (Kozel	   et	   al.,	   1991).	   Incubation	   with	   Mg-­‐EGTA	   to	   chelate	  calcium	   that	   is	   required	   for	   classical	   pathway	   activation	   did	   not	   change	   the	   C3	  binding	   dynamics	   supporting	   the	   dominant	   role	   of	   the	   alternative	   complement	  pathway	  during	  cryptococcosis	  (Kozel	  et	  al.,	  1991).	  According	  to	  the	  complement	  model,	   the	   activation	   of	   the	   alternative	   pathway	   relies	   on	   spontaneous	  decomposition	   of	   C3	   to	   C3b	   and	   Bb	   upon	   pathogen	   interaction.	   Similarly,	   closer	  examination	  of	  the	  binding	  process	  of	  C3	  to	  the	  yeast	  cell	  by	  immunofluorescence	  revealed	   an	   initial	   slow	   C3	   deposition	   in	   small	   loci	   with	   following	   expansion	   to	  larger	  areas	  after	  a	  lag	  (Kozel	  et	  al.,	  1991).	  Investigation	  into	  the	  molecular	  form	  of	  bound	   C3	   by	   SDS-­‐page	   of	   eluted	   radioactive	   labeled	   fragments	   revealed	   a	   rapid	  decay	  of	  the	  C3	  hydrolysis	  product	  C3b	  into	  the	  inactive	  form	  iC3b,	  which	  in	  turn,	  is	   the	   dominant	   fragment	   bound	   to	   the	   cryptococcal	   capsule	   (Kozel	   et	   al.,	   1986,	  Pfrommer	  et	  al.,	  1993).	  	  The	   two	  major	   functions	  of	   the	  complement	  system	  during	  cryptococcosis	  are	   to	  stimulate	   the	   chemotaxis	   of	   phagocytic	   effector	   cells	   and	   enhance	   the	   uptake	   of	  cryptococcal	   cells	   by	   these	   phagocytes.	   Early	   evidence	   for	   the	   involvement	   of	  complement	  in	  opsonization	  of	  C.	  neoformans	  was	  drawn	  from	  phagocytosis	  assays	  with	  heat-­‐inactivated	  serum	  (Diamond	   et	  al.,	  1972).	  Assays	  with	  phagocytic	   cells	  and	  serum,	  depleted	  in	  specific	  components	  of	  the	  complement	  pathways,	  revealed	  the	   requirement	   of	   the	   complement	   pathway	   for	   phagocytosis	   of	   cryptococci	   by	  neutrophils	  (Diamond	  et	  al.,	  1974),	  polymorphonuclear	  leukocytes	  and	  monocytes	  in	   an	   antibody	   free	   situation	   (Davies	   et	   al.,	   1982).	   However,	   although	   the	  alternative	   pathway	   is	   sufficient	   for	   yeast	   opsonization,	   the	   classical	   pathway	   is	  required	  for	  optimal	  opsonization	  kinetics	  (Diamond	  et	  al.,	  1974).	  Laxalt	  and	  Kozel	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(1979)	  and	  Diamond	  and	  Erickson	   (1982)	  observed	   the	   chemotactic	  potential	  of	  serum;	   serum-­‐opsonized	   encapsulated	   or	   non-­‐encapsulated	   C.	   neoformans	   are	  both	  able	  to	  chemotactically	  attract	  neutrophils	  and	  monocytes	   in	  vitro	   (Laxalt	  et	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Figure	   5:	   Summary	   of	   the	   complement	   pathways	   activated	   upon	   infection	   with	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The	   cryptococcal	   polysaccharide	   capsule	   is	   a	  well-­‐known	   factor	   required	   for	   the	  pathogen’s	  virulence,	  e.g.	  by	  inhibiting	  phagocytosis	  (reviewed	  in	  (Zaragoza	  et	  al.,	  2009)).	  C.	  neoformans	  mutants	  with	  a	  capsule-­‐deficient	  phenotype	  are	  avirulent	  in	  mice	   (Chang	   et	   al.,	   1994,	   Kwon-­‐Chung	   et	   al.,	   1986).	   Several	   studies	   with	  encapsulated	  and	  nonencapsulated	  C.	  neoformans	  strains	  also	  showed	  a	  difference	  in	   complement	   activation	   dependent	   on	   capsulation.	   The	   capsule	   inhibits	   the	  binding	   of	   mannan	   binding	   lectin	   and	   thus	   the	   activation	   of	   the	   complement	  system	  via	  the	  lectin	  pathway	  in	  C.	  neoformans	  (Panepinto	  et	  al.,	  2007).	  The	  total	  number	   of	   bound	   C3	   molecules	   is	   similar	   in	   different	   cryptococcal	   strains	  independent	  of	  the	  capsule	  size	  (Kozel	  et	  al.,	  1988).	  However,	  a	  comparison	  of	  the	  deposition	   of	   C3	   on	   the	  C.	   neoformans	   strain	   145	   grown	  under	   capsule	   inducing	  and	   non-­‐capsule	   inducing	   conditions	   indicates	   a	   relationship	   between	   capsule	  diameter	  and	  C3	  density	  under	  high	  yeast	   cell	   concentrations.	  The	   small	   capsule	  variant	  bound	  more	  C3	  molecules	  per	  µm3	  capsule	  than	  the	  population	  with	  a	  large	  capsule	  (Kozel	  et	  al.,	  1996).	   In	  contrast,	   the	  non-­‐capsular	  strain	  602	  accumulates	  significantly	   less	   C3	   on	   the	   cellular	   surface	   than	   capsulated	   strains	   (Kozel	   et	   al.,	  1991,	  Kozel,	  1993a,	  Kozel	   et	  al.,	  1992).	  The	  decay	  rate	  of	  C3b	  to	   iC3b	   is	   lower	   in	  nonencapsulated	   C.	   neoformans	   than	   in	   capsulated	   forms	   (70	   %	   versus	   100	   %	  respectively,	  after	  20	  minutes	  incubation	  with	  Factor	  H	  and	  I)	  (Kozel	  et	  al.,	  1986,	  Pfrommer	   et	  al.,	   1993).	  Furthermore,	   the	  acapsular	   strain	  602	  activates	  not	  only	  the	  alternative	  but	  also	  the	  classical	  complement	  pathway	  (Kozel	  et	  al.,	  1991).	  C3	  binding	   to	   the	   acapsular	   strain	   occurs	   immediately	   without	   any	   lag	   phase	   and	  rather	   than	   the	   characteristic	   small	   C3	   deposition	   sites	   in	   encapsulated	   strains,	  sudden	   and	   rapid	   binding	   of	   C3	   to	   the	   entire	   cell	   surface	   can	   be	   observed.	   This	  accumulation	   is	   ongoing	   and	   does	   not	   stop	   after	   eight	   minutes	   as	   seen	   in	  encapsulated	  C.	  neoformans.	  However,	  the	  dynamics	  described	  for	  capsular	  strains	  can	  be	  re-­‐induced	  by	   treatment	  with	  Mg-­‐EGTA	  (Kozel	   et	  al.,	  1991).	   Interestingly,	  there	   seems	   to	   be	   a	   species-­‐specific	   difference	   in	   activation	   of	   the	   complement	  system.	  Although	  the	  binding	  efficiency	  of	  C3	  to	  C.	  gattii	  serotype	  B	  and	  C	  strains	  is	  higher	   than	   C.	   neoformans	   serotype	   A	   and	   D	   strains	   (Sahu	   et	   al.,	   1994),	   total	  accumulation	  is	  only	  half	  of	  the	  latter	  (Washburn	  et	  al.,	  1991,	  Young	  et	  al.,	  1993).	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The	   complement	   system	   is	   the	   first	   line	   of	   defense	   against	   Cryptococcus	   in	   the	  bloodstream	  and,	  by	  opsonising	  the	  pathogen	  and	  attracting	  immune	  effector	  cells,	  performs	   important	  preparations	   for	   the	   subsequent	  host	  defense	   response.	  The	  capsule	  probably	  functions	  as	  an	  inhibitor	  of	  complement	  related	  host	  responses,	  such	   as	   uptake	   by	   phagocytosis,	   by	   inhibiting	   the	   classical	   pathway	   and	  constriction	  of	  C3-­‐convertase	  activity	  by	  efficient	  removal	  of	  C3b	  (in	  form	  of	  iC3b),	  an	   essential	   part	   of	   the	   alternative	   C3-­‐convertase,	   thus	   limiting	   activity	  amplification.	  Differences	  in	  complement	  activation	  between	  C.	  neoformans	  and	  C.	  
gattii	  might	  be	  important	  for	  the	  increased	  virulence	  of	  certain	  serotype	  B	  strains.	  In	  addition,	  recent	  data	  from	  Factor	  B-­‐	  or	  C3-­‐deficient	  mice	  survival	  assays	  after	  C.	  
gattii	   infection	   have	   suggested	   that	   complement	   pathways	   other	   than	   the	  alternative	  activation	  pathway	  contribute	  to	  the	  host’s	  protection	  (Mershon	  et	  al.,	  2009).	  	  
1.2.1.2	   PHAGOCYTIC	  EFFECTOR	  CELLS	  IN	  THE	  HOST	  IMMUNE	  RESPONSE	  TO	  
CRYPTOCOCCUS	  	  Research	   over	   the	   last	   few	   decades	   has	   shown	   the	   importance	   of	   phagocytic	  effector	   cells	   during	   the	  host’s	   immune	   response	   to	   cryptococcal	   infections.	   This	  section	  will	  describe	  how	  the	  yeast	  cells	  are	  taken	  up	  and	  discuss	  the	  interaction	  with	  the	  different	  types	  of	  phagocytes.	  	  	  1.2.1.2.1	   PHAGOCYTOSIS	  Uptake	  of	  cryptococcal	  cells	  has	  been	  shown	  repeatedly	  by	  a	  variety	  of	  leukocytes	  (Bulmer	   et	  al.,	  1967)	  such	  as	  rat	  and	  mouse	  peritoneal	  macrophages	  (Mitchell	   et	  
al.,	   1972,	   Griffin,	   1981,	   Kozel	   et	   al.,	   1981),	   guinea	   pig	   pulmonary	   macrophages	  (Bulmer	  et	  al.,	  1975),	  human	  neutrophils	  and	  macrophages	  (Dong	  et	  al.,	  1997)	  and	  swine	   microglia	   (Lipovsky	   et	   al.,	   1997).	   Phagocytosis	   is	   triggered	   by	   direct	  recognition	   of	   the	   yeast	   or	   by	   receptor-­‐mediated	   recognition	   via	   complement	   or	  antibodies	  (Mitchell	  et	  al.,	  1995).	  Conserved	  structures	  such	  as	  the	  components	  of	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the	   cryptococcal	   capsule	   can	   be	   directly	   recognized	   by	   pattern	   recognition	  receptors.	   C.	   neoformans	   glucuronoxylomannan	   (GXM)	   can	   bind	   to	   Toll-­‐like	  receptor	  4	  (Shoham	  et	  al.,	  2001),	  the	  mannose	  receptor	  of	  dendritic	  cells	  binds	  to	  mannoproteins	  expressed	  on	  the	  yeast’s	  surface	  (Pietrella	  et	  al.,	  2005)	  and	  in	  the	  absence	  of	  complement	  to	  CD18,	  a	  subunit	  of	  the	  complement	  receptors	  (Dong	  et	  
al.,	   1997).	   Serum	   opsonized	   (i3Cb)	   C.	   neoformans	   are	   recognized	   either	   by	   the	  complement	   receptor	   CR1	   (CD35)	   or	   by	   the	   heteromeric	   β2-­‐integrins	   CR3	  (CD11b/CD18)	  and	  CR4	  (CD11c/CD35)	  (Levitz	  et	  al.,	  1991,	  Zaragoza	  et	  al.,	  2003).	  Studies	   with	   the	   receptors	   heterologously	   expressed	   in	   Chinese	   hamster	   ovary	  cells	   indicate	  that	  binding	  occurs	   independently	   to	  any	  of	   the	  receptors,	  with	  the	  greatest	  binding	  avidity	  being	  shown	  to	  CR3	   followed	  by	  CR1	  and	  CR4	  (Levitz	   et	  
al.,	   1997b).	   Antibody-­‐opsonized	   yeast	   cells	   are	   recognized	   by	   Fcγ	   receptor	  molecules	   expressed	   on	   the	   surface	   of	   macrophages,	   neutrophils	   and	   dendritic	  cells	  (Griffin,	  1981,	  Luo	  et	  al.,	  2006,	  Monari	  et	  al.,	  1999,	  Syme	  et	  al.,	  2002).	  	  	  1.2.1.2.2	   DENDRITIC	  CELLS	  (DCS)	  
Cryptococcus	  neoformans	  is	  phagocytosed	  by	  human	  primary	  dendritic	  cells	  in	  vitro	  (Syme	  et	  al.,	  2002,	  Kelly	  et	  al.,	  2005)	  and	  also	  in	  the	  mouse	  model	  (Wozniak	  et	  al.,	  2006).	   Dendritic	   cells	   function	   as	  major	   antigen	   presenting	   cells	   that	   constantly	  monitor	  the	  current	  antigen	  population	  and	  modulate	  adaptive	  immune	  responses	  accordingly	  (Crowley	  et	  al.,	  1990).	  During	  cryptococcal	  infections	  DCs	  are	  thought	  to	  be	  the	  major	  initiators	  of	  protective	  cell-­‐mediated	  immunity	  (CMI)	  (Bauman	  et	  
al.,	   2000,	   Osterholzer	   et	   al.,	   2009a).	   Not	   only	   are	   major	   antigens	   (e.g.	  mannoproteins	   and	   glycoantigens)	   for	   the	   activation	   of	   anticryptococcal	   T-­‐cell	  responses	  dominantly	  presented	  by	  DCs	  (Mansour	  et	  al.,	  2006,	  Levitz	  et	  al.,	  2006)	  but	   the	   induction	  of	  T-­‐cell	   responses	  by	  DCs	   is	  also	  much	  more	  efficient	   than	  by	  alveolar	  or	  peritoneal	  macrophages	  (Mansour	  et	  al.,	  2006,	  Syme	  et	  al.,	  2002).	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1.2.1.2.3	   NEUTROPHILS	  Neutrophils	  are	  thought	  to	  contribute	  strongly	  to	  the	  innate	  immune	  response	  to	  cryptococcosis.	   Upon	   cryptococcal	   challenge,	   the	   number	   of	   polymorphonuclear	  cells	   increases	   at	   the	   site	   of	   infection	   in	   animal	  models	   (Gadebusch	   et	   al.,	   1966,	  Perfect	  et	  al.,	  1980).	  In	  vitro,	  the	  oxidative	  burst	  exerted	  by	  neutrophils	  effectively	  kills	   C.	   neoformans	   (Chaturvedi	   et	   al.,	   1996,	   Mambula	   et	   al.,	   2000,	   Miller	   et	   al.,	  1991).	  However,	  despite	  rapid	  antimicrobial	  activity	   in	  vivo,	   cryptococci	  are	  only	  partially	  cleared	  from	  the	  infected	  site	  (Perfect	  et	  al.,	  1980,	  Gadebusch	  et	  al.,	  1966).	  Interestingly,	   induced	   neutropenia	   in	   mice	   increases	   survival	   after	   pulmonary	  challenge	   with	   C.	   neoformans	   (Mednick	   et	   al.,	   2003),	   a	   counter-­‐intuitive	   finding	  that	  may	  be	  due	  to	  the	  absence	  of	  neutrophils	  resulting	  in	  more	  interleukin	  (IL)-­‐4	  and	  IL-­‐10	  signaling	  which,	   in	  turn,	  modifies	  the	   inflammatory	  status	  and	  reduces	  tissue	   damage	   due	   to	   the	   aggressive	   oxidative	   burst	   (Mednick	   et	   al.,	   2003).	  Together	  with	  data	  showing	  neutrophils	  being	  present	   in	   infected	  tissues	  only	   in	  low	  numbers	  and	  at	  early	  stages	  of	   infection	  (Feldmesser	  et	  al.,	  2000)	  this	  might	  suggest	  a	  more	  immune-­‐regulatory	  than	  antimicrobial	  role	  of	  neutrophils.	  	  Besides	   killing	   of	   pathogens	   by	   means	   of	   respiratory	   burst,	   neutrophils	   also	  produce	  antimicrobial	  peptides	  and	  proteins	  as	  part	  of	  the	  antimicrobial	  response	  (Lehrer	  et	  al.,	  1990).	  	  One	  such	  family	  of	  antimicrobial	  peptides	  –	  the	  defensins	  –	  is	  found	   in	   abundance	   in	   human,	   rat,	   rabbit	   and	   guinea	   pig	   neutrophils,	   however,	  expression	   is	   lacking	   in	  mouse	  neutrophils	   (Eisenhauer	   et	  al.,	  1992).	  As	  mice	  are	  routinely	  used	  as	   system	   to	  model	   cryptococcal	  disease,	   this	   finding	  needs	   to	  be	  considered	  when	  assessing	  the	  role	  of	  neutrophils	  in	  the	  anticryptococcal	  immune	  defence.	  The	  lack	  of	  defensins	  might	  also	  be	  a	  reason	  for	  high	  susceptibly	  of	  mice	  towards	  challenge	  with	  the	  yeast.	  	  	  	  
Chapter	  1:	  Introduction	  
	   25	  
1.2.1.2.4	   MACROPHAGES	  The	   importance	  of	  macrophages	   in	  cryptococcal	   infections	  has	  become	  more	  and	  more	  obvious	   in	   the	   last	  decade.	  Research	  has	   revealed	  an	   intriguing	   interaction	  between	  the	  phagocytic	  effectors	  and	  yeast	  cells	  that	  revealed	  C.	  neoformans	  as	  an	  intracellular	   parasite	   (Figure	   6)	   (Feldmesser	   et	   al.,	   2001b).	   After	   phagocytosis,	  
Cryptococcus	  might	  be	  killed	  by	  but	  can	  also	  survive	  within	  the	  host	  cell.	  This	  can	  result	   in	   either	   a	   latent	   state	   or	   yeast	   proliferation	   within	   macrophages.	  Eventually,	   the	  host	  cell	   is	  exited	  by	   lysis	  or	  a	  non-­‐lytic	  escape	  mechanism	  called	  expulsion	  to	  colonise	  different	  tissues.	  Furthermore,	   lateral	  transfer	  of	  yeast	  cells	  from	  one	  macrophage	  to	  another	  has	  been	  described	  (Ma	  et	  al.,	  2007,	  Alvarez	  et	  al.,	  2007,	  Del	  Poeta,	  2004,	  Feldmesser	  et	  al.,	  2000,	  Feldmesser	  et	  al.,	  2001b,	  Tucker	  et	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Figure	   6:	   Schematic	   interaction	   between	  macrophages	   and	   Cryptococcus.	   After	   the	  yeast	  is	  ingested	  by	  macrophages	  it	  can	  be	  killed	  (1),	  go	  into	  a	  latent	  state	  (2)	  or	  start	  to	  proliferate	  within	  the	  phagocytes	  (3).	  Escape	  from	  within	  macrophages	  can	  occur	  by	  host	  cell	   lysis	   or	   non-­‐lytic	   by	   expulsion	   (4)	   and	   result	   in	   colonization	   of	   other	   tissues.	  Furthermore,	   the	  yeast	  can	  be	  directly	   transferred	   from	  one	  macrophage	   to	  another	  (5).	  (Taken	  and	  modified	  from	  Ma	  and	  May	  2009	  (Ma	  et	  al.,	  2009b)).	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1.2.2	   THE	  ADAPTIVE	  IMMUNE	  RESPONSE	  TO	  CRYPTOCOCCUS	  	  The	   development	   of	   an	   adaptive	   immune	   response	   is	   essential	   to	   overcoming	  cryptococcal	   infection.	   This	   section	   will	   concentrate	   on	   the	   antibody	   and	   cell	  mediated	  immune	  response	  towards	  Cryptococcus.	  	  	  
1.2.2.1	   ANTIBODY	  MEDIATED	  IMMUNE	  RESPONSE	  TO	  CRYPTOCOCCUS	  	  With	   Cryptococcus	   being	   a	   facultative	   intracellular	   pathogen,	   there	   is	   some	  controversy	  about	  the	  importance	  of	  antibody-­‐mediated	  immune	  mechanisms	  for	  effective	  microbial	  clearance.	  Several	  cases	  of	  cryptococcosis	  have	  been	  reported	  in	   patients	   with	   primary	   or	   acquired	   B	   cell,	   antibody	   or	   lymphoproliferative	  deficiencies	  (Casadevall	  et	  al.,	  2005)	  and	  antibodies	  against	  cryptococcal	  proteins	  and	   capsular	   polysaccharides	   are	   routinely	   found	   in	   individuals	   without	   an	  apparent	   infection	   (Abadi	   et	   al.,	   1999,	   Fleuridor	   et	   al.,	   1999,	  Houpt	   et	   al.,	   1994),	  indicating	  either	  latent	  or	  asymptomatic	  cleared	  infections.	  Passive	  administration	  of	   capsule	   binding	   antibody	   prolongs	   survival	   and/or	   reduces	   fungal	   burdens	   in	  experimental	   cryptococcosis	   (Mukherjee	   et	   al.,	   1992,	   Fleuridor	   et	   al.,	   1998).	  Anticryptococcal	   antibodies	   elicit	   their	   protective	   function	   by	   opsonising	  pathogens	  for	  Fc-­‐receptor	  dependent	  phagocytosis	  and	  by	  activating	  the	  classical	  complement	   pathway.	   In	   addition,	   direct	   antibody	   opsonization	   of	   cryptococci	  leading	   to	   complement-­‐independent	   (but	   complement	   receptor-­‐dependent	   via	  CD18)	  uptake	  into	  macrophages	  has	  been	  described	  (Netski	  et	  al.,	  2002,	  Taborda	  
et	   al.,	   2002).	   The	   specificity	   of	   antibodies	   seems	   to	   be	   of	   great	   importance	   for	  protective	   efficacy.	   Generally,	   it	   is	   thought	   that	   the	   two	   domains	   of	   antibodies	  fulfill	  two	  different	  functions:	  the	  variable	  region	  is	  responsible	  for	  antigen	  binding	  and	  the	  constant	  region	  for	  the	  effector	  functions.	  In	  studies	  with	  C.	  neoformans	  it	  has	   been	   shown	   that	   this	   classical	   view	   might	   have	   to	   be	   rethought,	   since	  antibodies	   identical	   in	   their	  variable	  region	  but	  differing	   in	   their	  constant	  region	  show	  diverse	  binding	  affinity	  and	  specificity	  to	  a	  univalent	  peptide	  antigen	  (Torres	  
et	  al.,	  2007,	  Dam	  et	  al.,	  2008,	  Torres	  et	  al.,	  2008).	  In	  addition,	  antibody	  subgroups	  developed	   from	   the	   same	   B-­‐cell	   can	   be	   either	   protective	   or	   non-­‐protective	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according	  to	  their	  staining	  pattern	  (annular	  or	  punctuate).	  Although	  derived	  from	  the	   same	   B-­‐cell,	   the	   two	   subtypes	   recognize	   spatially	   distinct	   areas	   of	   the	  cryptococcal	   capsule	   and	   only	   a	   punctuate	   opsonization	   pattern	   can	   induce	   a	  protective	   immune	   response	   in	   mice	   (Mukherjee	   et	   al.,	   1995,	   Nussbaum	   et	   al.,	  1997).	   The	   preponderance	   of	   protective	   compared	   to	   non-­‐protective	   antibodies	  determines	   the	   efficacy	   of	   the	   antibody-­‐mediated	   response	   to	   C.	   neoformans	  infection.	   It	   appears	   that	   small	   differences	   in	   antibody	   epitope	   specificities	  may	  have	   a	   large	   impact	   on	   the	   protective	   effect	   afforded	   by	   anticryptococcal	  antibodies.	   Those	   that	   are	   protective	   show	   a	   punctuate	   distribution	   within	   the	  capsule	   and	   those	   with	   an	   annular	   pattern	   of	   capsular	   distribution	   are	   non-­‐protective	   (Mukherjee	   et	   al.,	   1995).	   Furthermore,	   enhancement	   of	   cryptococcal	  disease	   has	   been	   described	   due	   to	   excess	   antibodies	   triggering	   immune-­‐unresponsiveness	   (Savoy	   et	   al.,	   1997,	   Kozel	   et	   al.,	   1977).	   The	   concentration	   of	  antibody	   plays	   an	   important	   role	   for	   its	   protective	   functions.	   In	   mouse	   models,	  administration	  of	   antibody	   in	  higher	   concentrations	   can	  be	   less	   effective	   than	   in	  lower	  concentrations	  when	  subsequently	  challenged	  with	  C.	  neoformans.	  This	  so-­‐called	  prozone-­‐like	  activity	  suggests	  that	  antibodies	  during	  cryptococcosis	  can	  be	  protective,	   non-­‐protective	  or	   even	  disease	   enhancing	  depending	  on	   the	   antibody	  isotype	  and	  dose	  (Taborda	  et	  al.,	  2002,	  Taborda	  et	  al.,	  2001).	  Evidence	  from	  mouse	  models	  suggests	  that	  the	  protective	  effect	  of	  antibodies	  is	  at	  least	  partly	  due	   to	  an	   interaction	  with	  cell-­‐mediated	   immunity.	  Mice	  defective	   in	  CD4,	   IFN-­‐γ	   and	   Th1/Th2	   associated	   cytokines	   cannot	   be	   protected	   by	   passive	  administration	   of	   IgG1	   antibodies,	   whereas	   mice	   deficient	   in	   CD8,	   natural	   killer	  cells	  or	  complement	   factor	  C3	  can	  (Shapiro	  et	  al.,	  2002,	  Beenhouwer	  et	  al.,	  2001,	  Yuan	   et	   al.,	   1997).	  Thus,	   antibody-­‐mediated	   immunity	   is	   a	   significant	  part	   in	   the	  host	   defense	   that	   integrates	   into	   a	   complex	   network	   of	   different	   elements	   of	  protective	  anticryptococcal	  immunity.	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1.2.2.2	   CELL	  MEDIATED	  IMMUNE	  RESPONSE	  TO	  CRYPTOCOCCUS	  	  The	   number	   of	   cryptococcosis	   cases	   drastically	   increased	   with	   the	   onset	   of	   the	  AIDS	   pandemic	   and,	   to	   date,	   the	   highest	   incidence	   is	   still	   found	   in	   HIV-­‐stricken	  sub-­‐Saharan	   Africa	   (Park	   et	   al.,	   2009).	   Besides	   HIV	   patients,	   individuals	   with	  extensive	  corticosteroid	  treatment,	  organ	  transplantation,	  leukemia	  or	  lymphoma	  and	  sarcoidosis	  belong	  to	  a	  high-­‐risk	  group	  for	  cryptococcal	  infections	  (Mitchell	  et	  
al.,	   1995).	  The	   common	   feature	  of	   all	   of	   these	  predispositions	   is	   a	  defect	   in	  CMI.	  This	  part	  of	  the	  host	  defence	  contributes	  to	  cryptococcal	  killing	  either	  directly	  by	  cytotoxic	  effects	  or	  indirectly	  by	  regulatory	  functions	  of	  natural	  killer	  (NK)	  cells	  or	  T	  lymphocytes.	  NK,	  CD4+	  and	  CD8+	  cells	  all	  exhibit	  direct	  antimicrobial	  activity	  to	  
C.	   neoformans	   (Levitz	   et	   al.,	   1994,	   Zheng	   et	   al.,	   2007)	   and	   secrete	   the	   proteins	  granulysin	  and	  perforin	  that	  are	  both	  able	  to	  induce	  cryptococcal	  permeabilization	  and	   lysis	   (Ernst	   et	  al.,	  2000,	  Voskoboinik	   et	  al.,	  2006).	  Although	  NK	  cells	  express	  both	  proteins,	  perforin	  is	  the	  main	  mediator	  of	  anticryptococcal	  killing	  via	  a	  PI3K-­‐dependent	  ERK1/2	  signaling	  pathway	  (Ma	  et	  al.,	  2004,	  Marr	  et	  al.,	  2009,	  Wiseman	  
et	  al.,	  2007).	   In	  contrast,	  CD4+	  and	  CD8+	   lymphocytes	  utilize	   the	  anticryptococcal	  function	  of	  granulysin	  that	  is	  expressed	  upon	  activation	  of	  STAT5	  and	  PI3K	  in	  the	  presents	  of	  IL-­‐2/IL-­‐15	  and	  IL-­‐15,	  respectively	  (Ma	  et	  al.,	  2002,	  Zheng	  et	  al.,	  2008,	  Zheng	  et	  al.,	  2007).	  In	  HIV	  patients,	  these	  two	  pathways	  are	  defective,	  resulting	  in	  inefficient	  killing	  of	  C.	  neoformans	  (Zheng	  et	  al.,	  2007).	  	  Alongside	  the	  ability	  to	  directly	  lyse	  cryptococci,	  the	  regulatory	  arm	  of	  CMI	  seems	  to	   be	   an	   even	   more	   important	   part	   of	   fungal	   clearance.	   The	   outcome	   of	  cryptococcosis	   depends	   on	   the	   immune	   status	   of	   the	   infected	   individual	   and	   the	  expression	  of	  host	  cytokines,	  regulatory	  immune	  signaling	  molecules,	  generated	  in	  response	  to	  the	  pathogen.	  Cytokines	  regulate	  the	  induction	  of	  the	  three	  main	  lines	  of	   immune	   response:	   Th1,	   Th2	   and	   Th17.	   Th1	   and	   Th17	   immune	   profiles	   are	  proinflammatory	   and	   activate	   antimicrobial	   functions	   of	   effector	   cells	   upon	  infection	  with	   intracellular	  pathogens.	  A	  Th2	  response	  is	  activated	  after	   infection	  with	   extracellular	   pathogens	   and	   results	   in	   an	   antibody-­‐mediated	   immune	  response	   (Mosmann	   et	   al.,	   1989).	   Both	   Th1	   and	   Th2	   cytokines	   are	   involved	   in	  protection	   against	   C.	   neoformans,	   but	   whereas	   Th1	   associated	   cytokines	   are	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essential	  for	  natural	  immunity,	  Th2	  associated	  immunity	  is	  not	  protective	  in	  mice	  (Beenhouwer	  et	  al.,	  2001,	  Hoag	  et	  al.,	  1997,	  Huffnagle,	  1996).	  Increased	  expression	  of	   Th1	   cytokines,	   such	   as	   TNF-­‐α	   and	   IFN-­‐γ,	   results	   in	   improved	   fungal	   control	  (Flesch	  et	  al.,	  1989,	  Kawakami	  et	  al.,	  1995,	  Milam	  et	  al.,	  2007,	  Wormley	  et	  al.,	  2007)	  and	  supports	  pulmonary	  clearance	  (Zhang	  et	  al.,	  2009)	  whilst	  IFN-­‐γ	  knockout	  mice	  show	  increased	  fungal	  burden	  (Arora	  et	  al.,	  2005).	  In	  addition,	  Müller	  et	  al.	  (2007)	  have	   recently	   demonstrated	   a	   significant	   role	   for	   IL-­‐17	   and	   the	   associated	  Th17	  response	   in	   modulating	   survival	   of	   C.	   neoformans–infected	   mice	   (Muller	   et	   al.,	  2007,	  Kleinschek	   et	   al.,	   2006).	   In	   contrast,	   Th2	   cytokines	   such	   as	   IL-­‐4	   and	   IL-­‐13	  reduce	  the	  host’s	  ability	  to	  deal	  with	  C.	  neoformans	  in	  vivo	  (Blackstock	  et	  al.,	  2004,	  Decken	   et	  al.,	   1998,	  Muller	   et	  al.,	   2007,	  Kawakami	   et	  al.,	   1999).	  The	   incidence	  of	  cryptococcosis	   increases	   throughout	   the	   course	   of	   HIV	   infection	   and	   correlates	  with	   the	   loss	   of	   Th1	   response	   in	   HIV-­‐infected	   patients	   (Altfeld	   et	   al.,	   2000)	   and	  with	   a	   Th2	   cytokine	   profile	   in	   transplant	   patients	   (Singh	   et	   al.,	   2008).	   Thus,	   the	  Th1-­‐Th2-­‐Th17	  balance	  is	  essential	  for	  survival	  of	  cryptococcosis.	  	  In	  addition	  to	  DCs	  and	  neutrophils,	  primary	  lymphocytes	  and	  NK	  cells	  as	  well	  as	  γδ	  T	   cells	   are	   involved	   in	   the	  maintenance	  of	   this	   cytokine	  balance	  during	   infection	  (Wozniak	  et	  al.,	  2006,	  Mednick	  et	  al.,	  2003,	  Nanno	  et	  al.,	  2007,	  Uezu	  et	  al.,	  2004).	  NK	  cells	  produce	  high	  concentrations	  of	  IFN-­‐γ	  and	  IL-­‐4	  that	  trigger	  Th1	  mediated	  immunity	   but	   not	   Th2	   related	   immune	   responses	   (Kawakami	   et	   al.,	   2001).	   This	  activation	  is	  opposed	  by	  the	  function	  of	  γδ	  T	  cells;	  depletion	  of	  γδ	  T	  cells	  in	  a	  mouse	  model	   leads	   to	   a	   decreased	   fungal	   burden	   and	   reduced	   IFN-­‐γ	   levels	   (Uezu	   et	   al.,	  2004).	  Since	  Th1	  immunity	  is	  proinflammatory,	  exaggerated	  Th1	  activation	  during	  infection	   might	   have	   negative	   consequences	   for	   individuals	   and	   thus	   γδ	   T	   cells	  might	  function	  as	  down-­‐regulators	  of	  Th1	  responses	  to	  sustain	  a	  healthy	  Th1-­‐Th2	  balance	  (Kawakami,	  2004).	  However,	  C.	  neoformans	   is	  able	  to	  actively	  change	  the	  Th1/Th2	   balance	   towards	   a	   Th2	   profile	   by	   expressing	   eicosanoids	   (e.g.	  prostaglandins	   and	   leukotrienes),	   which	   are	   potent	   inhibitors	   of	   Th1-­‐type	  immunity	   (Noverr	   et	   al.,	   2003).	   In	   addition,	   expression	   of	   the	   virulence	   factor	  urease	   promotes	   a	   Th2	   immune	   response	   within	   the	   lungs	   via	   an	   unknown	  mechanism	  (Cox	  et	  al.,	  2000).	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1.2.3	   IMMUNOTHERAPY	  IN	  CRYPTOCOCCAL	  DISEASE	  	  Current	   anti-­‐fungal	   treatment	   regimes	   involve	   combination	   therapy	   of	  amphotericin	   B,	   flucytosine	   and	   fluconazole	   (Perfect	   et	   al.).	   However,	   all	   are	  associated	   with	   toxic	   side	   effects	   and	   low	   cost-­‐efficiency	   (Centre	   for	   Disease	  Control	   and	   Prevention).	   In	   addition,	   the	   new	   generation	   of	   antifungals,	  echinocandins,	   are	   not	   active	   against	  C.	   neoformans	   and	   in	   consequence	   are	   not	  used	  in	  clinical	  practice,	  thus	  limiting	  the	  range	  of	  antifungals	  available	  to	  treat	  the	  disease	   (Maligie	   et	   al.,	   2005).	   The	   introduction	   of	   highly	   active	   antiretroviral	  therapy	   (HAART)	   has	   reduced	   the	   incidence	   of	   cryptococcosis	   in	   developed	  countries,	   but	   not	   the	   short-­‐term	  mortality	   and	  hence	  HAART	  has	   not	   improved	  the	   clinical	   outcome	   of	   cryptococcosis.	   Despite	   rapid	   clinical	   intervention,	   the	  three-­‐month	   mortality	   of	   acute	   cryptococcal	   meningoencephalitis	   is	   as	   high	   as	  20	  %	   in	   HIV	   patients	   (Lortholary	   et	   al.,	   2006,	   Dromer	   et	   al.,	   2007).	   This	   poor	  prognosis	  has	  resulted	  in	  the	  need	  for	  exploration	  of	  alternative	  treatment	  regimes	  such	   as	   immunotherapy,	   passive	   immunization	   and	   cytokine-­‐based	   treatment	  strategies.	   One	   promising	   approach	   might	   be	   the	   use	   of	   adjunctive	   passive	  immunotherapy	   with	   monoclonal	   antibodies.	   As	   the	   administration	   of	   anti-­‐capsular	  antibodies	  is	  protective	  in	  infected	  mice	  (Dromer	  et	  al.,	  1987,	  Graybill	  et	  
al.,	  1981)	  a	  phase	  I	  trial	  with	  the	  monoclonal	  antibody	  18B7	  was	  conducted	  in	  HIV	  patients	  recovered	  from	  cryptococcal	  meningitis	  (Larsen	  et	  al.,	  2005).	  Therapy	  was	  well	   tolerated	   for	   antibody	   concentrations	   up	   to	   1	   mg/kg	   with	   higher	   doses	  showing	   pharmacological	   effects	   (Larsen	   et	   al.,	   2005).	   A	   second	   antibody,	   2G8,	  targeting	   the	   cell	   wall	   glucan	   has	   exerts	   remarkable	   anticryptococcal	   activity	   in	  
vitro	   and	   in	   vivo	   and	   might	   be	   a	   good	   candidate	   as	   a	   new	   therapeutic	   agent	  (Rachini	  et	  al.,	  2007).	  Thus,	  there	  is	  clear	  potential	  for	  anticryptococcal	  antibody-­‐mediated	  therapy.	  However,	  it	  remains	  a	  significant	  challenge	  to	  design	  treatment	  strategies	   considering	   the	   complex	   pharmacodynamics	   of	   administrated	  antibodies	   and	   antigens	   within	   the	   host	   as	   well	   as	   drug-­‐associated	   toxicity.	  Vaccination	   with	   GXM-­‐tetanus	   toxoid	   conjugates	   in	   mouse	   model	   systems	   has	  shown	  promise	  (Devi	  et	  al.,	  1991,	  Devi,	  1996)	  but	  is	  not	  yet	  approved	  for	  clinical	  use.	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Cytokine-­‐based	  treatments	  have	  also	  been	  proposed	  for	  cryptococcosis	  treatment.	  IFN-­‐γ	   levels	   at	   the	   site	   of	   infection	   correlate	  with	   fungal	   burden	   (Siddiqui	   et	   al.,	  2005)	   and	   administration	   of	   IFN-­‐γ	   has	   successfully	   improved	   the	   outcome	   of	  systemic	  cryptococcosis	   in	  mice	  model	   systems	  (Lutz	   et	  al.,	  2000,	  Clemons	   et	  al.,	  2001)	   and	   in	   one	   human	   patient	   (Netea	   et	   al.,	   2004).	   However,	   although	   IFN-­‐γ	  seems	  to	  have	  a	  protective	  role	  in	  mice	  (Hoag	  et	  al.,	  1997,	  Arora	  et	  al.,	  2005)	  and	  to	  increase	  fungicidal	  activity	  of	  murine	  macrophages	  (Flesch	  et	  al.,	  1989),	  the	  same	  treatment	   reduces	   anticryptococcal	   activity	   in	   human	  macrophages	   (Reardon	   et	  
al.,	   1996,	   Levitz	   et	   al.,	   1990),	   suggesting	   that	   this	   line	   of	   treatment	  may	   be	   less	  advantageous	  for	  human	  patients.	  	  Recent	  approaches	  also	  tested	  radioimmunotherapy	  for	  treatment	  of	  high	  burden	  of	   C.	   neoformans	   in	   mice.	   Mortality	   was	   reduced	   and	   no	   evidence	   found	   for	  selection	   of	   radio-­‐resistant	   cells.	   Although	   this	   strategy	  was	  more	   effective	   than	  antifungal	  treatment,	  residual	  yeast	  cells	  that	  were	  likely	  shielded	  by	  a	  biofilm,	  an	  abscess	  or	  within	  host	   cells,	  were	  able	   to	  survive	  and	  proliferate	  after	   treatment	  (Bryan	  et	  al.,	  2009,	  Bryan	  et	  al.,	  2010).	  	  Since	   C.	   neoformans	   is	   a	   major	   pathogen	   of	   immunocompromised	   patients,	   new	  strategies	  need	  to	  consider	  targeted	  modification	  of	  the	  patient’s	  immune	  system,	  for	   instance	   by	   the	   selective	   administration	   of	   pro-­‐inflammatory	   cytokines,	   to	  encourage	  the	  expression	  of	  a	  protective	  immune	  profile.	  Intracellular	  localisation	  provides	   Cryptococcus	   with	   a	   niche	   to	   escape	   host	   immune	   mechanisms	   (e.g.	  complement	  and	  antibodies)	  and	  also	   reduces	   the	  exposure	   to	  antifungal	   agents.	  Future	  research	  will	  need	  to	  consider	  the	  ability	  to	  parasitise	  host	  cells	  in	  order	  to	  advance	  therapeutic	  schemes.	  Targeting	  intracellular	  survival	  and	  growth	  and/or	  cryptococcal	  virulence	  factors	  expressed	  during	  disease	  might	  offer	  new	  strategies	  to	  improve	  anticryptococcal	  treatment.	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1.3	   MACROPHAGE-­CRYPTOCOCCUS	  INTERACTION:	   	  INTRACELLULAR	  
PROLIFERATION	  AND	  EXIT	  STRATEGIES	  
	  Pathogens	  have	  evolved	  a	  great	  variety	  of	  strategies	  to	  achieve	  survival	  within	  the	  host	   environment.	   Intracellular	   parasitism,	   as	   one	   of	   these	   strategies,	   has	   a	  significant	   impact	   on	   pathogenesis	   and	   important	   implications	   for	   the	  effectiveness	  of	   both	   the	  host’s	   immune	   response	   and	   therapeutic	   reagents.	  This	  section	   discusses	   the	   ability	   of	   the	   pathogenic	   cryptococci	   to	   proliferate	  intracellularly	   and	   examines	   the	   different	   strategies	   cryptococci	   use	   to	   exit	   host	  cells.	  It	  will	  also	  address	  the	  importance	  of	  these	  two	  traits	  in	  pathogenesis.	  	  	  
1.3.1	   CRYPTOCOCCUS	  AS	  AN	  INTRACELLULAR	  PROLIFERATOR	  
In	  vitro,	   intracellular	  multiplication	  (Figure	  7)	  of	  C.	  neoformans	  was	  first	  reported	  in	   isolated	   murine	   peritoneal	   macrophages	   (Mitchell	   et	   al.,	   1972)	   and	   in	  macrophages	   derived	   from	   human	   peripheral	   blood	  monocytes	   (Diamond	   et	   al.,	  1973a)	  and	  has	  since	  also	  been	  shown	  in	  human	  fetal	  microglia	  (Lee	  et	  al.,	  1995),	  in	  murine	   alveolar	  macrophages	   (Tucker	   et	   al.,	   2002)	   and	   in	   human	   endothelial	  cells	   (Coenjaerts	   et	   al.,	   2006).	   Although	   an	   earlier	   study	   observed	   effective	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intracellular	   killing	   of	   C.	   neoformans	   by	   human	   leukocytes	   during	   the	   first	   four	  hours	   of	   infection	   (Tacker	   et	   al.,	   1972),	   a	   subsequent	   study	   demonstrated	   that	  
C.	  neoformans	  first	  needs	  to	  adapt	  to	  the	  host	  cell	  environment	  before	  commencing	  replication	  (Diamond	  et	  al.,	  1973a).	  Thus,	  experiments	  over	  a	  shorter	  time-­‐frame	  might	  underestimate	  the	  intracellular	  proliferative	  potential.	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Nowadays,	   Cryptococcus	   is	   generally	   accepted	   as	   a	   facultative	   intracellular	  pathogen	  that	  can	  replicate	  inside	  host	  cells	  whilst	  retaining	  the	  ability	  to	  grow	  in	  an	  extracellular	  niche	  within	   the	  host	  and	   in	   the	  environment	   (Feldmesser	   et	  al.,	  2001a).	  The	  intracellular	  location	  provides	  a	  dual	  benefit	  to	  Cryptococcus,	  both	  in	  avoiding	   extracellular	   host	   immune	   mechanisms,	   such	   as	   complement,	   and	   in	  reducing	   exposure	   to	   antifungal	   agents.	   Indeed,	   maintenance	   of	   Cryptococcus	  within	  phagocytic	  cells	  is	  important	  for	  progression	  of	  cryptococcosis	  (Kechichian	  
et	  al.,	  2007).	  The	  establishment	  of	  different	   in	  vitro	   systems	   that	  utilize	  cell	   lines	  (Mukherjee	  et	  al.,	  1994,	  Lee	  et	  al.,	  1995)	  and	  the	  application	  of	  techniques	  such	  as	  live	  cell	   imaging	  (Ma	   et	  al.,	  2006,	  Alvarez	   et	  al.,	  2006),	  have	  contributed	   to	  rapid	  advances	   in	   our	   understanding	   of	   the	   molecular	   mechanisms	   influencing	  
Cryptococcus’s	  ability	  to	  parasitize	  macrophages.	  	  
1.3.1.1	   THE	   ORIGIN	   AND	   EVOLUTION	   OF	   CRYPTOCOCCAL	   INTRACELLULAR	  
PROLIFERATION	  	  The	  question	  of	  how	  and	  why	  Cryptococcus	  has	  acquired	  and	  maintained	  virulence	  mechanisms	   that	   enable	   intracellular	   proliferation	   is	   still	   unanswered.	  However,	  the	   interactions	   between	   C.	   neoformans	   and	   environmentally	   widespread	  invertebrates	   and	   protists	   has	   led	   to	   the	   proposal	   that	   virulence	   towards	  mammalian	  cells	  might	  have	  arisen	  from	  protective	  mechanisms	  used	  by	  the	  yeast	  against	   environmental	   predators.	   Co-­‐incubation	   of	   the	   free-­‐living	   soil	   amoebae	  
Acanthamoeba	  castellanii	  or	  Dictyostelium	  discoideum	  with	  C.	  neoformans	  results	  in	  intracellular	   budding	   and	   growth,	   eventually	   causing	   lysis	   of	   the	   host	   amoebae	  (Steenbergen	   et	   al.,	   2003,	   Steenbergen	   et	   al.,	   2001).	   Interestingly,	   mutations	   in	  known	  mammalian	  virulence	  factors	  significantly	  inhibited	  cryptococcal	  growth	  in	  this	   system.	   Interestingly,	  melanization	  protects	   acapsular,	  but	  not	   encapsulated,	  strains	   from	   amoeboid	   killing	   (Steenbergen	   et	   al.,	   2001),	   suggesting	   that	  melanization	   is	  not	   a	   critical	   virulence	   factor	   in	   this	  host.	  Notably,	  D.	   discoideum	  mutants	   impaired	   in	  phagocytosis	  or	   exocytosis	   (Tuxworth	   et	   al.,	   2001,	  Wood	   et	  
al.,	  1996,	  Brazill	  et	  al.,	  2000),	  are	  both	  susceptible	  to	  the	  hypovirulent	  strain	  Cap67	  
Chapter	  1:	  Introduction	  
	   37	  
(Steenbergen	   et	   al.,	   2003).	   Thus,	   as	   in	   humans,	   the	   outcome	   of	   intracellular	  parasitism	  results	  from	  a	  complex	  interaction	  between	  host	  and	  pathogen	  factors.	  Intriguingly,	   repeated	   passage	   of	  C.	   neoformans	   through	  D.	   discoideum	   results	   in	  increased	  virulence	  in	  mice	  (Steenbergen	  et	  al.,	  2003).	  This	  increase	  is	  correlated	  with	   phenotypic	   changes,	   such	   as	   increased	   capsule	   size	   and	   more	   rapid	  melanization	   (Steenbergen	   et	   al.,	   2003),	   and	   is	   probably	   a	   microevolutionary	  process	  similar	  to	  that	  previously	  reported	  in	  HIV-­‐infected	  patients	  with	  recurrent	  cryptococcocal	  meningitis	  (Sullivan	  et	  al.,	  1996).	  	  Cryptococcal	  proliferation	  within	  amoebae	   is	   remarkably	   similar	   to	   replication	   within	   mammalian	   phagocytes.	  Therefore,	   the	   selective	   pressure	   to	   survive	   and	   replicate	   within	   amoebae	   may	  have	  driven	  evolution	  of	  adaptation	  mechanisms	  to	  mammalian	  hosts	  and	  may	  be	  critical	  for	  the	  maintenance	  of	  intracellular	  proliferation	  traits	  in	  this	  organism.	  	  However,	  although	  these	  interactions	  offer	  explanations	  for	  mechanisms	  involved	  in	   virulence	   and	   in	   intracellular	   proliferation	   in	   the	   immunocompromised	   host,	  they	   do	   not	   explain	   the	   recent	   origin	   of	   certain	   hypervirulent	   C.	   gattii	   strains	  (Stephen	   et	   al.,	   2002,	   Hoang	   et	   al.,	   2004,	   Bartlett	   et	   al.,	   2008,	  MacDougall	   et	   al.,	  2007).	   Strikingly,	   data	   on	   the	   maximal	   intracellular	   proliferation	   rates	   (IPR)	   of	  different	   C.	   gattii	   strains	   show	   that	   an	   enhanced	   ability	   to	   replicate	   within	  macrophages	   might	   have	   enabled	   certain	   C.	   gattii	   strains	   to	   cause	   symptomatic	  infections	   in	   otherwise	   healthy	   individuals.	   A	   comparison	   of	   C.	   gattii	   strains	   of	  different	   genotypes	   revealed	   an	   increase	   in	   IPRs	   in	   genotype	   VGIIa	   strains	  (AFLP6A),	   the	   hypervirulent	   genotype	   responsible	   for	   the	   Vancouver	   Island	  Outbreak	  (VIO)	  (Kidd	  et	  al.,	  2004).	  Since	  there	  is	  also	  a	  clear	  correlation	  between	  IPR	   and	   virulence	   in	   mice,	   the	   exceptional	   virulence	   of	   the	   Vancouver	   Island	  
Cryptococcus	   population	   seems	   to	   be	   a	   direct	   result	   of	   an	   enhanced	   ability	   to	  multiply	   intracellularly	   in	   mammalian	   macrophages	   (Ma	   et	   al.,	   2009a).	   Whole-­‐genome	  microarray	  analysis	  has	  identified	  a	  large	  number	  of	  candidate	  genes	  that	  may	   influence	   proliferative	   capacity	   and	   revealed	   an	   unexpected	   role	   for	  mitochondrial	   genes	   in	   regulating	   cryptococcal	   hypervirulence	   in	   the	   Vancouver	  Island	   strains.	   Upon	   encounter	   of	   the	   intracellular	   niche,	   expression	   of	  mitochondrial	  genes	  is	  upregulated	  in	  these	  strains	  whilst	  the	  mitochondrial	  DNA	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copy	  number	   remains	  unaffected	   (Ma	   et	   al.,	   2009a).	  Moreover,	  Vancouver	   Island	  isolates	  show	  a	  distinctive	  mitochondrial	  phenotype.	   	  The	  mitochondrial	  network	  can	  appear	  diffuse,	  globular	  or	  tubular.	  Highly	  virulent	  strains	  VGIIa	  strains	  show	  a	  significant	   increase	   in	  mitochondria	   with	   tubular	  morphology	   after	  macrophage	  passage	  compared	  to	  low	  proliferative	  strains	  (Ma	  et	  al.,	  2009a).	  Previous	  work	  in	  the	  related	  species	  C.	  neoformans	  has	  demonstrated	   that	  mitochondrial	  genotype	  does	   not	   influence	   virulence	   (Toffaletti	   et	   al.,	   2004).	   Thus,	   mitochondrial	  regulation	   of	   virulence	   must	   have	   evolved	   after	   C.	   gattii	   and	   C.	   neoformans	  diverged	   and	   may	   potentially	   explain	   the	   very	   different	   behavior	   of	   these	   two	  pathogens.	  	  Mitochondrial	   functions	   include	   oxidative	   respiration,	   resistance	   to	   oxidative	  stress	  (Grant	  et	  al.,	  1997),	  certain	  heme	  synthesis	  reactions	  (Oh-­‐hama,	  1997)	  and	  sterol	   synthesis	   (Rossier,	   2006).	   C.	   neoformans	   mutants	   with	   impaired	  mitochondrial	  functions	  show	  reduced	  oxidative	  respiration	  and	  higher	  sensitivity	  to	  reactive	  oxygen	  species	  under	  low	  oxygen	  conditions	  (Ingavale	  et	  al.,	  2008).	  In	  this	   context,	   increased	   intracellular	   replication	   might	   be	   due	   to	   additional	  mitochondrial	  genes,	  polymorphisms	  or	  greater	  mitochondrial	  plasticity	  that	  allow	  for	  more	  rapid	  adaptation	  to	  environmental	  changes	  such	  as	  available	  oxygen	  and	  oxidative	   stress.	   Furthermore,	   a	   high	   percentage	   of	   tubular	   mitochondria	   will	  allow	  closer	  proximity	  of	  proteins	   involved	   in	  mitochondrial	   functions	  and	  might	  enable	  to	  compensate	  for	  proteins	  damaged	  by	  host	  cell	  stresses.	  Future	  research	  will	   hopefully	   reveal	   how	   mitochondria	   influence	   cryptococcal	   intracellular	  proliferation	  at	  the	  molecular	  level.	  	  
	  
1.3.2	   CRYPTOCOCCAL	  ESCAPE	  FROM	  THE	  HOST	  CELL	  To	  cause	  the	  disease	  state	  observed	  in	  cryptococcosis,	  cryptococci	  must	  eventually	  escape	   the	   phagocyte	   in	   which	   they	   initially	   replicate.	   Different	   escape	   routes	  influence	  both	  secondary	  disease	  states	  and	  the	  role	  that	  the	  adaptive	  and	  innate	  immune	  system	  will	  play	  in	  subsequent	  pathology.	  More	  generally,	  host	  cell	  escape	  may	   be	   important	   both	   for	   the	  multi-­‐tissue	   passage	   of	  Cryptococcus	   through	   the	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body	  and	  for	  maintaining	  latency.	  At	  least	  three	  exit	  strategies	  for	  Cryptococcus	  are	  currently	   recognized:	   lysis,	   expulsion	   and	   lateral	   transfer.	   Each	   of	   these	   is	  addressed	  in	  turn	  below.	  	  
1.3.2.1	   HOST	  CELL	  LYSIS	  	  Host	   cell	   lysis	   is	   the	   most	   common	   escape	   route	   for	   intracellular	   pathogens	  (Figure	  8).	   Microorganisms	   are	   often	   enclosed	   in	   at	   least	   two	   membranes	   (an	  endocytic	  or	  phagocytic	  one,	  as	  well	  as	  the	  host	  cell	  plasma	  membrane)	  and	  must	  disrupt	   these	   to	   escape.	   Many	   virulence	   factors,	   such	   as	   pore	   forming	   proteins	  (PFPs),	  phospholipases	  and	  proteases,	  are	  thought	  to	  function	  through	  lysing	  host	  cell	  membranes.	  The	  mechanisms	  of	  host	   cell	  membrane	  disruption	  are	  not	  well	  understood	   but	   are	   assumed	   to	   involve	   a	   combination	   of	   pore	   forming	   and	  phospholipase	  proteins.	  To	  date,	  no	  pore	  forming	  proteins	  that	  function	  to	  attack	  host	   membranes	   have	   been	   identified	   in	   the	   Cryptococcus	   genome,	   but	  phospholipase	   B	   (plb1)	   is	   an	   obvious	   candidate	   cell-­‐lysis	   factor.	   Although	  cryptococcal	   parasitism	  of	  macrophages	   does	   not	   obviously	   require	   escape	   from	  the	   phagosome,	   three	   experimental	   observations	   suggest	   that	   Cryptoccocus-­containing	   phagosomes	  may	   be	   permeabilised.	   	   Firstly,	   phagosomal	   membranes	  containing	   Cryptococcus	   appear	   to	   have	   holes	   when	   viewed	   by	   transmission	  electron	   microscopy	   (Feldmesser	   et	   al.,	   2002,	   Tucker	   et	   al.,	   2002).	   Secondly,	  fluorescent	   dextran	   that	   is	   phagocytosed	   along	   with	   cryptococci	   subsequently	  diffuses	  out	  of	  the	  phagosome	  into	  the	  cytoplasm	  (Tucker	  et	  al.,	  2002,	  Johnston	  et	  
al.,	  2010).	  Finally,	  Cryptococcus	  containing	  phagosomes	  cannot	  maintain	  an	  acidic	  pH	  (Tucker	  et	  al.,	  2002).	  This	  permeabilisation	  of	  the	  phagosome	  may	  be	  required	  to	   provide	   access	   to	   cytoplasmic	   nutrients	   to	   support	   proliferation,	   as	   the	   PLB1	  mutant	   is	   growth-­‐inhibited	   in	  macrophages	   (Noverr	   et	   al.,	   2003).	   	   Nevertheless,	  the	  lysis	  of	  phagosomes	  or	  host	  cells	  by	  PLB	  has	  not	  been	  shown	  directly.	  	  	  	  Mechanical	   burden	   alone,	   in	   the	   absence	   of	   permeabilising	   factors,	   is	   not	   well	  described	  as	  a	  mechanism	  for	  host	  cell	  lysis	  for	  intracellular	  pathogens.	  However,	  the	   concurrent	   expansion	   of	   the	   cryptococcal	   capsule	   and	   rapid	   proliferation	   of	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1.3.2.2	   EXPULSION	  Many	  intracellular	  pathogens	  have	  mechanisms	  for	  controlled	  expulsion	  from	  host	  cells.	   These	   generally	   fall	   into	   two	   types;	   actin-­‐based	   protrusion	   and	  membrane	  extrusion.	  Actin-­‐based	  protrusion	  has	  been	  described	   for	  Listeria	  monocytogenes,	  
Rickettsia	   sp.,	   Shigella	   flexneri	   and	  Burkholderia	   pseudomallei,	  all	   of	  which	   hijack	  the	   host	   actin	   cytoskeleton	   to	   form	   plasma	   membrane	   projections	   that	   are	  endocytosed	  by	  neighbouring	  cells	  (Stevens	  et	  al.,	  2006).	  In	  contrast,	  cryptococcal	  expulsion	  	  (Figure	  9)	  occurs	  without	  any	  obvious	  reliance	  on	  the	  actin	  cytoskeleton	  (Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006).	   	   Two	   other	   superficially	   similar	   exit	  strategies	  have	  been	  reported,	  the	  triple	  membrane	  single	  cell	  budding	  of	  Orientia	  
tsutsugamushi	  (Schaechter	  et	  al.,	  1957)	  and	  the	  large	  vacuole	  multi-­‐cell	  extrusion	  of	  Chlamydia	  spp.	  (Hybiske	  et	  al.,	  2007).	  	  Cryptococcal	  expulsion	  bears	  a	  striking	  resemblance	  to	  exocytosis,	  the	  process	  by	  which	  internal	  vesicles	  fuse	  with	  the	  plasma	  membrane	  and	  release	  their	  contents	  to	   the	   outside	   environment.	   The	   presentation	   of	   antigens	   also	   relies	   on	   the	  exocytic	   machinery,	   a	   process	   that	   is	   especially	   important	   in	   phagocytes.	  Exocytosis	   of	   large	   particles	   has	   been	   observed	   only	   once,	   though,	   in	   the	   social	  amoeba	  Dictyostelium	  discoideum	  (Clarke	  et	  al.,	  2002).	  	  Expulsion	  of	  C.	  neoformans	  and	  C.	  gattii	  occurs	  in	  macrophage	  cell	  lines	  (Alvarez	  et	  
al.,	   2008,	   Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006),	   primary	   murine	   macrophages	  (Alvarez	   et	   al.,	   2006)	   and	   primary	   human	   macrophages	   (Alvarez	   et	   al.,	   2006,	  Alvarez	  et	  al.,	  2009).	  The	  rate	  of	  expulsion	  is	  increased	  2.5	  fold	  in	  primary	  human	  macrophages	   (Ma	   et	   al.,	   2006),	   suggesting	   that	   it	   may	   be	   a	   frequent	   event	   in	  infected	  patients.	  	  After	  expulsion	  of	  cryptococci,	  macrophages	  are	  still	  motile	  and	  able	  to	  divide	  (Alvarez	  et	  al.,	  2006,	  Ma	  et	  al.,	  2006).	  Expelled	  cryptococci	  are	  also	  viable	  (Alvarez	  et	  al.,	  2006,	  Ma	  et	  al.,	  2006)	  and	  can	  be	  re-­‐phagocytosed	  (Alvarez	  et	  
al.,	   2008).	   Expulsion	   appears	   to	   be	   a	   process	   triggered	   by	   the	   yeast,	   since	   heat	  killed	  cryptococci	  are	  not	  expelled	  (Alvarez	  et	  al.,	  2006,	  Ma	  et	  al.,	  2006),	  a	  finding	  that	  contrasts	  with	  the	  expulsion	  of	  dead	  yeast	  fragments	  by	  Dictyostelium	  (Clarke	  
et	  al.,	  2002).	  Expulsion	  events	  are	  rare	  during	  the	  first	  two	  hours	  of	  infection	  but,	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after	   this	   initial	   lag	   phase,	   events	   are	   randomly	   distributed	   over	   the	   period	   of	  observation	  (Alvarez	  et	  al.,	  2006,	  Ma	  et	  al.,	  2006).	  The	  expulsion	  event	  itself	  takes	  approximately	  60	  seconds	  (Alvarez	  et	  al.,	  2006,	  Ma	  et	  al.,	  2006)	  but	  detailed	  data	  on	  the	  kinetics	  of	  expulsion	  is	  not	  currently	  available.	  Expulsion	  occurs	  with	  both	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A	  key	  unanswered	  question	  in	  the	  field	   is	  the	  role	  played	  by	  different	  phagocytic	  uptake	  routes	  on	  subsequent	  cryptococcal	  behavior.	  	  The	  molecular	  processes	  that	  underlie	  phagocytosis	  vary	  extensively	  with	  different	  receptors	  as	  well	  as	  with	  size	  and	   shape	   of	   the	   engulfed	   particle	   (Champion	   et	   al.,	   2006,	   Huynh	   et	   al.,	   2007).	  Although	  the	  route	  of	  phagocytic	  uptake	  is	  not	  predictive	  of	  cryptococcal	  expulsion	  (Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006),	   frequency	   is	   reduced	   with	   complement	  opsonization	   (Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006).	   Since	   the	   phagocytosis	   of	  
Cryptococcus,	   even	  when	   heavily	   opsonized,	   will	   likely	   include	  multiple	   types	   of	  receptors,	  the	  behavior	  of	  each	  engulfed	  cell	  is	  likely	  to	  be	  influenced	  by	  a	  complex	  interplay	  of	  multiple	   signaling	  pathways.	  Antibody-­‐opsonized	   yeast	   cells	   exit	   the	  macrophages	   as	   biofilm	   like	   colonies	   aggregated	   by	   polysaccharides	   whereas	  complement-­‐opsonized	  cryptococci	  are	  expelled	  individually	  (Alvarez	  et	  al.,	  2008).	  Prior	   to	   expulsion	   or	   proliferation,	   phagosomes	   containing	   Cryptococcus	   mature	  normally	   and	   fuse	   with	   lysosomes	   (Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006)	   and	  perturbation	   of	   this	   process	   modulates	   expulsion.	   Expulsion	   is	   reduced	   upon	  treatment	  with	  concanamycin	  A	  (Alvarez	  et	  al.,	  2006,	  Ma	  et	  al.,	  2006),	  an	  inhibitor	  of	   the	   V-­‐type	   ATPase	   that	   is	   responsible	   for	   acidification	   of	   endosomes	   and	  lysosomes	   that	   fuse	   with	   the	   phagosome	   (Drose	   et	   al.,	   1997).	   In	   contrast,	  chloroquine,	   a	   weak	   base	   that	   accumulates	   in	   acidic	   vesicles,	   buffering	   the	   pH,	  enhances	   the	   rate	   of	   expulsion	   (Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006).	   Since	  chloroquine	   and	   concanamycin	   A	   should	   produce	   similar	   effects	   on	   the	  phagosome,	   the	   difference	   in	   modulating	   expulsion	   may	   be	   due	   to	   a	   secondary	  activity	  of	   chloroquine,	   for	   example	  on	   the	  Cryptococcus	   vacuole	   (Harrison	   et	  al.,	  2002).	   	   Chloroquine	   has	   been	   previously	   described	   to	   enhance	   anticryptococcal	  activity	  of	  bone	  marrow	  macrophages	  and	  is	  protective	  in	  murine	  infection	  (Levitz	  
et	  al.,	  1997a).	  The	  discovery	  that	  chloroquine	  increases	  expulsion	  therefore	  raises	  the	   possibility	   that	   the	   enhancement	   of	   anticryptococcal	   activity	  may	   be	   due	   to	  increased	   expulsion	   of	  Cryptococcus	   into	   the	   extracellular	  milieu	  where	   they	   are	  susceptible	  to	  killing	  by	  complement.	  Expulsion	  does	  not	  require	  activation	  of	  macrophages	  with	  particular	  cytokines	  or	  other	  agonists	  (Alvarez	  et	  al.,	  2006,	  Ma	  et	  al.,	  2006).	  However,	  the	  rate	  of	  expulsion	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is	   significantly	   higher	   in	   macrophages	   activated	   by	   so-­‐called	   Type	   I	   cytokines	  (interferon	   gamma,	   or	   tumour	   necrosis	   factor	   alpha)	   than	   in	   those	   activated	   by	  Type	  II	  cytokines	  (e.g.	  interleukins	  4	  or	  13)	  (Voelz	  et	  al.,	  2009).	  	  Phagosomes	  and	  other	  cellular	  vesicles,	  even	  very	  small	  ones,	  are	  relatively	  flat	  at	  the	  scale	  of	  the	  fusion	  of	  membrane	  bilayers.	  Thus,	  for	  fusion	  to	  occur,	  a	  significant	  charge	   barrier	   must	   be	   overcome	   by	   a	   local	   and	   transient	   high	   membrane	  curvature.	   Phagosomes	   containing	   even	   a	   single	   cryptococcal	   cell	   are	   relatively	  large	   and	   those	   in	  which	   substantial	   cryptococcal	   proliferation	  has	   occurred	   can	  represent	   a	   significant	   proportion	   of	   the	   host	   cell’s	   volume.	   This,	   and	   other,	  energetic	   barriers	   make	   a	   purely	   mechanical	   explanation	   for	   cryptococcal	  expulsion	   highly	   unlikely.	   This	   is	   supported	   by	   experimental	   evidence	   that	   inert	  particles	   (heat-­‐killed	   yeast	   or	   polystyrene	   beads)	   are	   never	   expelled	   by	  macrophages	   (Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006).	   Normally,	   macrophages	  function	  in	  the	  lung	  to	  clear	  indigestible	  particles	  and	  then	  travel	  up	  and	  out	  of	  the	  lungs	   before	   being	   swallowed	   (Brain,	   1980).	   Were	   macrophages	   to	   freely	   expel	  indigestible	  material,	  lung	  clearance	  would	  be	  severely	  impaired.	  The	   molecular	   mechanism	   of	   cryptococcal	   expulsion	   is	   unknown	   but,	   since	  exocytosis	   is	   regulated	   by	   a	   large	   number	   of	   protein	   complexes	   that	   are	  responsible	   for	   membrane	   fusion	   and	   specificity,	   it	   is	   extremely	   unlikely	   that	  
Cryptococcus	  provides	  all	  these	  components	  itself.	   	   Instead,	  one	  possibility	   is	  that	  cryptococcal	   expulsion	   involves	   the	   hijacking	   of	   host	   cell	   factors	   in	   order	   to	  harness	  the	  host	  cell’s	  exocytic	  machinery	  for	  expulsion.	  An	  analogous	  mechanism	  occurs	   in	   other	   intracellular	   pathogens,	   such	   as	   the	   Gram	   positive	   bacterium	  
Listeria	  monocytogenes,	  which	  uses	   the	  bacterial	  protein	  ActA	   to	   ‘hijack’	   the	  host	  Arp2/3	  complex	  in	  order	  to	  stimulate	  the	  production	  of	  an	  actin	  tail	   for	  bacterial	  motility	  (May	  et	  al.,	  1999).	  Such	  hijacking	  factors,	  however,	  are	  yet	  to	  be	  identified	  in	  Cryptococcus.	  	  A	   recent	   publication	   has	   shown	   that	   actin	   might	   indeed	   play	   an	   important	   role	  during	   expulsion.	   The	   study	   revealed	   that	   phagosomes	   containing	   cryptococci	  undergo	   repeated	   cycles	   of	   actin	   polymerization;	   so-­‐called	   actin	   flashes.	   These	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flashes	  occur	  in	  form	  of	  a	  dynamic	  actin	  cage	  around	  the	  phagosome	  immediately	  after	   permeabilization	   of	   the	   phagolysosomal	   membrane.	   Interestingly,	   the	  occurrence	   of	   actin	   flashes	   and	   cryptococcal	   expulsion	   is	   inversely	   correlated	  indicating	  that	  the	  actin	  cage	  might	  act	  to	  inhibit	  expulsion	  (Johnston	  et	  al.,	  2010).	  	  	  
1.3.2.3	   LATERAL	  TRANSFER	  	  A	  number	  of	   intracellular	   bacteria	   can	  be	   transferred	   laterally	   between	  host	   cell	  types	   (Bernardini	   et	   al.,	   1989,	   Portnoy	   et	   al.,	   2002,	   Stevens	   et	   al.,	   2006)	   but	   the	  mechanism	   of	   transmission	   of	   bacteria	   that	   spread	   from	   cell	   to	   cell	   is	   not	   well	  understood	   even	   when	   the	   mechanism	   of	   escape	   is.	   Listeria	   monocytogenes	  polymerizes	   a	   tail	   of	   host	   actin	   that	   propels	   the	   bacterium	   into	   the	   plasma	  membrane	  (Dabiri	  et	  al.,	  1990),	  whereupon	  the	  resulting	  membrane	  protrusion	  is	  engulfed	   by	   neighboring	   cells	   and	   the	   bacteria	   internalized.	   Internalization	   is	   an	  active	  process,	  since	  the	  force	  of	  the	  membrane	  protrusion	  alone	  is	  insufficient,	  but	  further	  details	  are	  unknown	  (Robbins	  et	  al.,	  1999).	  	  	  Similarly,	   Cryptococcus	   can	   be	   directly	   transferred	   from	   macrophage	   to	  macrophage	  in	  both	  macrophage	  cell	  lines	  (Figure	  10)	  (Alvarez	  et	  al.,	  2007,	  Ma	  et	  
al.,	  2007),	  and	  primary	  macrophages	  (Alvarez	  et	  al.,	  2007,	  Ma	  et	  al.,	  2007).	  Lateral	  transfer	  shares	   the	  same	  basic	  requirements	  as	  expulsion:	   it	  does	  not	  occur	  with	  heat-­‐killed	  Cryptococcus	  or	  latex	  beads	  (Alvarez	  et	  al.,	  2007)	  and	  is	  independent	  of	  both	   the	   phagocytic	   receptor	   type	   and	   the	   cryptococcal	   strain	   (Ma	   et	   al.,	   2007).	  Unlike	  expulsion,	  however,	  lateral	  transfer	  is	  dependent	  on	  the	  actin	  cytoskeleton	  since	   treatment	   with	   the	   actin	   depolymerising	   drug	   cytochalasin	   D	   completely	  inhibits	  lateral	  transfer.	  The	  relationship	  between	  expulsion	  and	  lateral	  transfer	  is	  unclear,	  but	   it	   is	   easy	   to	   imagine	   that	   lateral	   transfer	  may	  occur	  when	  expulsion	  occurs	  in	  the	  close	  proximity	  of	  a	  suitable	  acceptor	  cell	  that	  can	  receive	  the	  ejected	  
Cryptococcus.	  As	  cytochalasin	  D	  does	  not	  inhibit	  expulsion,	  it	  is	  therefore	  likely	  that	  it	   is	  the	  process	  of	  acceptance	  that	  is	  actin	  dependent,	  as	  with	  normal	  phagocytic	  processes.	   A	   second	   possibility	   is	   that	   a	   transient	   (actin-­‐dependent)	   channel	   is	  opened	   between	   the	   two	   cells	   for	   transfer	   of	   Cryptococcus.	   Since	   macrophages	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1.3.2.4	   MACROPHAGES	  AND	  THE	  BLOOD-­BRAIN-­BARRIER	  
Cryptococcus	   predominantly	   infects	   the	   central	   nervous	   system	   after	  dissemination	   and	   hence	   has	   to	   cross	   the	   blood-­‐brain-­‐barrier	   (BBB).	   An	  understanding	   of	   the	   mechanism(s)	   by	   which	   the	   yeast	   invades	   the	   CNS	   is	  fundamental	  in	  deciphering	  disease	  pathogenesis	  during	  cryptococcosis.	  	  Currently,	   three	  potential	  hypotheses	  have	  been	  proposed	   for	  cryptococcal	  entry	  into	   the	  brain,	   although	   little	   experimental	   evidence	  exists	   to	  date.	   Firstly,	   it	   has	  been	   suggested	   that	   the	  yeast	   can	   cross	   the	  endothelial	   cell	   layer	   transcellularly.	  
C.	  neoformans	  can	  be	  mechanically	  trapped	  in	  small	  mouse	  brain	  capillaries	  (Shi	  et	  
al.,	  2010),	  adhere	  to	  and	  be	  internalized	  by	  endothelial	  cells	  in	  vitro	  (Ibrahim	  et	  al.,	  1995)	  and	  by	  endothelial	  cells	  of	  the	  leptomeningeal	  capillaries	  in	  vivo	  (Chretien	  et	  
al.,	   2002).	   Secondly,	   the	   potential	   of	   a	   ‘Trojan	   Horse’-­‐like	   mechanism	   where	  
Cryptococcus	   is	   transferred	   within	   macrophages	   across	   the	   BBB	   has	   been	  proposed.	   	   Evidence	   in	   support	   of	   this	  model	   has	   come	   from	   the	   observation	   of	  mononuclear	   cells	   containing	   intracellular	   yeast	   within	   meningeal	   capillaries	  (Chretien	   et	   al.,	   2002)	   and	   also	   from	   a	   study	   in	   a	  mouse	  model	  where	   infection	  with	   macrophages	   containing	   cryptococci	   led	   to	   threefold	   increase	   in	   fungal	  burden	  within	   the	  brain	   compared	   to	   injection	  of	   free	  yeast	   cells	   (Charlier	   et	  al.,	  2009).	   Thirdly,	   the	   potential	   for	   lateral	   transfer	   of	   cryptococcal	   cells	   from	  circulating	   leukocytes	   to	   the	   brain	   endothelium,	   as	   is	   known	   to	   occur	   from	   one	  macrophage	   to	  another,	  has	  been	  discussed	  as	  potential	  mechanism	   for	   invading	  the	  CNS.	  	  	  It	   is	   now	   clear	   that	   cryptococci	   are	   adept	   intracellular	   pathogens,	   with	   complex	  mechanisms	   that	  allow	  them	  to	  proliferate	  within,	  and	  eventually	  exit	   from,	  host	  phagocytes.	  However,	  a	  vital	  and	  unanswered	  question	  is	  how	  the	  different	  facets	  of	  intracellular	  behaviour	  affect	  the	  progress	  of	  cryptococcal	  disease.	  	  There	  can	  be	  little	  doubt	  that	  intracellular	  proliferation	  ultimately	  benefits	  the	  pathogen,	  but	  the	  question	  of	  whether	  expulsion	  and/or	   lateral	   transfer	   slows	  or	  enhances	  disease	  progression	   remains	   unanswered.	   On	   the	   one	   hand,	   cryptococci	   expelled	   from	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1.4	   CRYPTOCOCCAL	  VIRULENCE	  MECHANISMS	  IN	  THE	  INTERACTION	  
WITH	  HOST	  CELLS	  
	  Pathogens	  have	  evolved	  a	  great	  variety	  of	  strategies	  to	  gain	  advantage	  within	  the	  host	  environment	  and	   to	  successfully	  undermine	   the	  host’s	  defense	  mechanisms.	  Intracellular	   parasitism	   in	   particular	   is	   associated	   with	   a	   continuous	   struggle	  between	  the	  pathogen	  and	  its	  host	  cell.	  Within	  host	  cells,	  Cryptococcus	  encounters	  a	  harsh	  environment	  of	  reactive	  oxygen	  and	  nitrogen	  species;	  oxygen,	  nutrient	  and	  metal	   ion	   deprivation;	   low	   pH	   and	   high	   temperatures.	   Therefore,	   the	   yeast	  expresses	  multiple	  virulence	  factors	  including	  a	  capsule,	  melanin	  and	  a	  variety	  of	  secreted	  enzymes	  that	  can	  modify	  the	  host’s	  defense	  mechanisms.	  This	  section	  will	  focus	  on	  strategies	  applied	  by	  Cryptococcus	  that	  counteract	  the	  host’s	  responses	  in	  order	  to	  establish	  itself	  within	  the	  intracellular	  niche.	  	  Interestingly,	  Cryptococcus	  does	  not	  seem	  to	  utilize	  manipulative	  strategies	  similar	  to	  those	  used	  by	  other	  intracellular	  pathogens.	  In	  fact,	  the	  yeast	  seems	  to	  be	  well	  adapted	   to	   the	   harsh	   environment	  within	   the	   host	   cell.	   In	   contrast	   to	   pathogens	  such	   as	  Listeria	  monocytogenes	   or	   Shigella	   flexneri,	  C.	   neoformans	   resides	   in	   and	  does	  not	  escape	  from	  the	  phagosome	  (Southwick	  et	  al.,	  1996,	  Shoham	  et	  al.,	  2005,	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Levitz	  et	  al.,	  1999).	  Moreover,	  C.	  neoformans	  does	  not	  inhibit	  phagosome-­‐lysosome	  fusion	   in	   human	   macrophages	   (Levitz	   et	   al.,	   1999)	   as	   has	   been	   shown	   for	  
Legionella	   pneumophila	   (Horwitz,	   1983)	   nor	   does	   the	   yeast	   interfere	   with	  phagosome	   maturation	   or	   acidification,	   as	   occurs	   during	   infections	   with	  
Histoplasma	   capsulatum	   or	  Mycobacterium	   avium	   (Sturgill-­‐Koszycki	   et	   al.,	   1994,	  Strasser	   et	   al.,	   1999,	   Shoham	   et	   al.,	   2005,	   Levitz	   et	   al.,	   1999).	   Instead	   the	   yeast	  survives	   and	   replicates	   in	   the	   acidic	   phagolysosome	   and,	   in	   fact,	   any	   increase	   in	  phagosomal	   pH	   (e.g.	   by	   experimental	   addition	   of	   chloroquine	   or	   ammonium	  chloride),	  leads	  to	  reduced	  intracellular	  proliferation	  (Levitz	  et	  al.,	  1997a).	  The	   cryptococcal	   polysaccharide	   capsule	   is	   the	   best-­‐studied	   virulence	   factor	  (reviewed	   in	   (Zaragoza	   et	   al.,	   2009)).	   It	   inhibits	   phagocytosis	   by	   macrophages	  (Levitz	   et	   al.,	   1989,	   Granger	   et	   al.,	   1985,	   Bolanos	   et	   al.,	   1989),	   dendritic	   cells	  (Vecchiarelli	   et	   al.,	   2003)	   and	   neutrophils	   (Kozel	   et	   al.,	   1984,	   Dong	   et	   al.,	   1997,	  Diamond	   et	   al.,	   1972)	   and	   consequently	   non-­‐encapsulated	   strains	   are	  phagocytosed	   three-­‐times	   more	   effectively	   by	   human	   leukocytes	   (Bulmer	   et	   al.,	  1967,	  Cross	  et	  al.,	  1997).	  This	  effect	  seems	  to	  result	  from	  a	  masking	  mechanism	  of	  opsonins	  where	  the	  polysaccharides	  form	  a	  barrier	  between	  the	  opsonin	  and	  their	  receptor	  (McGaw	  et	  al.,	  1979).	  Once	  infection	  is	  established,	  high	  concentrations	  of	  free	   glucuronoxylomannan	   (GXM),	   the	   major	   component	   of	   the	   cryptococcal	  capsule,	  are	  found	  in	  patient’s	  bodily	   fluids	  making	  it	   likely	  that	  many	  antibodies	  form	  immune	  complexes	  before	  they	  can	  efficiently	  opsonise	  yeast	  cells	  (Powderly	  
et	   al.,	   1994).	   In	   addition,	   C.	   neoformans	   expresses	   the	   factor	   anti-­‐phagocytic	  protein	  1	  (APP1)	  that	  inhibits	  uptake	  through	  a	  complement-­‐mediated	  mechanism	  of	   binding	   to	   complement	   receptors	   2	   and	   3	   (Luberto	   et	   al.,	   2003,	   Stano	   et	   al.,	  2009).	  	  Besides	   its	   anti-­‐phagocytic	   properties,	   the	   cryptococcal	   capsule	   also	   provides	  protection	   against	   reactive	   oxygen	   (ROS)	   and	   nitrogen	   species	  within	   host	   cells.	  Part	  of	   the	  strategy	  by	  which	  phagocytic	  cells	  kill	  pathogens	   is	   the	  production	  of	  oxygen	  and	  nitrogen	  radicals	  (Diamond	  et	  al.,	  1972,	  Alspaugh	  et	  al.,	  1991,	  Hibbs	  et	  
al.,	   1987,	   Lovchik	   et	   al.,	   1995,	   Murray	   et	   al.,	   1983,	   Walker	   et	   al.,	   1981).	   The	  cryptococcal	   polysaccharide	   capsule	   is	   an	   important	   factor	   in	   protecting	   against	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oxidative	  stress	  by	  buffering	  reactive	  oxygen	  species	  (ROS).	  The	  capsule	  becomes	  enlarged	  upon	  interaction	  with	  phagocytic	  cells	  in	  vivo	  and	  in	  vitro	  (Feldmesser	  et	  
al.,	  2001a)	  and	  is	  important	  for	  the	  yeast’s	  ability	  to	  multiply	  intracellularly,	  since	  encapsulated,	   but	   not	   acapsular,	   yeast	   cells	   can	   replicate	   inside	   macrophages	  (Feldmesser	  et	  al.,	  2000).	  Cryptococcal	  susceptibility	  to	  ROS	  is	  directly	  correlated	  with	  capsule	  size;	  ROS	  kill	  cells	  with	  larger	  capsules	  less	  efficiently	  than	  cells	  with	  smaller	  capsules	  (Zaragoza	  et	  al.,	  2008).	  The	  effect	  can	  be	  mimicked	  in	  cells	  with	  a	  small	   capsule	   by	   adding	   soluble	   capsular	   polysaccharide	   to	   the	   medium,	   thus	  demonstrating	   that	   resistance	   is	   directly	   mediated	   by	   the	   presence	   of	   capsular	  material	  (Zaragoza	  et	  al.,	  2008).	  In	  fact,	  an	  earlier	  study	  showed	  that	  GXM	  reduces	  cryptococcal	   killing	   and	  production	  of	   superoxide	   in	  primary	  human	  neutrophils	  (Monari	   et	   al.,	   2003).	   This	   effect	   may	   underlie	   the	   phenomenon	   of	   phenotypic	  switching,	  characterized	  by	  a	  switch	   in	  cryptococcal	  colony	  morphology	  between	  smooth	   and	   mucoid,	   with	   the	   latter	   showing	   increased	   survival	   in	   the	   murine	  macrophage	  cell	  line	  J774	  (Fries	  et	  al.,	  2001,	  Jain	  et	  al.,	  2006,	  Guerrero	  et	  al.).	  	  Furthermore,	   during	   intracellular	   growth	   a	   range	   of	   secreted	   enzymes	   are	  involved	  in	  detoxifying	  oxygen	  and	  nitrogen	  radicals:	  superoxide	  dismutase	  (SOD)	  (Cox	   et	   al.,	   2003),	   an	   alternative	   oxidase	   (AOX1)	   (Akhter	   et	   al.,	   2003),	   a	  flavinhemoglobin	   denitrosylase	   (FHB1)	   (de	   Jesus-­‐Berrios	   et	   al.,	   2003),	   urease	  (URA1)	  (Cox	  et	  al.,	  2000),	  glutathione	  peroxidase	  (GLR1)	  (Missall	  et	  al.,	  2004)	  and	  thiol	   peroxidase	   (TSA1)	   (Missall	   et	   al.,	   2004).	   Superoxide	   dismutase	   (SOD)	  converts	   superoxide	   to	   hydrogen	   peroxide	   and	   oxygen	   (Fridovich,	   1995)	   and	   a	  
C.	  neoformans	   sod1	  mutant	   strain	   exhibits	   significantly	   attenuated	   growth	   inside	  primary	   human	   and	   murine	   macrophages	   (Cox	   et	   al.,	   2003).	   Disruption	   of	   the	  alternative	   oxidase	   gene	   aox1	   also	   leads	   to	   significantly	   slower	   growth	   within	  murine	   alveolar	   macrophages	   (Akhter	   et	   al.,	   2003).	   Similarly,	   FHB1,	   a	  flavohemoglobin	   denitrosylase,	   plays	   an	   important	   role	   in	   the	   response	   to	  nitrosative	   stress	   and	   knockout	   of	   fbh1	   leads	   to	   reduced	   proliferation	   in	   the	  murine	  macrophage	  cell	   line	  MH-­‐S	  (de	  Jesus-­‐Berrios	  et	  al.,	  2003).	  In	  addition,	  the	  urease	  URE1	  (Cox	  et	  al.,	  2000)	  and	  the	  thiol	  peroxidase	  TSA1	  (Missall	  et	  al.,	  2004)	  have	   been	   shown	   to	   be	   involved	   in	   counteracting	   oxidative	   and	   nitrosative	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stresses,	   although	   there	   are	   no	   direct	   data	   on	   the	   impact	   of	   these	   proteins	   on	  intracellular	  proliferation.	  The	   function	  of	  all	   these	  enzymes	   is	  dependent	  on	   the	  availability	   of	   NADPH.	   Two	   sources	   of	   NADPH	   are	   glucose-­‐6-­‐phosphate	  dehydrogenase	  (ZWF1)	  and	  NADP(+)-­‐dependent	  isocitrate	  dehydrogenase	  (IDP1).	  Whilst	   deletion	   of	   zwf1	   does	   not	   change	   cryptococcal	   susceptibility	   to	   oxidative	  stress,	   mutation	   of	   idp1	   results	   in	   a	   sensitivity	   phenotype	   towards	   nitrosative	  stress	  (Brown	  et	  al.,	  2010).	  The	   pigment	   melanin,	   produced	   by	   the	   enzyme	   laccase,	   is	   thought	   to	   provide	  protection	   from	   both	   oxygen-­‐	   and	   nitrogen	   reactive	   species	   in	   Cryptococcus	   by	  virtue	   of	   its	   antioxidant	   properties	   (Wang	   et	   al.,	   1994,	   Wang	   et	   al.,	   1995).	   The	  melanized	   C.	   neoformans	   strain	   145	   is	   more	   resistant	   to	   cell	   death	   caused	   by	  lymphocytes	  than	  the	  less	  melanized	  strain	  52	  (Huffnagle	  et	  al.,	  1995).	  A	  model	  for	  the	  regulation	  of	  melanin	  production	  by	  the	  sphingolipid	  pathway	  in	  Cryptococcus	  proposes	  activation	  of	  protein	  kinase	  C1	  (PKC1)	  via	  inositol-­‐phosphoryl	  ceramide	  synthase	  (IPC1)	  through	  the	  regulation	  of	  diacylglycerol	  (DAG)	  and	  phytoceramide	  concentrations,	  resulting	  in	  subsequent	  PKC1-­‐dependent	  laccase	  activation	  (Heung	  
et	   al.,	   2004).	   Deletion	   of	   pkc1	   shows	   that	   the	   gene	   is	   essential	   for	   the	   defense	  against	   oxidative	   and	   nitrosative	   stresses,	   however,	   as	   deletion	   of	   downstream	  targets	   in	   the	   signaling	   cascade	  does	  not	   show	   the	   same	   effect,	   PKC1	  might	   also	  function	   independent	   of	   the	   MAP-­‐kinase	   pathway	   (Gerik	   et	   al.,	   2008).	   An	   ipc1	  mutant	   shows	   a	   decrease	   in	   melanin	   production	   (Luberto	   et	   al.,	   2001)	   and	  significant	   down-­‐regulation	   of	   intracellular	   growth	   in	   J774	   macrophages.	   IPC1	  consumes	  phytoceramide	  to	  produce	  complex	  sphingolipids	  and	  DAG.	  Thus,	   IPC1	  probably	  increases	  cryptococcal	  survival	  via	  the	  activation	  of	  melanin	  production	  (Luberto	  et	  al.,	  2001).	  Interestingly,	  DAG	  has	  been	  implicated	  in	  activation	  of	  PKC1,	  an	  activator	  of	  laccase	  (Heung	  et	  al.,	  2004).	  The	  enzyme	  laccase	  is	  also	  involved	  in	  the	   synthesis	   of	   melanin	   by	   oxidizing	   catecholamine	   substrates	   (Williamson,	  1997).	  However,	  Liu	  et	  al.	  (1999)	  (Liu	  et	  al.,	  1999)	  reported	  a	  protective	  function	  of	   laccase	   that	   is	   independent	  of	  melanin	  synthesis.	  The	  C.	  neoformans	  strain	  2E-­‐TU,	  a	  laccase-­‐deficient	  strain,	  is	  more	  sensitive	  towards	  killing	  by	  murine	  alveolar	  macrophages	   than	   the	   laccase-­‐positive	   strain	   2E-­‐TUC.	   This	   laccase-­‐mediated	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protection	   from	   killing	   by	   macrophages	   also	   occurs	   in	   media	   lacking	   suitable	  catecholamine	  substrates	  and	   thus	  does	  not	  require	  melanin	  production.	  Further	  investigation	  revealed	  an	  iron	  oxidase	  function	  of	  laccase	  that	  may	  maintain	  iron	  in	  an	   oxidized	   form,	   thereby	   inhibiting	   production	   of	   hydroxyl	   radicals	   by	   the	   host	  cell	  (Liu	  et	  al.,	  1999).	  	  Glucosylceramide	   (GlcCer),	   a	   glycosphingolipid	   found	   at	   the	   surface	   of	  
C.	  neoformans	  cells,	  has	  been	  identified	  as	  a	  regulator	  of	  fungal	  virulence	  in	  recent	  years	  (Rittershaus	  et	  al.,	  2006).	  Knockout	  of	  the	  GlcCer	  synthase	  GCS1	  results	  in	  a	  very	   interesting	   phenotype	   in	   mouse	   models	   where	   the	   mutant	   is	   rendered	  avirulent	   following	   nasal	   inhalation	   yet	   causes	   fatal	   disease	   when	   injected	  intravenously	   (Rittershaus	   et	   al.,	   2006).	   The	   Δgcs1	   strain	   also	   shows	   a	   specific	  growth	   defect	   under	   high	   CO2	   and	   at	   neutral	   pH	   but	   still	   grows	   well	   within	  macrophages	   (Rittershaus	   et	   al.,	   2006).	  Within	   tissues,	   the	   CO2	   concentration	   is	  relatively	  high	  at	  5	  %	  compared	  to	  0.04	  %	  in	  the	  atmosphere,	  suggesting	  that	  the	  sphingolipid	   might	   be	   involved	   in	   adaptation	   to	   the	   conditions	   within	   the	   host	  environment	  and	  that	  the	  mutant	  is	  impaired	  in	  traversing	  the	  lung	  tissue	  to	  reach	  the	  intracellular	  niche	  (Mitchell,	  2006).	  Within	   the	   intracellular	   environment,	   Cryptococcus	   is	   deprived	   of	   oxygen	   and	  nutrients.	   Cryptococcus	   grows	   very	   well	   under	   atmospheric	   oxygen	   condition	  (21	  %	   O2)	   but	   has	   to	   face	   low	   oxygen	   concentrations	   in	   the	   host	   ranging	   from	  approximately	   12	  %	   in	   the	   blood	   to	   only	   3-­‐6	  %	   in	   tissues	   and	   the	   brain.	   In	   this	  context,	  Chun	  et	  al.	  (2007)	  (Chun	  et	  al.,	  2007)	  and	  Chang	  et	  al.	  (2007)	  (Chang	  et	  al.,	  2007)	   identified	   a	   mutant	   of	   the	   sterol	   regulatory	   element	   binding	   protein	  (SREBP)	   homolog	   Sre1p	   that	   is	   unable	   to	   grow	   under	   hypoxic	   conditions	   and	  shows	  reduced	  virulence	  in	  a	  mouse	  model.	  The	  Sre1p	  homolog	  is	  believed	  to	  be	  an	  oxygen-­‐sensing	  component	  of	  the	  cholesterol	  biosynthesis	  regulatory	  pathway	  in	  mammals	  that	  is	  required	  for	  the	  induction	  of	  sterol	  synthesis	  genes	  under	  low	  oxygen	  concentrations	  (Lee	  et	  al.,	  2007,	  Chang	  et	  al.,	  2007).	  In	  mammals,	  SREBPs	  are	  localized	  in	  the	  ER-­‐membrane	  and	  contain	  two	  transmembrane	  segments	  in	  a	  hairpin	  fashion	  with	  the	  N-­‐	  and	  C-­‐terminus	  pointing	  towards	  the	  cytoplasm.	  The	  N-­‐terminal	   region	   functions	   as	   a	   basic	   helix-­‐loop-­‐helix-­‐leucine	   zipper	   transcription	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factor	  whereas	   the	  C-­‐terminal	   region	  binds	   the	   cleavage	   activating	  protein	   SCAP	  (Figure	  11)	  (Rawson,	  2003).	  A	  similar	  pathway	  has	  been	  found	  in	  the	  fission	  yeast	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Under	  nutrient	  limitation,	  autophagy	  appears	  to	  be	  one	  way	  in	  which	  Cryptococcus	  acquires	  additional	  nutrients	  upon	  starvation.	  A	  cryptococcal	  strain	  lacking	  vps34,	  a	   component	   of	   the	   type	   I	   kinase	   sub-­‐complex	   that	   is	   required	   for	   autophagy,	   is	  rapidly	   killed	   by	   murine	   macrophages	   (Kihara	   et	   al.,	   2001).	   In	   addition,	   no	  autophagic	  bodies	  were	  detected	   in	   the	  mutant	  cells	   (Hu	   et	  al.,	  2008).	  Strikingly,	  autophagy	   is	   normally	   a	   host	   response	   to	   control	   the	   replication	   of	   intracellular	  pathogens	   such	   as	   Mycobacterium	   tuberculosis	   (Gutierrez	   et	   al.,	   2004)	   and	  
Legionella	   pneumophila	   (Amer	   et	   al.,	   2005).	   Cryptococcus	   therefore	   represents	   a	  rare	   example	   of	   a	   pathogen,	   rather	   than	   its	   host,	   utilizing	   autophagy	   during	  intracellular	   growth.	   There	   is	   also	   growing	   evidence	   that	   cryptococci	   increase	  nutrient	   flow	   into	   the	   phagolysosome	   via	  membrane	   disruption.	   Phospholipases	  hydrolyze	   ester	   linkages	   in	   glycerophospholipids,	   which	   can	   result	   in	  destabilization	   of	   membranes,	   cell	   lysis	   and	   release	   of	   second	   messengers	  (Ghannoum,	  2000,	  Schmiel	  et	  al.,	  1999).	  Phagocytosed	  C.	  neoformans	  cells,	  negative	  for	   phospholipase	   B	   (PLB)	   expression,	   display	   a	   defect	   in	   the	   onset	   of	   budding.	  This	  leads	  to	  a	  lag	  in	  intracellular	  proliferation	  relative	  to	  wild	  type	  cells	  (Cox	  et	  al.,	  2001).	  As	  phospholipases	   can	   cause	  membrane	  damage	  and	  are	   also	   involved	   in	  lipid	   metabolism	   (Wright	   et	   al.,	   2007),	   they	   may	   therefore	   be	   important	   for	  increasing	  nutrient	  availability	  to	  the	  pathogen.	  	  Beside	   nutrient	   and	   oxygen	   starvation,	   intracellular	   cryptococci	   also	   experience	  low	   concentrations	   of	  metal	   ions.	  Many	   cryptococcal	   virulence	   enzymes	   such	   as	  laccase,	   SOD,	   catalase	   and	   urease,	   depend	   upon	   metal	   ions	   and	   thus	   cation-­‐homeostasis	   is	   important	   for	   their	   functions.	   C.	   neoformans	   expresses	   two	  ferroxidases	   CFO1	   and	   CFO2.	   CFO1	   is	   required	   for	   the	   reductive	   iron	   uptake	  system	  and	   enables	   the	  utilization	  of	   transferrin	   as	   iron	   source	  during	   infection.	  Deletion	   of	   cfo1	   reduces	   cryptococcal	   virulence	   in	   mice	   (Jung	   et	   al.,	   2009).	   To	  inhibit	   cryptococcal	   replication,	   macrophages	   actively	   try	   to	   reduce	   the	  concentration	   of	   metal	   ions	   in	   the	   phagolysosome.	   The	   macrophage-­‐expressed	  protein	  NRAMP1	   (natural	   resistance-­‐associated-­‐macrophage	   protein	   1),	  which	   is	  homologous	   to	   the	   membrane	   transporters	   SFM1	   and	   SFM2	   in	   Saccharomyces	  
cerevisiae,	  has	  been	  suggested	  to	  be	  involved	  in	  transport	  of	  divalent	  cations,	  such	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as	  Mn2+,	  Zn2+	  or	  Fe2+,	   across	   the	  phagosome	  membrane	  (Supek	   et	  al.,	  1996).	  The	  
Nramp1-­	   bone	   marrow	   derived	   macrophage	   cell	   line	   129.1	   shows	   significantly	  reduced	  anticryptococcal	  activity	   in	  the	  first	  six	  hours	  after	   infection	  (Blasi	  et	  al.,	  2001).	  This	  might	   reflect	   an	  altered	   intracellular	   environment	  with	  better	   cation	  availability	   for	   cryptococcal	   metal-­‐dependent	   enzymes	   and	   therefore	   higher	  enzymatic	   activity	   and	   better	   protection	   from	   oxidative	   and	   nitrosative	   stress.	  Notably,	  many	  studies	  on	  Cryptococcus-­‐host	  cell	   interactions	  use	  macrophage	  cell	  lines	  (e.g.	  RAW)	  derived	  from	  BALB/c	  mice	  (Barton	  et	  al.,	  1995).	  However,	   it	  has	  been	   shown	   that	   these	  mice	   have	   defects	   in	  NRAMP1,	   and	   thus	   the	   intracellular	  proliferative	  potential	  might	  be	  overestimated	  in	  some	  cases.	  	  Following	   uptake,	   the	   phagolysosome	   pH	   rapidly	   decreases	   to	   below	   pH	   5.5	  (Sturgill-­‐Koszycki	   et	   al.,	   1994)	   to	   improve	   antimicrobial	   activity.	   However,	  
Cryptococcus	  actively	  prefers	  an	  acidic	  environment	  and	  phagosome	  alkalinization,	  by	   agents	   such	   as	   chloroquine,	   inhibits	   cryptococcal	   survival	   and	   intracellular	  proliferation	   (Levitz	   et	   al.,	   1999).	   In	   addition,	   increased	   pH	   also	   reduces	   cation	  availability	   and	  might	   inhibit	   yeast	   enzyme	   functions.	   Nonetheless,	  Cryptococcus	  still	   needs	   to	   adapt	   to	   the	   low	   phagolysosomal	   pH.	   The	   enzyme	   inositol	  phosphosphingolipid-­‐phospholipase	   C	   (ISC1),	   an	   enzyme	   generating	  phytoceramide,	   seems	   to	   be	   important	   in	   providing	   protection	   from	   the	   acidic	  milieu.	  In	  S.	  cerevisiae,	  phytoceramide	  plays	  an	  important	  role	  in	  regulating	  PMA1	  (Ferreira	   et	   al.,	   2001,	   Gaigg	   et	   al.,	   2005),	   an	   ATPase	   that	   is	   involved	   in	   the	  regulation	   of	   intracellular	   pH	   (Holyoak	   et	   al.,	   1996,	   Stadler	   et	   al.,	   2001,	  Soteropoulos	  et	  al.,	  2000)	  as	  well	  as	  oxidative	  (Sigler	  et	  al.,	  1991)	  and	  nitrosative	  stress	  (Zhao	  et	  al.,	  2004).	  In	  fact,	  intracellular	  survival	  in	  J774	  macrophages	  of	  the	  
isc1	  mutant	  strain	  was	  significantly	  reduced	  and	  the	  strain	  was	  more	  sensitive	  to	  oxidative,	   nitric	   and	   acidic	   stress	   (Shea	   et	   al.,	   2006).	   The	   cryptococcal	   VSP41	  homolog	  has	  also	  been	  implicated	  in	  regulating	  metal	  ion	  concentrations	  by	  copper	  loading	  of	  the	  iron	  transporter	  FET3	  in	  yeast	  (Radisky	  et	  al.,	  1997).	  Disruption	  of	  
vps41	   in	   C.	  neoformans	   results	   in	   abolishment	   of	   intracellular	   growth	   in	   J774	  macrophages	  as	  well	  as	  reduced	  cryptococcal	  growth	  on	  iron-­‐	  and	  copper-­‐deficient	  media	  (Liu	  et	  al.,	  2006).	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It	   is	   clear	   that	   the	   processes	   that	   allow	   the	   transition	   between	   extracellular	   and	  intracellular	   proliferation	   of	   Cryptococcus	   in	   host	   cells	   are	   controlled.	   However,	  very	  little	  is	  known	  about	  the	  signaling	  pathways	  regulating	  the	  expression	  of	  the	  virulence	   factors	   described	   above.	   The	   cryptococcal	   two-­‐component	   stress	  regulator	   SKN7	   has	   been	   shown	   to	   be	   involved	   in	   oxidative	   stress	   signaling	   in	  endothelial	   cells.	   Disruption	   of	   skn7	   results	   in	   significantly	   impaired	   growth	   in	  primary	   human	   umbilical-­‐vein	   endothelial	   cells	   (Coenjaerts	   et	   al.,	   2006).	   In	  addition,	   the	   Rho-­‐type	   GTPases	   CDC42	   and	   RAC	   have	   been	   implicated	   in	   the	  regulation	   of	   high	   temperature	   growth,	   mating	   and	   cell	   morphology	   in	  
C.	  neoformans	  (Alspaugh	  et	  al.,	  2000,	  Nichols	  et	  al.,	  2007,	  Vallim	  et	  al.,	  2005,	  Waugh	  
et	   al.,	   2003)	   whilst	   RDI1	   (a	   Rho-­‐GTPase	   dissociation	   inhibitor	   that	   regulates	  GTPase	   activity	   in	   fission	   yeast	   (Koch	   et	   al.,	   1997,	   Nakano	   et	   al.,	   2003))	   is	  important	  for	  intracellular	  growth	  (Price	  et	  al.,	  2008).	  In	  addition	  to	  host	  cell	  and	  Cryptococcus	  factors,	  immune-­‐signaling	  molecules	  such	  as	   cytokines	   regulate	   yeast	   survival.	   Cytokine	   signaling	   leads	   to	   downstream	  activation	   or	   inhibition	   of	   antimicrobial	   effects	   in	   other	   immune	   cells	   such	   as	  phagocytic	   effector	   cells;	   Th1	   cytokines	   activate	   macrophages	   to	   create	   an	  oxidative	  and	  nitrosative	  burst	   as	  microbicidal	  mechanisms	   (classically	   activated	  macrophages)	  (Shoham	  et	  al.,	  2005,	  Huffnagle,	  1996)	  whereas	  Th2	  polarized	  host	  responses	   lead	   to	   inhibition	   of	   phagocyte	   activity	   (alternatively	   activated	  macrophages)	  and	  enhanced	  susceptibility	  to	  C.	  neoformans	  (Koguchi	  et	  al.,	  2002).	  This	   alternative	   activation	   is	   associated	   with	   up-­‐regulated	   expression	   of	   genes	  involved	  in	  tissue	  repair	  such	  as	  arginase-­‐1	  and	  the	  mannose	  receptor	  (reviewed	  in	   (Gordon,	   2003)).	   Arginase-­‐1	   competes	   with	   inducible	   nitric	   oxidase	   for	   the	  substrate	  L-­‐arginine	  and	  so	  decreases	  synthesis	  of	  nitric	  oxide	  (Hesse	  et	  al.,	  2001).	  Furthermore,	  a	  recent	  study	  has	  suggested	  that	  anti-­‐inflammatory	  cytokines	  might	  enhance	  iron	  uptake	  and	  storage	  by	  macrophages	  by	  suppressing	  the	  activation	  of	  iron	   regulatory	   protein	   1	   and	   2,	   leading	   to	   translational	   repression	   of	   the	   iron	  storage	   protein	   ferritin	   or	   translational	   activation	   of	   the	  membrane	   receptor	   for	  iron	  uptake	   (Osterholzer	   et	   al.,	   2009b).	  This	  would	   result	   in	   increased	  metal	   ion	  availability	   and	   thus	   increased	   activity	   of	   virulence	   factors.	   In	   fact,	   intracellular	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cryptococcal	  proliferation	   is	  significantly	  higher,	  and	   the	  occurrence	  of	  expulsion	  significantly	  lower,	  in	  macrophages	  activated	  by	  Th2	  cytokines	  IL-­‐4	  or	  IL-­‐13	  than	  in	  cells	  stimulated	  by	  Th1	  cytokines,	  such	  as	  IFN-­‐γ	  and	  TNF-­‐α	  (Figure	  12)	  (Voelz	  et	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Figure	  12:	  Th1/Th2/Th17	  balance	  during	  cryptococcosis.	  The	  ability	  of	  macrophages	  to	   inhibit	   cryptococcal	   growth	   is	   strongly	  dependent	  on	  cytokine	  balance.	  A	  Th1	  and/or	  Th17	   cytokine	  profile	   leads	   to	   less	   intracellular	  C.	   neoformans	  and	   C.	   gattii	  proliferation	  whereas	   a	   dominant	   Th2	   cytokine	   profile	   increases	   cryptococcal	   proliferative	   potential.	  The	   three	   panels	   show	   intracellular	   yeast	   proliferation	   at	   0,	   9,	   18	   and	   21	   hours	   after	  treatment	  with	  the	  Th1	  cytokine	  TNF-­‐α,	  the	  Th17	  cytokine	  IL-­‐17	  and	  the	  Th2	  cytokine	  IL-­‐13.	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1.5	  	   AIMS	  AND	  STRATEGY	  
Cryptococcosis	  is	  a	  constant	  and	  increasing	  medical	  problem,	  due	  to	  both	  the	  HIV	  pandemic	   and	   to	   the	   emergence	   of	   highly	   virulent	   strains.	   In	   addition,	   currently	  applied	  antifungal	  treatment	  regimes	  are	  not	  satisfactory	  for	  a	  number	  of	  reasons.	  This	  has	   led	  to	  a	  substantially	   increased	  effort	  to	  understand	  the	  pathogenesis	  of	  the	   fungus	   in	   recent	   years.	   We	   now	   have	   an	   understanding	   of	   how	   the	   host	  immune	  system	  tries	  to	  clear	  the	  yeast	  during	  an	  infection	  and	  have	  also	  started	  to	  decipher	   the	   mechanisms	   by	   which	   Cryptococcus	   undermines	   the	   host	   immune	  system.	   Much	   of	   these	   recent	   data	   highlight	   the	   importance	   of	   the	  cryptococcal/macrophage	   interaction	   –	   not	   only	   as	   an	   intracellular	   niche	   but	  potentially	   also	   as	   trafficking	   vehicle	   for	   dissemination.	   This	   leaves	   us	   with	   a	  complex	  network	  that	  has	  to	  be	  considered	   in	  the	  development	  of	  more	  effective	  anticryptococcal	   therapies.	   Future	   research	   will	   not	   only	   have	   to	   focus	   on	   the	  molecular	   mechanisms	   of	   pathogenicity	   but	   also	   on	   the	   effect	   on	   cryptococcal	  disease	  within	  a	  treated	  host.	  The	  research	  presented	  in	  this	  thesis	  tries	  to	  deepen	  the	   understanding	   of	   the	   role	   macrophages	   play	   during	   cryptococcosis	   and	  concentrates	  on	  four	  aspects.	  	  The	  first	  study	  focuses	  on	  the	  host,	  in	  particular	  on	  the	  effect	  of	  immune	  regulation	  on	   the	   interaction	  between	  macrophages	   and	  Cryptococcus.	   It	   is	  well	   established	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that	  C.	  neoformans	   is	  a	  pathogen	  of	   the	   immunocompromised	  showing	  defects	   in	  CMI,	  and	  also	  that	  Th1	  but	  not	  Th2	  cytokine	  profiles	  are	  protective	  in	  cryptococcal	  disease.	  However,	  these	  facts	  rely	  on	  observations	  made	  in	  whole	  organisms.	  This	  part	   of	   the	   thesis	   analyses	   the	   effect	   of	   different	   cytokine	   profiles	   on	   the	  interaction	  with	  macrophages	   in	  an	  attempt	  to	  understand	  the	   importance	  of	  the	  Th1/Th2	  balance	  during	  disease.	  	  The	   second	  part	   of	   this	   thesis	   is	   a	   technical	   chapter.	   Current	   approaches	   for	   the	  investigation	   of	   macrophage-­‐Cryptococcus	   interactions	   are	   very	   time-­‐consuming	  and	  low	  throughput.	  This	  section	  reports	  the	  analysis	  of	  yeast	  uptake,	  intracellular	  replication	  and	  occurrence	  of	  expulsion	  via	  a	  flow	  cytometry	  approach	  by	  creating	  GFP-­‐expressing	   cryptococcal	   type	   strains.	   The	   mutant	   phenotypes	   are	   analysed	  and	  strategies	  for	  automated	  analysis	  described.	  	  The	  third	  study	  concentrates	  on	  the	  question	  of	  how	  certain	  C.	  gattii	  strains	  have	  acquired	   a	   hypervirulent	   phenotype	   that	   causes	   disease	   in	   immunocompetent	  individuals.	   This	   section	   examines	   the	   role	   of	  mitochondria	   in	   adaptation	   to	   the	  intracellular	  environment	  within	  macrophages	  and	  examines	  the	  effect	  of	  different	  host	   cell	   stresses	   on	   the	  morphology	   of	   yeast	  mitochondria	   and	   the	   behavior	   of	  cryptococcal	   mitochondria	   within	   host	   cells	   over	   time.	   In	   addition,	   available	  mitochondrial	  genomes	  are	  investigated	  and	  the	  first	  steps	  towards	  a	  comparative	  mitochondrial	  genome	  analysis	  undertaken.	  The	  final	  chapter	  presents	  data	  on	  the	  involvement	  of	  the	  sterol	  response	  element	  binding	   protein	   1	   (Sre1p)	   in	   oxygen	   signaling	   during	   interaction	   between	  macrophages	  and	  Cryptococcus.	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IPR	  in	  PMA	  
activated	  J774	  
macrophages	  
(Ma	  et	  al.,	  
2009a)	  
Additional	  Information	  
C.	  neoformans	  H99	  	   A	   1	   1.42	   Clinical	  isolate,	  USA	  
C.	  neoformans	  ATCC90112	   A	   1	   2.85	   Clinical	  isolate	  from	  cerebrospinal	  fluid,	  USA	  
C.	  neoformans	  JEC21	   D	   2	   2.12	   Clinical	  isolate,	  AIDS	  case,	  USA	  
C.	  gattii	  R265	   B	   6	  	   1.74	   Clinical	  isolate	  from	  Vancouver	  Island	  outbreak,	  Canada	  
C.	  gattii	  A1M-­‐R271	   B	   6	   2.04	   Clinical	  isolated	  from	  immunocompetent	  male,	  British	  Columbia,	  Canada	  
C.	  gattii	  A1M-­‐F2932	   B	   6	   2.98	   Clinical	  isolated	  from	  immunocompetent	  male,	  British	  Columbia,	  Canada	  
C.	  gattii	  ENV152	   B	   6	   2.28	   Alder	  tree,	  Vancouver	  Island,	  Canada	  
C.	  gattii	  CBS7229T	   B	   4	   0.56	   Meningitis,	  China	  
C.	  gattii	  CBS8684	   B	   6	   0.90	   Wasp	  nest,	  Uruguay	  
C.	  gattii	  CBS7750	   B	   6	   0.93	   E.	  camaldulensis,	  USA	  
C.	  gattii	  CBS1930	   B	   6	   1.14	   Sick	  goat,	  Aruba	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2.1.2	   SACCHAROMYCES	  CEREVISIAE	  STRAIN	  AND	  CULTIVIAITON	  The	  uracil	  negative	  Saccharomyces	  cerevisiae	  MLY40	  (Lorenz	  et	  al.,	  1997)	  was	  used	  for	  homologous	  recombination	  in	  this	  study.	  The	  yeast	  was	  cultured	  either	  on	  YPD	  plates	   or	   in	   liquid	   media	   at	   30°C	   with	   shaking	   at	   180	   rpm.	   Stocks	   were	   frozen	  down	  in	  15	  %	  glycerol	  at	  -­‐80°C.	  
	  
2.1.3	   ESCHERICHIA	  COLI	  STRAIN	  AND	  CULTIVIATION	  The	  Escherichia	  coli	  strain	  DH5α	  was	  cultured	  on	  LB	  broth	  media	  either	  on	  plates	  or	   in	   liquid	  media	  at	  37°C	  with	  shaking	  at	  220	  rpm.	  Stocks	  were	   frozen	  down	   in	  40	  %	  glycerol	  at	  -­‐80°C.	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2.2	   CELL	  CUTLURE	  TECHNIQUES	  
	  
2.2.1	   MAMMALIAN	  CELLS	  AND	  GROWTH	  CONDITIONS	  The	  semi-­‐adherent	  macrophage-­‐like	  cell	  line	  J774	  and	  human	  primary	  monocyte-­‐derived	  macrophages	  were	   used	   for	   experimental	  work.	   The	   cell	   line	   is	   derived	  from	  a	  reticulum	  sarcoma	  that	  arose	  in	  a	  female	  BALB/c/NIH	  mouse	  (Ralph	  et	  al.,	  1975).	  The	  cells	  were	  used	  between	  passage	  5	  and	  20	  after	  thawing	  and	  cultured	  in	   Dulbecco’s	   Modified	   Eagle	   Medium	   (DMEM)	   supplemented	   with	   10	   %	   heat-­‐inactivated	  fetal	  bovine	  serum	  (FBS),	  2	  mM	  glutamine,	  100	  units/ml	  streptomycin	  and	   100	   units/ml	   penicillin	   (culture	   media)	   at	   37°C	   and	   5	   %	   CO2	   (Voelz	   et	   al.,	  2009,	  Ma	  et	  al.,	  2006).	  Human	  primary	  peripheral	  blood	  monocytes	  were	  isolated	  from	  Buffy	  coats	  from	  eight	  independent	  healthy	  volunteers	  supplied	  by	  the	  local	  blood	  transfusion	  unit.	  To	  separate	  and	  collect	  mononuclear	  cells,	  the	  sample	  was	  diluted	   two-­‐fold	   and	   30	   ml	   was	   centrifuged	   over	   a	   20	   ml	   Ficoll-­‐Paque	   PLUS	  cushion	  at	  400	  relative	  centrifugal	   force	  (rcf)	   for	  30	  min.	  The	  mononuclear	   layer	  was	  collected	  and	  washed	  multiple	  times	  with	  phosphate-­‐buffered	  saline	  (PBS,	  pH	  7.2)	   to	   remove	   platelets.	   Monocytes	   were	   isolated	   by	   adherence	   to	   plastic	   at	   a	  concentration	   of	   4-­‐6	   x	   106	   cells/ml	   in	   RPMI	   1640	   media	   supplemented	   with	  2	  %	  FBS,	  2	  mM	  glutamine,	  100	  units/ml	  streptomycin	  and	  100	  units/ml	  penicillin	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at	  37°C	  and	  5	  %	  CO2	  for	  1	  hr.	  Non-­‐adherent	  lymphocytes	  were	  removed	  with	  warm	  PBS	   and	   adherent	   cells	   differentiated	   into	   macrophages	   in	   RPMI	   1640	   media	  supplemented	  with	   10	  %	   FBS,	   2	  mM	   glutamine,	   100	   units/ml	   streptomycin	   and	  100	   units/ml	   penicillin	   at	   37°C	   and	   5	   %	   CO2	   (culture	   media)	   containing	  100	  units/ml	   GM-­‐CSF.	   After	   incubation	   overnight,	   the	   cells	   were	   washed	   with	  warm	   PBS	   and	   detached	  with	   ice-­‐cold	   PBS	   on	   ice	   for	   30	  min.	   The	  macrophages	  were	   collected,	   resuspended	  and	  plated	   into	  24	  well	  plates	   at	   a	   concentration	  of	  5	  x	  105	   cells/well	   in	   RPMI	   1640	   culture	  media	   containing	   100	   units/ml	   GM-­‐CSF.	  The	  next	  day,	   the	  media	  was	   replaced	  by	  GM-­‐CSF	   free	  RPMI	  1640	  culture	  media	  and	  the	  cells	  cultured	  for	  another	  4	  days	  at	  37°C	  and	  5	  %	  CO2	  before	  assays	  were	  commenced	  (Voelz	  et	  al.,	  2009).	  	  	  
2.2.2	   FREEZING	  DOWN	  STOCKS	  OF	  J774	  MACROPHAGES	  To	   freeze	  down	   J774	  macrophage	  stocks,	   cells	  were	  grown	  until	  90	  %	  confluent,	  mechanically	   detached	   from	   the	   tissue	   culture	   flask	   using	   a	   cell	   scraper	   and	  transferred	  into	  centrifuge	  tubes.	  Cells	  were	  collected	  by	  centrifugation	  for	  10	  min	  at	   1000	   rcf	   and	   20°C.	   The	   supernatant	   was	   discarded	   and	   the	   macrophages	  resuspended	  in	  filter	  sterilized	  freezing	  media	  containing	  50	  %	  FBS,	  40	  %	  DMEM	  and	  10	  %	  Dimethyl	  sulfoxide	  (DMSO).	  Aliquots	  were	  frozen	  down	  for	  3	  hr	  at	  -­‐20°C	  and	  24	  hr	  at	  -­‐80°C	  before	  being	  transferred	  to	  -­‐80°C.	  Quick	  handling	  was	  required	  to	  avoid	  cell	  damage	  caused	  by	  DMSO.	  	  
2.2.3	   DEFROSTING	  J774	  CELLS	  FROM	  LIQUID	  NITROGEN	  Aliquots	   of	   J774	   cells	  were	   defrosted	   from	   liquid	   nitrogen	   storage	   and	   10	  ml	   of	  DMEM	   culture	   media	   was	   added	   immediately	   to	   avoid	   cell	   damage	   caused	   by	  DMSO.	  The	  cells	  were	  collected	  for	  10	  min	  at	  1000	  rcf	  and	  20°C.	  The	  supernatant	  was	  removed,	   fresh	  pre-­‐warmed	  culture	  media	  added	  and	  transferred	  into	  tissue	  culture	  flasks	  for	  cell	  culture.	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2.3	   ANALYSIS	  OF	  MACROPHAGE	  PARASITISM	  BY	  CRYPTOCOCCUS	  
	  
2.3.1	   CONDITIONS	   USED	   FOR	   INFECTION	   OF	   MACROPHAGES	   WITH	   CRYPTOCOCCUS	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Table	  3:	  Treatments	  and	  concentration	  used	  for	  infection	  of	  macrophages.	  
Condition	   Concentration	  
PMA	  IFN-­‐ γ	  
TNF-­‐α	  
IL-­‐17	  IL-­‐4	  IL-­‐13	  Cobalt	  Chloride	  
150	  ng/ml	  10	  U/ml	  1	  ng/ml	  10	  ng/ml	  10	  ng/ml	  10	  ng/ml	  0.1	  mM	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2.3.2	   INFECTION	  OF	  MACROPHAGES	  WITH	  CRYPTOCOCCUS	  
Cryptococcus	   strains	  were	  cultured	   in	   liquid	  YPD	  media	  (1	  %	  peptone,	  1	  %	  yeast	  extract,	  2	  %	  D-­‐(+)-­‐glucose)	  for	  24	  hr	  at	  25°C	  with	  shaking	  at	  240	  rpm	  or	  rotating	  at	  20	   rpm	  prior	   to	  experimental	  use	   (Voelz	   et	  al.,	   2009,	  Ma	   et	  al.,	   2006).	  One	  ml	  of	  J774	  cells	  (105	  cells/ml)	   in	  culture	  media	  were	  plated	  into	  each	  well	  of	  a	  24-­‐well	  tissue-­‐culture-­‐treated	  plate	  24	  hr	  prior	  to	  infection	  and	  kept	  at	  37°C	  and	  5	  %	  CO2.	  One	  hr	  before	  infection,	  J774	  cells	  were	  switched	  to	  serum-­‐free	  DMEM	  (as	  culture	  media	  but	  without	  FBS)	  with,	  if	  applicable,	  the	  culture	  condition	  to	  be	  tested	  (see	  section	   2.3.1).	   The	   human	   primary	   macrophages	   were	   pre-­‐incubated	   in	   the	  conditions	  to	  be	  tested	  24	  hr	  prior	  to	  the	  experiment	  in	  RPMI	  1640	  culture	  media	  and	   1	   hr	   in	   serum-­‐free	   RPMI	   1640	   culture	   media	   before	   infection.	   At	   the	   same	  time,	  Cryptococcus	  cells	  from	  24-­‐hr-­‐old	  liquid	  cultures	  were	  washed	  3	  x	  with	  PBS,	  counted	   in	   a	   haemocytometer	   and	   opsonized	   with	   10	   µg/ml	   of	   the	   monoclonal	  antibody	  18B7	  (a	  kind	  gift	  from	  Arturo	  Casadevall)	  or	  10	  %	  human	  serum	  at	  37°C	  for	  1	  hr.	  	  Human	  serum	  was	  obtained	  from	  blood	  drawn	  from	  healthy	  volunteers,	  which	  was	  allowed	  to	  clot	  for	  3	  hr	  at	  37°C	  before	  the	  serum	  fraction	  was	  drawn	  off	  and	   used	   immediately.	   After	   pre-­‐incubation,	   the	   opsonized	   yeast	   cells	   were	  directly	  added	  to	  J774	  cells	  or	  peripheral	  blood	  macrophages	  at	  a	  ratio	  of	  ten	  yeast	  cells	  per	  macrophage	  and	  phagocytosis	  was	  allowed	  to	  proceed	  for	  2	  hr	  at	  37°C	  in	  a	  5	  %	  CO2	  atmosphere.	  Afterwards,	  non-­‐internalized	  yeast	  cells	  were	  removed	  by	  extensive	   washes	   with	   pre-­‐warmed	   PBS	   and	   effectiveness	   of	   washing	   was	  controlled	  under	  a	  microscope	  (Voelz	  et	  al.,	  2009,	  Ma	  et	  al.,	  2006).	  	  
2.3.3	   PHAGOCYTOSIS	  ASSAY	  To	   assess	   the	   extent	   of	  Cryptococcus	   phagocytosis,	   J774	   cells	   or	   human	   primary	  macrophages	   were	   grown	   on	   13	  mm	   glass	   coverslips	   and	   infected	   as	   described	  above.	  Coverslips	  for	  cell	  culture	  were	  prepared	  by	  acid-­‐wash	  to	  remove	  any	  dirt	  or	   detergent	   and	   to	   enhance	   cell	   adhesion.	   The	   coverslips	   were	   covered	   with	  1	  M	  hydrochloride	   acid	   and	   swirled	   for	   five	   minutes.	   Afterwards,	   the	   acid	   was	  rinsed	  with	   copious	   amounts	   of	   distilled	  water	   followed	  by	   several	  washes	  with	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100	  %	  ethanol.	  The	  coverslips	  were	  kept	  in	  100	  %	  ethanol	  until	  further	  use.	  Cells	  were	   fixed	   on	   the	   coverslips	   with	   4	   %	   formaldehyde	   for	   20	   min	   at	   4°C.	   The	  coverslips	   were	   washed	   three	   times	   in	   PBS	   and	   twice	   in	   distilled	   water	   before	  being	  mounted	  in	  Mowiol	  mounting	  media	  (100	  mM	  Tris-­‐HCl	  pH	  8.5,	  9	  %	  Mowiol,	  25	  %	  glycerol)	  on	  microscope	  glass	  slides.	  Mowiol	  mounting	  media	   is	  a	  polyvinyl	  alcohol	   solution	   with	   hardening	   properties.	   Due	   to	   its	   optical	   properties	   –	   non-­‐absorbent	   and	   not	   light	   scattering	   when	   used	   with	   immersion	   oil	   -­‐	   it	   prepares	  sample	  cover	  slips	  for	  microscopy.	  A	  total	  of	  at	  least	  1000	  cells	  were	  observed	  per	  sample	   coverslip	   and	   scored	   for	   cells	  with	   internalized	   yeast	   cells.	   The	   extent	   of	  
Cryptococcus	   phagocytosis	   was	   calculated	   as	   the	   percentage	   of	   cells	   with	  internalized	  Cryptococcus	  (percentage	  phagocytosis)	  (Voelz	  et	  al.,	  2009).	  	  	  
2.3.4	   PROLIFERATION	  ASSAY	  The	   ability	   of	   Cryptococcus	   to	   proliferate	   within	   J774	   cells	   and	   human	   primary	  macrophages	   was	   analyzed	   in	   proliferation	   assays.	   Following	   infection,	   fresh	  serum-­‐free	  culture	  media	  was	  added	  to	  the	  wells	  and	  further	  cultured	  at	  37°C	  in	  a	  5	   %	   CO2	   atmosphere.	   When	   pre-­‐treated,	   the	   cultures	   were	   maintained	   at	   the	  concentrations	  mentioned	  above.	  Samples	  were	  taken	  after	  infection	  and	  removal	  of	  non-­‐internalized	  yeast	  cells	  at	  0,	  18,	  24,	  48	  and	  72	  hr.	   Intra-­‐	  and	  extracellular	  yeast	   cells	   were	   counted	   separately	   after	   Trypan	   blue	   staining	   with	   a	  haemocytometer.	   For	   extracellular	   yeast	   numbers,	   the	   extracellular	   media	   was	  collected	  in	  a	  reaction	  tube	  and	  the	  well	  washed	  with	  200	  µl	  PBS	  and	  collected	  in	  the	  same	  tube	  to	  collect	  any	  remaining	  extracellular	  yeast.	  Cells	  with	  intracellular	  
Cryptococcus	   cells	   remain	   attached	   to	   the	   bottom	   of	   the	   dish.	   To	   count	   the	  intracellular	  yeast	  cell	  number,	  cells	  were	  lysed	  in	  200	  µl	  distilled	  H2O	  at	  37°C	  for	  30	  min.	  The	  cells	  were	  scraped	  off	  and	  collected,	  and	  an	  additional	  200	  µl	  PBS	  was	  used	   to	   wash	   the	   well	   and	   added	   to	   the	   same	   collection	   tube.	   The	   intracellular	  yeast	  cell	  number	  was	  then	  counted	  and	  calculated	  relative	  to	  time	  point	  T=0.	  The	  maximal	   Intracellular	   Proliferation	   Rate	   (IPR)	   was	   used	   as	   a	   measure	   of	  intracellular	   proliferative	   capacity	   and	   is	   calculated	   as	   the	   highest	   intracellular	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yeast	  count	  (typically	  at	  18	  or	  24hrs)	  divided	  by	  the	  initial	  intracellular	  yeast	  count	  at	  T=0.	  The	  IPR	  was	  calculated	  separately	  for	  each	  individual	  experiment	  and	  for	  each	  condition	  (relative	   to	  cells	   incubated	  with	   the	  same	  condition	  to	  control	   for	  differential	  uptake)	  (Voelz	  et	  al.,	  2009).	  	  
2.3.5	   LIVE	  CELL	  IMAGING	  Following	   infection	   of	   J774	   cells	   and	   human	   primary	   macrophages	   with	  
Cryptococcus	   as	   described	   above,	   fresh	   serum-­‐free	   culture	   media	   and	   the	  corresponding	   condition	   used	   for	   pre-­‐treatment	  were	   added	   to	   the	  wells	   before	  further	  culture	  at	  37°C	  and	  5	  %	  CO2	  in	  a	  controlled	  chamber	  (OKOLAB).	  Cells	  were	  imaged	   on	   a	   Nikon	   Eclipse	   TE2000-­‐U	   microscope	   with	   20	   x	   phase	   contrast	  objective	  and	  1	  x	  optivar.	   Images	  were	  captured	  every	  90	  seconds	  for	  20	  hr	  on	  a	  Nikon	  Digital	  Sight	  DS-­‐Qi1MC	  camera	  and	  compiled	   into	   time	   lapse	  movies	  using	  the	   software	   NIS-­‐Elements	   AR	   3.0.	   The	   number	   of	   expulsion	   events	   in	   three	  independent	   experiments	   for	   each	   cytokine	   was	   counted	   by	   eye	   (Voelz	   et	   al.,	  2009).	  	  	  
2.3.6	   ACCUTASE	  TREATMENT	  	  J774	  macrophages	  were	  detached	  and	  separated	  by	  Accutase	  (PAA)	  treatment.	  The	  cells	  were	  incubated	  with	  the	  undiluted	  proteolytic	  and	  collagenolytic	  enzyme	  mix	  for	  15	  min	  at	  37°C	  and	  then	  gently	  dissociated	  by	  pipetting	  to	  ensure	  a	  single	  cell	  suspension;	  cell	  separation	  was	  checked	  by	  eye	  under	  a	  microscope.	  	  	  
2.3.7	   FLOW	  CYTOMETRY	  	  Samples	  were	  fixed	  by	  adding	  an	  equal	  volume	  of	  2	  %	  formaldehyde	  and	  2	  %	  FBS	  in	   PBS.	   Flow	   cytometry	   parameters	   were	   measured	   using	   a	   FACSCaliber	  instrument	  (BD	  Biosciences)	  and	  analysed	  with	  CellQuestPro	  (BD	  Biosciences).	  To	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2.4	   ANALYSIS	  OF	  CRYPTOCOCCAL	  STRAINS	  
	  
2.4.1	   SUSCEPTIBILITY	  TREATMENT	  OF	  CRYPTOCOCCUS	  STRAINS	  To	  test	  C.	  gattii	  strains	  for	  their	  susceptibility	  towards	  different	  stress	  conditions,	  different	   settings	   were	   created	   to	   mimic	   different	   degrees	   of	   hypoxia	   (0,	   0.025,	  0.05,	  0.075,	  0.1,	  0.15,	  0.3	  and	  0.6	  mM	  CoCl2),	  oxidative	  (0,	  0.125,	  0.25,	  0.5,	  1,	  3,	  6	  and	  14	  mM	  H2O2),	  nitrosative	  (0,	  0.25,	  0.5,	  2.5,	  5,	  10,	  15	  and	  20	  mM	  NaNO2),	  cell	  wall	  (0,	  0.005,	  0.01,	  0.025,	  0.05,	  0.1,	  0.25	  and	  0.5	  %	  sodium	  dodecyl	  sulphate	  (SDS)	  and	   0.0001,	   0.001,	   0.01,	   0.025,	   0.05,	   0.1	   and	   0.3	   mM	   NaCl)	   and	   radiation	   (UV	  254nm;	   0,	   0.005,	   0.01,	   0.02,	   0.03,	   0.04,	   0.06,	   0.08	   and	   0.1	   J/cm2)	   stress.	  
Cryptococcus	   strains	  were	  cultured	   in	   liquid	  YPD	  media	  (1	  %	  peptone,	  1	  %	  yeast	  extract,	   2	  %	   D-­‐(+)-­‐glucose)	   for	   24	   hr	   at	   25°C	  with	   shaking	   at	   240	   rpm	   prior	   to	  experimental	   use	   (Ma	   et	   al.,	   2006).	   Cryptococcus	   cells	   from	   24-­‐hr-­‐old	   liquid	  cultures	   were	   washed	   three	   times	   with	   PBS,	   counted	   in	   a	   haemocytometer	   and	  adjusted	  to	  105	  cells	  per	  ml	  in	  serum-­‐free	  DMEM.	  One	  ml	  of	  the	  yeast	  solution	  was	  added	   into	   each	   well	   of	   a	   48-­‐well	   plate	   and	   the	   stress	   factor	   was	   transferred	  accordingly.	   The	   yeast	   was	   then	   incubated	   at	   37°C	   and	   5	  %	   CO2.	   To	   assess	   the	  influence	  of	  the	  stresses	  on	  cryptococcal	  growth,	  serial	  dilutions	  were	  plated	  and	  colony-­‐forming	  units	   (CFUs)	  counted	  after	  0	  and	  24	  hr.	  For	  UV	  treatments,	  yeast	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was	   allowed	   to	   recover	   for	   30	  min	   at	   37°C	   before	   plating.	   CFUs	   relative	   to	   time	  point	  0	  and	  relative	  to	  an	  untreated	  control	  were	  calculated	  to	  enable	  comparison	  between	  several	  Cryptococcus	  strains	  with	  different	  growth	  rate.	  	  	  
	  	  GFP	   expressing	   strains	   were	   tested	   for	   their	   susceptibility	   towards	   cellular	  stresses	   with	   the	   following	   conditions:	   hypoxia	   (3	  %	   oxygen	   or	   treatment	   with	  0.05,	  0.1	  and	  0.3	  mM	  CoCl2	  (Lee	  et	  al.,	  2007)),	  oxidative	  (0.25,	  0.5	  and	  1	  mM	  H2O2)	  or	   nitrosative	   (1,	   5	   and	   20	  mM	  NaNO2)	   stress,	   or	   exposure	   to	   cell	   wall	   damage	  (0.005,	  0.01	  and	  0.05	  %	  SDS	  or	  0.05,	  0.1	  and	  0.3	  mM	  NaCl)	  in	  serum-­‐free	  DMEM,	  the	  medium	   routinely	  used	   in	  macrophage	   assays.	   Cryptococcal	   cells	   from	  24	  hr	  old	  cultures	  were	  washed	  three	  times	  with	  PBS,	  counted	  in	  a	  haemocytometer	  and	  adjusted	   to	   105	   cells/ml	   in	   serum-­‐free	   DMEM.	   One	   ml	   of	   yeast	   solution	   was	  incubated	   with	   the	   appropriate	   stress	   in	   48-­‐well	   plates	   and	   left	   at	   37°C	   and	  5	  %	  CO2	  for	  24	  hr	  without	  shaking.	  To	  assess	  the	  influence	  of	  stress	  conditions	  on	  cryptococcal	   growth,	   serial	   dilutions	  were	   plated	   and	   CFUs	   counted	   after	   0	   and	  24	  hr.	  CFUs	  relative	  to	  time	  point	  0	  were	  calculated.	  	  	  
2.4.2	   MITOCHONDRIAL	  MORPHOLOGY	  ASSAY	  The	  mitochondrial	  morphology	  assays	  were	  conducted	  in	  a	  similar	  way	  to	  those	  in	  previous	  studies,	  with	  modifications	  (Ma	  et	  al.,	  2009a).	  C.	  gattii	  cells	  were	  grown	  overnight	   at	   37°C	   in	   DMEM	   untreated	   or	   under	   a	   stress	   condition	   (1	  mM	  H2O2,	  5	  mM	  NaNO2,	   0.1	  mM	  CoCl2,	   3	  %	  O2,	   0.005	  %	  SDS,	   0.05	  mM	  NaCl)	   in	   a	   5	  %	  CO2	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incubator	   without	   shaking	   for	   24	   hr,	   or	   isolated	   from	  macrophages	   24	   hr	   after	  infection.	  After	  UV	   treatment,	   yeast	  were	  allowed	   to	   recover	   for	  30	  min	  at	  37°C.	  Growth	   in	   YPD	   media	   at	   25°C	   was	   also	   included	   as	   control.	   For	   time	   course	  experiments,	  cells	  were	  recovered	  from	  macrophages	  and	  stained	  after	  0,	  2,	  6,	  12,	  18	  and	  24	  hr.	  The	  cells	  were	  harvested,	  washed	  with	  PBS	  twice	  and	  re-­‐suspended	  in	   PBS	   containing	   the	   Mito-­‐Tracker	   Red	   CMXRos	   (Invitrogen)	   at	   a	   final	  concentration	   of	   20	  nM.	   Cells	  were	   incubated	   for	   15	  min	   at	   37°C.	  After	   staining,	  cells	  were	  washed	  in	  triplicate	  and	  re-­‐suspended	  in	  PBS.	  For	  each	  condition,	  more	  than	   100	   yeast	   cells	   per	   replicate	   for	   each	   of	   the	   tested	   strains	   were	   chosen	  randomly	   and	   analyzed.	   For	   quantifying	   different	   mitochondrial	   morphologies,	  images	  were	  collected	  using	  a	  Zeiss	  Axiovert	  135	  TV	  microscope	  with	  a	  100	  x	  oil	  immersion	  Plan-­‐Neofluar	  objective.	  Both	   fluorescence	   images	  and	  phase	  contrast	  images	   were	   collected	   simultaneously.	   Images	   were	   captured	   with	   identical	  settings	   on	   a	   QIcam	   Fast	   1394	   camera	   using	   the	   QCapture	   Pro51	   version	   5.1.1	  software.	   All	   images	   were	   processed	   identically	   in	   ImageJ	   and	   mitochondrial	  morphologies	  were	  analyzed	  and	  counted	  blindly	  (Byrnes	  et	  al.,	  2010).	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2.5	  	   MOLECULAR	  METHODS	  
	  
2.5.1	   BIOLISTIC	  TRANSFORMATION	  	  Different	   systems	   have	   been	   applied	   to	   transform	   Cryptococcus	   including	  electroporation,	   biolistic	   and	   Agrobacterium-­‐mediated	   transformation.	   Problems	  have	   been	   encountered	   due	   to	   the	   polysaccharide	   capsule,	   different	  transformation	   efficiencies	   for	   different	   serotypes	   and	   ectopic	   or	  extrachromosomal	  insertion	  of	  DNA	  (Toffaletti	  et	  al.,	  1993,	  McClelland	  et	  al.,	  2005,	  Idnurm	  et	  al.,	  2004,	  Davidson	  et	  al.,	  2000,	  Varma	  et	  al.,	  1992a,	  Edman	  et	  al.,	  1990).	  	  The	   first	   successful	   transformation	   of	   C.	   neoformans	   was	   described	   in	   the	   early	  1990’s.	  DNA	  was	   introduced	   into	  yeast	   cells	  using	  an	  electric	   field.	  Short	  electric	  pulses	   of	   high	   voltage	   lead	   to	   short-­‐term	   increase	   in	   plasma	   membrane	  permeability	  and	  allow	  the	  entry	  of	  macromolecules	  such	  as	  DNA	  into	  the	  cell.	  The	  analysis	   of	   the	   transformants	   showed	   a	   very	   low	   efficiency	   of	   only	   12	  %	   stable	  transformation	  with	  linear	  DNA.	  Attempts	  to	  transform	  Cryptococcus	  with	  circular	  DNA	   resulted	   in	   even	   lower	   efficiencies.	   Furthermore,	   the	   DNA	   was	   ectopically	  integrated	   or	   maintained	   extrachromosomal	   in	   most	   of	   the	   cases.	   At	   this	   stage,	  only	   overexpression	   and	   complementation	   of	   genes	  was	   possible.	   To	   allow	   gene	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knockout	   or	   replacement	   studies	   improved	   transformation	   techniques	   were	  required	  (Edman	  et	  al.,	  1990,	  Varma	  et	  al.,	  1992a).	  	  June	   Kwon-­‐Chung’s	   group	   applied	   Agrobacterium-­‐mediated	   transformation	   to	  further	  increase	  transformation	  efficiencies.	  Agrobacterium	  tumefaciens	  is	  a	  gram-­‐negative	   soil	   bacterium	   that	   can	   cause	   crown	   galls	   in	   infected	   plants.	   During	  infection,	  a	  part	  of	  the	  so-­‐called	  bacterial	  Ti	  plasmid,	  the	  T-­‐DNA,	  can	  be	  transferred	  into	   and	   expressed	   in	   the	   host.	   High	   transformation	   efficiencies	   for	   all	   different	  serotypes	   were	   achieved	   using	   this	   method.	   More	   important,	   almost	   100	   %	   of	  these	  transformants	  were	  reported	  to	  be	  stable	  and	  50	  –	  80	  %	  showed	  only	  one	  T-­‐DNA	   insertion.	  Unfortunately,	  homologous	  recombination	  was	  not	  observed	  with	  this	  method	  (McClelland	  et	  al.,	  2005,	  Idnurm	  et	  al.,	  2004).	  	  Shortly	   after	   the	   first	   successful	   electroporation	   of	   Cryptococcus,	   biolistic	  transformation	  was	   tested	   to	   improve	   transformation	  efficiency.	  Particles	   coated	  with	   DNA	   were	   shot	   into	   cells	   using	   a	   so-­‐called	   gene	   gun.	   Transformation	  efficiencies	   were	   increased	   to	   15	   –	   24	   %	   with	   homologous	   recombination	  frequencies	   of	   up	   to	   50	  %	   in	   serotype	   A	   and	   1	   –	   4	   %	   in	   serotype	   D.	   Biolistic	  transformation	  also	  enabled	  transformation	  with	  circular	  DNA.	  However,	  this	  DNA	  delivery	  system	  did	  not	   result	   in	   sufficient	   stable	   transformation	  efficiencies	  and	  showed	   a	   high	   percentage	   of	   ectopic	   and	   extrachromosomal	   DNA	   integration	  (Davidson	  et	  al.,	  2000,	  Toffaletti	  et	  al.,	  1993).	  	  
	  
2.5.1.1	   CLONING	  STRATEGY	  Two	  slightly	  different	  strategies	  were	  applied	  for	  the	  knockout	  of	  the	  gene	  sre1	  and	  the	  knock	   in	  of	  a	  GFP	  cassette.	  The	   former	  comprised	   the	  creation	  of	  a	  knockout	  cassette	   by	   homologous	   recombination	   of	   overlapping	   PCR	   fragments	   in	   S.	  
cerevisiae,	   followed	  by	  biolistic	   bombardment	   and	  homologous	   recombination	   in	  the	   target	   genome	   (Figure	   13)	   whereas	   the	   latter	   randomly	   integrates	   a	   GFP-­‐expression	  cassette	  ligated	  into	  a	  plasmid	  in	  the	  target	  genome.	  For	  construction	  of	  GFP-­‐tagged	  cryptococcal	  strains,	  C.	  neoformans	  serotype	  A	  strain	  H99	  and	  C.	  gattii	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serotype	   B	   strain	   R265	   were	   transformed	   with	   a	   GFP	   construct	   by	   biolistic	  bombardment	   (Toffaletti	   et	  al.,	   1993).	  The	   insertion	  cassette	  was	   constructed	  by	  PCR	   amplification	   with	   overlapping	   primers	   of	   the	   C.	   neoformans	   JEC21	   act1	  promoter	  (AY483215),	  the	  GFP	  coding	  sequence	  and	  the	  C.	  neoformans	  JEC21	  trp1	  terminator	   (AY483215)	   followed	   by	   lithium	   acetate	   transformation	   in	   the	   uracil	  negative	   Saccharomyces	   cerevisiae	   strain	  MLY40	   (Lorenz	   et	   al.,	   1997)	   to	   achieve	  homologous	   recombination	   of	   overlapping	   DNA	   fragments	   into	   the	   plasmid	  pRS426	  (Christianson	  et	  al.,	  1992).	  The	  plasmid	  was	  recovered	  from	  S.	  cerevisiae,	  electroporated	  into	  Escherichia	  coli	  DH5α	  and	  the	  GFP	  construct	   isolated	  by	  PCR.	  After	  digestion	  with	  XhoI	  and	  BamHI	  the	  promoter/GFP/terminator	  cassette	  was	  ligated	   into	   the	   shuttle	   vector	   pAG32	   (Goldstein	   et	   al.,	   1999)	   for	   biolistic	   DNA	  delivery.	  The	  GFP	  construct	  containing	  shuttle	  vector	  pAG32	  was	  directly	  used	  for	  biolistic	  transformation.	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Figure	   13:	   Cloning	   strategy	   for	   the	   knockout	   of	   the	   target	   gene	   sre1.	   Overlapping	  fragments	  are	  combined	  with	  help	  of	  the	  DNA	  repair	  machinery	  of	  S.	  cerevisiae	  to	  create	  a	  knockout	   cassette	   containing	   a	   selection	  marker.	   The	   knockout	   cassette	   is	   amplified	   by	  PCR	   and	   introduced	   in	   the	   C.	   neoformans	   H99	   genome	   by	   biolistic	   bombardment.	   A	  recombination	   event	   between	   the	   flanking	   ends	   of	   the	   knockout	   cassette	   and	   genomic	  DNA	  leads	  to	  the	  knockout	  of	  the	  desired	  gene.	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2.5.1.2	  	   DNA	  ISOLATION	  FROM	  CRYPTOCOCCUS	  DNA	   from	  Cryptococcus	   for	   subsequent	   polymerase	   chain	   reactions	  was	   isolated	  using	  a	  method	  developed	  by	  Bolano	  et	  al.	  2001	   (Bolano	   et	  al.,	   2001).	  The	  yeast	  were	  cultured	  on	  YPD	  plates	  containing	  0.5	  M	  NaCl	  for	  two	  days	  at	  25°C	  to	  reduce	  the	   capsule	   size.	   A	   loopful	   of	   the	   yeast	   culture	   was	   added	   to	   an	   urea	   buffer	  containing	  10.7	  M	  urea,	  5.0	  M	  NaCl,	  1.0	  M	  TRIS	  pH	  8.0,	  1.0	  M	  Na2EDTA	  pH	  8.0	  and	  20	  %	  SDS	  and	  150	  µl	  sterile	  sand	  and	  incubated	  for	  3	  hr	  at	  room	  temperature	  to	  further	   break	   down	   the	   capsule.	   The	   cells	   were	   pelleted	   by	   centrifugation	   at	  4000	  rcf	  for	  2	  min	  and	  the	  supernatant	  was	  removed.	  The	  pellet	  was	  resuspended	  in	   an	   equal	   volume	  of	   lysis	   buffer	   containing	  0.5	  %	  SDS,	   0.5	  %	   sarkosyl,	   10	  mM	  TRIS	   and	   1	  mM	   EDTA	   pH	   7.5	   and	   phenol-­‐chloroform	   (1:1)	   and	   homogenized	   at	  30	  rounds	   per	   second	   for	   5	   min	   to	   lyse	   the	   cells.	   Cell	   debris	   was	   removed	   by	  centrifugation	  at	  13,500	  rcf	  for	  15	  minutes	  at	  4°C.	  The	  supernatant	  with	  the	  DNA	  was	  collected	  in	  a	  fresh	  tube,	  an	  equal	  volume	  of	  96	  %	  ethanol	  and	  0.13	  volume	  of	  3.0	  M	  ice-­‐cold	  sodium	  acetate	  were	  added	  and	  the	  mixture	  was	  gently	  mixed.	  DNA	  was	  precipitated	  for	  60	  min	  at	   -­‐20°C.	  The	  DNA	  was	  collected	  by	  centrifugation	  at	  13.500	  rcf	  for	  15	  min	  at	  4°C,	  the	  supernatant	  removed	  and	  the	  DNA	  pellet	  air	  dried	  before	  being	  resuspended	  in	  10	  mM	  TRIS	  and	  1	  mM	  EDTA	  pH	  7.5	  (TE	  buffer).	  DNA	  was	  stored	  at	  4°C.	  DNA	  from	  Cryptococcus	  for	  subsequent	  southern	  hybridization	  was	  isolated	  by	  an	  alternative	   protocol.	   50	   ml	   YPD	   media	   were	   inoculated	   with	   Cryptococcus	   and	  incubated	   at	   30°C	   and	   shaking	   at	   180	   rpm.	   The	   cells	   were	   collected	   by	  centrifugation	  at	  900	  rcf	  for	  10	  min	  and	  the	  pellet	   lyophilized	  at	  -­‐80°C	  overnight.	  The	  pellet	  was	  pulverized	  with	  3-­‐5	  ml	  of	  3	  mm	  glass	  beads	  and	  vigorous	  vortexing.	  The	   powder	  was	   resuspended	   in	   10	  ml	   of	   CTAB	   buffer	   (2	  %	   CTAB,	   1.4	  M	  NaCl,	  20	  mM	  EDTA	  and	  100	  mM	  TRIS-­‐HCl	  pH	  8.8)	  and	  the	  suspension	  incubated	  at	  65°C	  for	   30	   min.	   The	   sample	   was	   cooled	   before	   an	   equal	   volume	   of	   chloroform	   was	  added	   and	   mixed	   gently.	   The	   supernatant	   was	   collected	   by	   centrifugation	   at	  900	  rcf	  for	  10	  min,	  transferred	  to	  a	  fresh	  tube	  and	  an	  equal	  volume	  of	  isopropanol	  added.	  The	  DNA	  was	  pelleted	  at	  900	  rcf	  for	  10	  min	  and	  washed	  with	  ice-­‐cold	  70	  %	  ethanol.	  The	  pellet	  was	  then	  dried	  and	  resuspended	  in	  TE	  or	  water	  with	  20	  µg/ml	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RNase.	  The	  DNA	  was	  then	  recovered	  by	  phenol:chloroform	  extraction	  and	  ethanol	  precipitation.	  	  
2.5.1.3	  	   DNA	  EXTRACTION	  WITH	  PHENOL:CHLOROFORM	  	  Phenol:Chloroform	   extraction	  was	   conducted	   to	   remove	   proteins	   from	   extracted	  DNA.	  An	  equal	  volume	  of	  phenol:chloroform	  was	  added	  to	  the	  sample	  and	  mixed	  until	   an	   emulsion	   formed.	   The	   mixture	   was	   centrifuged	   for	   1	   min	   at	   maximum	  speed	  in	  a	  tabletop	  centrifuge	  and	  the	  aqueous	  phase	  transferred	  to	  a	  fresh	  tube.	  The	  process	  was	  repeated	  until	  no	  protein	  was	  visible	  in	  the	  interphase	  anymore	  and	  then	  phenol	  residues	  removed	  with	  an	  equal	  volume	  of	  chloroform.	  The	  DNA	  in	  the	  aqueous	  phase	  after	  centrifugation	  was	  recovered	  by	  ethanol	  precipitation.	  	  
2.5.1.4	  	   DNA	  ETHANOL	  PRECIPITATION	  	  Ethanol	   precipitation	   was	   carried	   out	   to	   recover	   DNA	   after	   phenol:chloroform	  extraction.	  1/10	  sample	  volume	  of	  3	  M	  sodium	  acetate	  and	  4	  volumes	  of	   ice-­‐cold	  100	  %	  ethanol	  were	  added	  to	  the	  DNA	  solution	  and	  incubated	  at	  -­‐20°C	  overnight.	  The	   DNA	   was	   collected	   by	   centrifugation	   for	   30	   min	   at	   maximum	   speed	   in	   a	  tabletop	  centrifuge.	  The	  supernatant	  was	  discarded	  and	  the	  pellet	  washed	  with	  a	  full	  volume	  of	  ice-­‐cold	  80	  %	  ethanol.	  Several	  washing	  steps	  were	  performed	  until	  traces	   of	   salts	   were	   removed	   fro	   the	   sample	   before	   the	   pellet	   was	   dried	   and	  resuspended	  in	  TE	  buffer.	  	  	  
2.5.1.5	  	   POLYMERASE	  CHAIN	  REACTION	  Target	   DNA	   sequences	   were	   amplified	   using	   specific	   primers	   (Table	   4)	   and	  polymerase	   produced	   by	   the	   hyperthermophilic	   archaebacterium	   Pyrococcus	  
furiosus	   or	   a	   thermostable	   DNA	   polymerase	   named	   after	   the	   thermophilic	  bacterium	  Thermus	  aquaticus	  in	  a	  polymerase	  chain	  reaction	  (PCR).	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Table	  4:	  Primers	  used	  for	  construction	  of	  the	  sre1KO	  and	  GFP	  expression	  cassette.	  F	  –	  forward,	  R	  –	  reverse.	  	  
Primer	  Sequence	  
5’	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3’	  
Anneal.	  
Temp.	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2.5.1.6	  	   PLASMIDS	  Different	   plasmids	   were	   used	   for	   the	   process	   of	   biolistic	   transformation	   of	  
Cryptococcus.	   The	  plasmid	  pJAF1	   (Figure	   14	  A)	   contains	   an	   ampicillin	   resistance	  gene	  and	  the	  KanMX	  cassette,	  a	  neomycin	  resistance	  gene	  under	  the	  control	  of	  the	  
C.	  neoformans	  H99	  act	  promoter	  and	   trp	   terminator,	  used	  as	  marker	   for	  positive	  transformation	   events.	   The	   plasmid	   pRS426	   (Figure	   14	   B)	   (Christianson	   et	   al.,	  1992)	  was	  used	  for	  creation	  of	  the	  sre1	  knockout	  cassette	  and	  the	  GFP	  expression	  construct	  by	  homologous	  recombination	   in	  S.	  cerevisiae.	  The	  plasmid	  contains	  an	  ampicillin	   resistance	   and	   the	   ura3	   gene.	   The	   GFP	   cassette	   was	   ligated	   into	   the	  plasmid	  pAG32	  (Figure	  14	  C)	  (Goldstein	  et	  al.,	  1999)	  containing	  the	  hygromycin	  B	  resistance	  and	  ampicillin	  resistance	  gene	  that	  was	  then	  randomly	   integrated	   into	  the	  C.	  neoformans	  H99	  genome.	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Figure	   14:	   Plasmids	   used	   in	   this	   study.	   (A)	   The	   selection	   marker	   KanMX	   for	   sre1	  knockout	   was	   isolated	   from	   the	   plasmid	   pJAF1	   (B)	   The	   plasmid	   pRS426	   was	   used	   for	  homologous	   recombination	   of	   overlapping	   PCR	   fragments	   in	   S.	   cerevisiae.	   (C)	   The	   GFP	  cassette	   for	   expression	   in	   Cryptococcus	   was	   ligated	   into	   the	   plasmid	   pAG32	   and	   then	  randomly	  integrated	  into	  the	  yeast	  genome	  by	  biolistic	  transformation.	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2.5.1.7	  	   PLASMIDS	  DNA	  PREPARATION	  Plasmid	  DNA	  from	  bacteria	  was	  isolated	  with	  the	  FastPlasmidTM	  kit	  (Eppendorf).	  A	  bacterial	  colony	  was	  grown	  over	  night	  in	  LB	  media	  with	  the	  appropriate	  selection	  marker,	   the	   cells	   collected	   by	   centrifugation	   at	   12,000	   rcf	   for	   1	   min	   and	   the	  supernatant	   discarded.	   The	   pellet	   was	   resuspended	   in	   400	   µl	   of	   ice-­‐cold	   lysis	  solution	  on	  a	  vortex	  and	  then	  incubated	  at	  room	  temperature	  for	  3	  min.	  The	  lysate	  was	  transferred	  to	  a	  spin	  column	  assembly	  and	  centrifuged	  for	  60	  sec	  at	  maximum	  speed	  in	  a	  tabletop	  centrifuge.	  The	  plasmid	  DNA,	  bound	  to	  the	  column,	  was	  washed	  with	   400	   µl	   of	   washing	   buffer,	   centrifuged	   and	   dried	   by	   another	   centrifugation	  step.	   To	   elute	   the	   plasmid	   DNA	   50	   µl	   of	   elution	   buffer	   was	   added	   to	   the	   spin	  column	  and	  centrifuged	  for	  60	  sec	  at	  maximum	  speed	  in	  a	  table	  top	  centrifuge.	  	  
2.5.1.8	  	   RESTRICTION	  DIGEST	  OF	  DNA	  FRAGMENTS	  AND	  PLASMIDS	  Restriction	  enzymes	   recognize	   specific	  DNA	  sequences	  and	  cut	  DNA	   into	   smaller	  fragments.	  The	  genomic	  DNA	  or	  plasmid	  DNA	  was	  incubated	  with	  5	  U/µg	  DNA	  of	  the	  appropriate	  restriction	  enzyme	   in	  1	  x	  buffer	  at	   the	  relevant	   temperature	  and	  0.5	  mg/ml	   bovine	   serum	   albumin	   (BSA)	   for	   1	   hr.	   Table	   5	   shows	   the	   restriction	  enzymes	   used	   in	   this	   study	   with	   their	   specific	   recognition	   sites	   and	   incubation	  temperature.	  The	  digested	  DNA	  was	  then	  check	  on	  an	  agarose	  gel	  and	  purified	  for	  further	  use.	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Site	   Temp.	  in	  °C	   Use	  
HindIII	   5’	  AAGCTT	  3’	  3’	  TTCGAA	  5’	   37	   Restriction	   of	   pRS426	   for	   homologous	  recombination	  in	  S.	  cerevisiae	  
BamHI	   5’	  GGATCC	  3’	  3’	  CCTAGG	  3’	   37	   Restriction	   of	   pRS426	   to	   check	   for	   sre1ko	  cassette	  Restriction	   of	   pAG32	   for	   ligation	   of	   GFP-­‐cassette	  
XhoI	  	   5’	  CTCGAG	  3’	  3’	  GAGCTC	  5’	   37	   Restriction	   of	   pAG32	   for	   ligation	   of	   GFP-­‐cassette	  Restriction	  of	  GFP	  cassette	  out	  of	  pRS426	  
AgeI	   5’	  ACCGGT	  3’	  3’	  TGGCCA	  5’	   37	   Restriction	   of	   cryptococcal	   genomic	   DNA	  for	  southern	  analysis	  of	  sre1	  mutants	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2.5.1.9	  	   ALKALINE	  PHOSPHATASE	  TREATMENT	  OF	  RESTRICTED	  PLASMID	  DNA	  To	  keep	  restricted	  plasmids	  in	  a	  linear	  form	  and	  to	  avoid	  undesirable	  ligation,	  the	  5’	  end	  phosphate	  groups	  of	  DNA	  can	  be	  removed	  with	  alkaline	  phosphatase.	  One	  unit	   of	   alkaline	   phosphatase	   (CIAP,	   Promega)	   and	   reaction	   buffer	   with	   a	   final	  concentration	  of	   1	   x	  was	  directly	   added	   in	   the	   restriction	  mix	   and	   incubated	   for	  1	  hr	   at	   37°C.	   Then,	   another	   unit	   of	   the	   enzyme	   was	   added	   for	   30	   min	   at	   37°C.	  Fragments	  was	  analysed	  on	  an	  agarose	  gel	  and	  extracted	  for	  further	  use.	  	  
2.5.1.10	   LIGATION	  OF	  PURIFIED	  DNA	  FRAGMENTS	  INTO	  A	  PLASMID	  To	  create	  a	  GFP-­‐containing	  plasmid	   for	  biolistic	   transformation,	   the	  GFP	  cassette	  was	  obtained	  from	  the	  plasmid	  pRS426	  by	  restriction	  digest	  with	  BamHI	  and	  XhoI.	  The	  target	  plasmid	  pAG32	  was	  prepared	  by	  restriction	  with	  the	  same	  enzymes	  and	  following	   alkaline	   phosphatase	   treatment.	   The	   fragments	   were	   analysed	   on	   an	  agarose	   gel	   and	   extracted.	   The	   concentrations	   of	   plasmid	   and	   insert	   were	  determined	   with	   a	   NanoDrop	   ND-­‐1000	   spectrometer.	   Integration	   of	   the	   GFP	  cassette	   into	  the	  target	  vector	  pAG32	  was	  performed	  at	  a	  plasmid:vector	  ratio	  of	  1:3	  with	  1	  U	  T4	  DNA	   ligase	   (Promega)	   in	  1	   x	   ligase	  buffer	  overnight	   at	  4°C.	  The	  optimal	  amount	  of	  insert	  was	  calculated	  with	  the	  following	  equation.	  	  	  
	  	  The	   ligation	  mix	  was	   then	   transformed	   into	  E.	  coli	  and	  plated	  on	  selective	  media	  containing	   200	   µg/ml	   Carbenicillin.	   Potentially	   positive	   transformants	   were	  analysed	  by	  restriction	  and	  PCR	  analysis.	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2.5.1.11	   AGAROSE	  GEL	  ELECTROPHORESIS	  Nucleic	  acids	  can	  be	  separated	  according	   to	   the	  molecular	  weight	  by	  agarose	  gel	  electrophoresis	  and	  detected	  with	  the	  intercalating	  and	  fluorescent	  agent	  ethidium	  bromide.	   For	   that	   purpose,	   1	   %	   agarose	   gels	   were	   prepared	   in	   1	   x	   TBE	   buffer	  (10	  mM	  TRIS,	  150	  mM	  NaCl	  pH	  7.6)	  or	  1	  x	  TBA	  buffer	  (89	  mM	  TRIS,	  89mM	  boric	  acid,	  2	  mM	  EDTA)	  and	  0.5	  µg/ml	  ethidium	  bromide.	  DNA	  samples	  were	  mixed	  with	  DNA	  loading	  buffer	  (Promega),	  loaded	  onto	  the	  gel	  and	  separated	  at	  2.3	  V/cm	  with	  1	  x	  TBE	  or	  TAE	  as	  running	  buffer.	  A	  1	  kb	  or	  100	  bp	  DNA	  ladder	  was	  also	  separated	  to	  estimate	  the	  fragment	  size.	  Fragments	  were	  detected	  by	  UV-­‐transillumination.	  	  	  
2.5.1.12	   DNA	  PURIFICATION	  AND	  GEL	  EXTRACTION	  DNA	   extraction	   and	   gel	   purification	   was	   performed	   using	   the	   GenEluteTM	   gel	  extraction	   kit	   (Sigma).	   To	   recover	   DNA	   from	   agarose	   gels,	   the	   gel	   slices	   were	  solubilized	   in	   3	   volumes	   (100	   mg	   gel	   equates	   to	   300	   µl)	   of	   gel	   solubilization	  solution	  by	  incubation	  at	  55°C	  for	  10	  min	  and	  vortexing	  every	  3	  min.	  To	  adjust	  the	  pH	  of	  the	  mixture,	  3	  M	  NaAc	  was	  added.	  The	  sample	  was	  mixed	  with	  1	  gel	  volume	  of	  100	  %	  isopropanol	  and	  loaded	  onto	  a	  prepared	  binding	  column	  and	  centrifuged	  for	   1	  min	   at	  maximum	   speed	   in	   a	   table	   top	   centrifuge.	   The	   binding	   column	  was	  prepared	  by	  adding	  500	  µl	  of	  column	  preparation	  solution	  and	  centrifugation	  for	  1	  min	  at	  maximum	  speed	  in	  a	  tabletop	  centrifuge.	  After	  binding	  of	  the	  DNA	  to	  the	  column,	   the	   column	   was	   washed	   with	   700	   µl	   of	   wash	   solution	   and	   then	   50	   µl	  elution	   solution	   was	   added,	   incubated	   for	   1	   min	   and	   centrifuged	   for	   1	   min	   at	  maximum	  speed	  in	  a	  table	  top	  centrifuge	  to	  elute	  the	  DNA.	  	  
2.5.1.13	   PREPARATION	  OF	  CHEMICALLY	  ESCHERICHIA	  COLI	  A	   single	   colony	   of	   Escherichia	   coli	   DH5α	   was	   grown	   in	   5	   ml	   liquid	   LB	   media	  overnight	  at	  37°C	  and	  shaking	  at	  220	  rpm.	  The	  next	  day	  the	  culture	  was	  diluted	  in	  500	  ml	  fresh	  LB	  media	  and	  further	  cultured	  at	  30°C	  and	  shaking	  at	  180	  rpm.	  At	  an	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optical	  density	  (OD)	  of	  OD595	  =	  0.2,	  sterile	  MgCl	  was	  added	  to	  a	  final	  concentration	  of	  20	  mM	  and	   then	   the	  culture	   further	   incubated.	  At	  OD595	  =	  0.5	   the	  culture	  was	  incubated	  for	  2	  hr	  in	  an	  ice-­‐water	  bath.	  The	  cells	  were	  pelleted	  by	  centrifugation	  at	  900	  rcf	  for	  5	  min	  at	  4°C,	  the	  supernatant	  removed	  and	  the	  cells	  resuspended	  in	  half	  of	   the	  original	  volume	  of	   ice	   cold	  Ca/Mn	  medium	  (100	  mM	  CaCl2,	  70	  mM	  MnCl2,	  40	  mM	   C2H3O2Na	   pH	   5.5).	   The	   cells	   were	   incubated	   on	   ice	   for	   a	   further	   2	   hr,	  pelleted	  by	  centrifugation	  at	  900	  rcf	  for	  5	  min	  at	  4°C,	  the	  supernatant	  removed	  and	  the	  cells	  resuspended	  in	  1/20	  of	  the	  original	  volume	  of	  Ca/Mn	  medium	  with	  15	  %	  glycerol.	  Aliquots	  were	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C.	  	  
2.5.1.14	  TRANSFORMATION	  OF	  DNA	  INTO	  E.	  COLI	  Chemically	  competent	  E.	  coli	  DH5α	  from	  -­‐80°C	  were	  thawed	  on	  ice.	  The	  DNA	  to	  be	  transformed	  was	  added,	   the	   sample	  was	  mixed	  and	   incubated	   for	  30	  min	  on	   ice.	  Afterwards,	  the	  cells	  were	  subjected	  to	  a	  heat	  shock	  at	  42	  °C	  for	  1	  min	  and	  30	  sec.	  The	   sample	  was	   cooled	  on	   ice	   before	  1	  ml	   of	   LB	  media	  was	   added	   and	   the	   cells	  recovered	   for	   40	   min	   at	   37	   °C.	   The	   cells	   were	   collected	   by	   centrifugation	   at	  2,500	  rcf	   for	   5	   min	   in	   a	   table	   top	   centrifuge,	   washed	   with	   500	   µl	   of	   ddH2O,	  resuspended	  in	  100	  µl	  of	  ddH2O	  and	  plated	  on	  selective	  media.	  	  
2.5.1.15	  LITHIUM	  ACETATE	  TRANSFORMATION	  OF	  YEAST	  The	  uracil	  negative	  strain	  of	  Saccharomyces	  cerevisiae	  MLY40	  (Lorenz	  et	  al.,	  1997)	  was	   transformed	   by	   lithium	   acetate	   transformation	   to	   achieve	   homologous	  recombination	  of	  overlapping	  DNA	  fragments	  into	  the	  HindIII	  cut	  plasmid	  pRS426.	  A	   5	   ml	   overnight	   culture	   in	   YPD	   was	   diluted	   into	   50	   ml	   of	   YPD	   and	   further	  incubated.	  At	  an	  OD595	  =	  0.7,	  the	  cells	  were	  harvested	  for	  5	  min	  at	  300	  rcf,	  washed	  twice	   with	   ddH2O	   before	   being	   resuspended	   in	   300	   µl	   of	   100	   mM	   LiAc.	  Transformations	  were	  conducted	  with	  50	  µl	  of	  the	  prepared	  yeast	  cells,	  40	  %	  PEG	  4000,	   1.5	  mg/ml	   sonicated	   salmon	   sperm	  DNA	   to	   enhance	   the	  DNA	   uptake.	   The	  mixture	  was	  mixed,	  LiAc	  pH	  7.5	  added	  to	  a	  final	  concentration	  of	  96	  mM	  and	  the	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mixture	  was	   vortexed	   again.	   The	   transformation	  mixture	  was	   incubated	   at	   30°C	  for	  20	  min	  and	  then	  heat	  shocked	  at	  42°C	  for	  15	  min.	  The	  cells	  were	  collected	  for	  1	  min	  at	  3,000	  rcf	  and	  resuspended	   in	  ddH2O.	  Serial	  dilutions	  were	  plated	  on	  SD	  media	   (0.17	   %	   yeast	   nitrogen	   base	   without	   amino	   acids,	   0.5	   %	   ammonium	  sulphate,	  2	  %	  glucose	  and	  2	  %	  agar)	  plates	  and	  incubated	  at	  30°C	  for	  5	  days.	  	  	  
2.5.1.16	   PLASMID	  RECOVERY	  FROM	  S.	  CEREVISIAE	  After	  homologous	  recombination	  in	  S.	  cerevisiae,	   the	  plasmid	  has	  to	  be	  recovered	  and	  transformed	   into	  E.	  coli	   for	   further	  amplification	   for	  biolistic	   transformation.	  Colonies	  were	  grown	  in	  5	  ml	  of	  liquid	  SD	  medium	  at	  30°C	  and	  180	  rpm	  overnight.	  The	  cells	  were	  collected	  for	  30	  sec	  at	  maximum	  speed	  in	  a	  tabletop	  centrifuge,	  the	  supernatant	  discarded.	  The	  cells	  were	  resuspended	  in	  100	  µl	  STET	  breaking	  buffer	  (8	  %	  sucrose,	  50	  mM	  TRIS-­‐HCl	  pH	  8.0,	  50	  mM	  EDTA,	  5	  %	  Triton	  X-­‐100),	  0.3	  g	  of	  0.5	  mm	  glass	  beads	  added	  and	  the	  cells	  ribolysed	  for	  5	  x	  20	  sec.	  Another	  100	  µl	  of	  STET	  buffer	  was	  added;	  the	  mixture	  was	  vortexed	  and	  then	  incubated	  at	  100°C	  for	  3	   minutes.	   The	   sample	   was	   cooled	   on	   ice	   and	   centrifuged	   for	   10	  min	   at	   4°C	   at	  maximum	   speed	   in	   a	   tabletop	   centrifuge.	   The	   top	   100	   µl	   were	   transferred	   to	  50	  µl	  7.5	  M	  ammonium	  acetate	  and	  the	  plasmid	  DNA	  freeze	  precipitated	  for	  1	  hr	  at	  -­‐20°C.	  Impurities	  were	  removed	  by	  centrifugation	  for	  10	  min	  at	  4°C	  and	  maximum	  speed	   in	   a	   tabletop	   centrifuge.	   The	   top	   100	   µl	   were	   transferred	   to	   200	   µl	  70	  %	  ethanol	   and	   centrifuged	   for	   10	  min	   at	   maximum	   speed	   in	   a	   tabletop	  centrifuge.	   The	   pellet	   was	   washed	   in	   70	  %	   ethanol	   and	   resuspended	   in	   ddH2O	  before	  being	  transformed	  into	  E.	  coli.	  	  
2.5.1.17	   BIOLISTIC	  TRANSFORMATION	  The	   process	   of	   biolistic	   transformation	   is	   divided	   into	   three	   steps:	   yeast	  preparation,	  DNA	  preparation	  and	  biolistic	  bombardment.	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For	   preparation	   of	   the	   parental	   strains	   H99	   and	   R265,	   the	   strains	   were	   grown	  overnight	  in	  50	  ml	  YPD	  media	  at	  30°C	  and	  shaking	  at	  180	  rpm.	  Cells	  were	  collected	  by	   centrifugation	   for	   5	   min	   at	   900	   rcf	   and	   washed	   with	   dH2O.	   Cells	   were	   then	  resuspended	  in	  ¼	  of	  the	  original	  volume	  and	  aliquots	  of	  300	  µl	  were	  plated	  on	  YPD	  plates	  containing	  1	  M	  sorbitol	  and	  left	  to	  dry.	  For	  preparation	  of	  the	  DNA,	  0.6	  µm	  gold	  micro	  carriers	  (BioRad)	  were	  subjected	  to	  subsequent	  washing	   steps	   in	   dH2O	   and	   1	  ml	   of	   100	  %	   ethanol.	   The	   sample	  was	  then	  aliquoted	  into	  250	  µl	  portions;	  another	  750	  µl	  of	  100	  %	  ethanol	  was	  added	  to	  each	   aliquot.	   Prepared	   gold	   micro	   carriers	   were	   stored	   at	   4°C.	   An	   aliquot	   of	  10	  µl	  gold	  micro	  carriers	  was	  mixed	  with	  10	  µl	  of	  1	  µg/µl	  DNA,	  10	  µl	  2.5	  M	  CaCl2	  and	   2	  µl	   of	   1	   M	   spermidine	   –	   free	   base	   and	   incubated	   for	   5	   minutes	   at	   room	  temperature	   to	   allow	   binding	   of	   the	   DNA	   to	   the	   gold	   particles.	   The	   gold	   micro	  carriers	  were	   then	  pelleted	  by	   centrifugation	   for	  1	  minute	   at	   800	   rcf,	  washed	   in	  500	  µl	   100	  %	  ethanol	   and	   afterwards	   resuspended	   in	  12	  µl	   100	  %	  ethanol.	   The	  2.5	  cm	  micro	   carrier	  biolistic	  discs	   (BioRad)	  were	  washed	   in	  100	  %	  ethanol	   and	  dried	   before	   the	   sample	   was	   applied	   to	   the	   centre	   of	   a	   prepared	   micro	   carrier	  biolistic	  disc.	  For	  biolistic	  bombardment,	  the	  gold	  micro	  carriers	  were	  accelerated	  in	  a	  helium-­‐generated	   vacuum	   (1350	   psi	   rupture	   discs,	   BioRad)	   and	   shot	   onto	   the	   prepared	  YPD	  plates	  with	  Cryptococcus	   in	  a	  BioRad	  PDS-­‐1000/He	  biolistic	  particle	  delivery	  system.	  After	  transformation,	  yeast	  cells	  on	  plates	  were	  recovered	  for	  5	  hr	  at	  30°C	  and	   then	   washed	   of	   with	   1	   ml	   of	   YPD	   media	   and	   plated	   on	   selection	   media	  containing	   250	   µg/ml	   hygromycin	  B	   for	   GFP	  mutants	   and	   containing	   300	   µg/ml	  G418	  for	  selection	  of	  sre1ko	  mutants.	  The	  plates	  were	  incubated	  for	  5	  days	  at	  30°C.	  Potential	   GFP	   transformants	   were	   analysed	   phenotypically;	   sre1	   knockout	   was	  confirmed	  by	  southern	  analysis.	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2.5.1.18	   SOUTHERN	  HYBRIDIZATION	  	  Southern	  analysis	  is	  used	  to	  identify	  specific	  DNA	  regions	  by	  hybridization	  with	  a	  labeled	   complementary	   DNA	   probe.	   In	   the	   context	   of	   this	   study,	   probes	   were	  designed	   and	   restrictions	   enzymes	  were	   chosen	   in	   a	  way	   that	   results	   in	   specific	  hybridization	   signals	   that	   allow	   for	   analysis	   of	   potential	   Cryptococcus	  transformants	   for	   knockout	   of	   sre1	   and	   control	   for	   potential	   undesired	   genomic	  rearrangements	   or	   random	   integration	   events.	  DNA	  was	   isolated	   from	   randomly	  selected	   colonies	   and	   DNA	   concentration	   measured	   with	   a	   NanoDrop	   ND-­‐1000	  spectrometer.	  Thirty	  µg	  of	  DNA	  subjected	  to	  restriction	  with	  the	  enzymes	  AgeI	  and	  
SpeI	  before	  the	  restricted	  DNA	  fragments	  were	  slowly	  separated	  on	  a	  1	  %	  agarose	  gel.	   The	  DNA	  was	   depurinated	   by	   gentle	   agitation	   in	   0.25	  M	  HCl	   for	   10	  min	   and	  denatured	   in	  0.4	  M	  NaOH	   for	  30	  min.	  The	  nitrocellulose	  membrane	   (GeneScreen	  hybridization	  membranes,	  NEN®	   Life	   Science	  Products)	  was	  wet	  with	  dH2O	   and	  eliquibrated	  in	  0.4	  M	  NaOH	  for	  10	  min.	  Alkaline	  capillary	  transfer	  with	  0.4	  M	  NaOH	  overnight	  transferred	  the	  DNA	  onto	  the	  membrane.	  The	  membrane	  was	  rinsed	  in	  2xSSC	  (0.03	  M	  sodium	  citrate,	  0.3	  NaCl,	  pH	  7.2)	  and	  partially	  dried	  before	  the	  DNA	  was	   cross-­‐linked	   to	   the	   membrane	   with	   ultraviolet	   light	   in	   a	   UV	   stratalinker	   at	  120,000	   µJoules/cm2.	   The	   membrane	   was	   pre-­‐hybridized	   in	   10	   ml	   of	   modified	  Church	  buffer	   (0.36	  M	  Na2HPO4,	   0.14	  M	  NaH2PO4,	   1mM	  EDTA	  and	  7	  %	  SDS)	   for	  30	  min	   at	   65°C.	   Hybridization	   probes	   were	   amplified	   with	   specific	   primers,	   the	  product	   separated	   on	   an	   agarose	   gel	   and	   extracted.	   The	   DNA	   probe	   was	   then	  labeled	  with	   the	  Prime-­‐a-­‐Gene	   labeling	  kit	   (Promega).	  The	  probe	  was	  denatured	  for	  2	  min	   at	   100°C	   and	   chilled	  on	   ice.	   6	  ng	  of	  DNA	  were	   labeled	   in	   a	   reaction	   in	  1	  x	  buffer,	   with	   20	   µM	   of	   each	   unlabeled	   dNTP,	   400	   µg/ml	   nuclease-­‐free	   BSA,	  333	  nM	  [α-­‐32P]dCTP	  (50µCi)	  and	  5	  U	  DNA	  polymerase	  I	  large	  Klenow	  fragment	  for	  1	   hr	   at	   room	   temperature.	   The	   reaction	   was	   then	   stopped	   at	   100°C	   for	   2	   min,	  chilled	  on	  ice	  and	  2	  µl	  of	  0.5	  M	  EDTA	  was	  added.	  The	  probe	  was	  added	  directly	  into	  the	  pre-­‐hybridization	  buffer	  and	  hybridization	  was	  allowed	  over	  night	  at	  65°C.	  To	  remove	  unspecific	  bound	  probe,	  the	  membrane	  was	  washed	  twice	  for	  15	  min	  with	  pre-­‐warmed	  wash	  buffer	  1	  (0.1	  %	  SDS,	  2xSSC),	  twice	  for	  15	  min	  with	  pre-­‐warmed	  wash	  buffer	  2	  (0.1	  %	  SDS,	  0.5xSSC)	  and	  twice	  for	  15	  min	  with	  pre-­‐warmed	  wash	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buffer	  3	  (0.1	  %	  SDS,	  0.1xSSC).	  DNA	  bound	  probe	  was	  detected	  by	  autoradiography	  overnight	  at	  -­‐80°C	  on	  a	  Fuji	  medical	  X-­‐ray	  film	  100	  NF.	  	  
2.5.1.19	   IDENTIFICATION	  OF	  GFP	  INTEGRATION	  SITE	  The	   GFP	   construct	   together	   with	   the	   unlinearised	   shuttle	   vector	   was	   randomly	  integrated	   in	   the	   cryptococcal	   genome.	   To	   identify	   the	   integration	   site,	   a	   single	  primer	  PCR	   approach	   followed	  by	   sequencing	  with	   a	   second	   specific	   sequencing	  primer	  was	  applied	  (Karlyshev	  et	  al.,	  2000).	  	  DNA	   was	   isolated	   from	   GFP-­‐tagged	   strains	   with	   the	   MasterPureTM	   Yeast	   DNA	  Purification	  Kit	   (Epicentre).	  Briefly,	  yeast	  cells	   from	  2	  ml	  YPD	  overnight	  cultures	  were	  collected	  and	  resuspended	  in	  300	  µl	  of	  Yeast	  Cell	  Lysis	  Solution.	  Cells	  were	  lysed	  by	  vortexing	  with	  glass	  beads	   for	  5	  min	   followed	  by	   incubation	  at	  65°C	  for	  15	  min.	   The	   samples	  were	   cooled	  down	  on	   ice	   for	   5	  min,	   150	  µl	   of	  MPC	  Protein	  Precipitation	  Reagent	  added	  and	  vortexed	  for	  10	  sec.	  Cellular	  debris	  was	  removed	  by	   centrifugation	   for	   10	  min	   at	   13,000	   rcf,	   the	   supernatant	   containing	   the	   DNA	  transferred	  to	  a	  fresh	  sample	  tube	  and	  500	  µl	  of	  isopropanol	  added	  to	  precipitate	  DNA.	   DNA	   was	   recovered	   by	   centrifugation	   for	   10	  min	   at	   13,000	   rcf,	   the	   pellet	  washed	  with	   500	   µl	   70	  %	   ethanol	   before	   being	   resuspended	   in	   50	   µl	   TE	   buffer.	  Subsequently,	  the	  RNA	  was	  degraded	  by	  RNase	  A	  treatment	  (1	  µl	  of	  5µg/µl	  RNase	  A)	   for	   30	  min	   at	   37°C	   and	   DNA	   extracted	   with	   phenol:	   chloroform	   followed	   by	  ethanol	  precipitation	  (Section	  5.1.3	  and	  5.1.4).	  	  The	   PCR	   strategy	   involved	   three	   rounds	   of	   amplification	   with	   a	   single	   specific	  primer	   for	   the	   integrated	   DNA	   fragment	   (Karlyshev	   et	   al.,	   2000).	   Firstly,	  integration-­‐specific	  templates	  were	  linearly	  amplified	  at	  an	  annealing	  temperature	  of	   50°C.	   This	   step	   was	   followed	   by	   a	   round	   of	   amplification	   at	   low	   annealing	  temperature	   (30°C)	   allowing	   for	   non-­‐specific	   primer	   binding	   on	   the	   opposite	  strand	   in	   regions	   adjacent	   to	   the	   integration	   site.	   Lastly,	   amplification	   at	   50°C	  annealing	   temperature	   allowed	   for	   further	   amplification	   of	   fragments.	   PCR	   was	  carried	  out	  with	  1.25	  U	  GoTaq	  Flexi	  DNA	  polymerase	   (Promega)	   in	  1	  x	   colorless	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2.6	   BIOINFORMATICS	  AND	  STATISTICAL	  ANALYSIS	  
	  
2.6.1	   BIOINFORMATICS	  ANALYSIS	  Cryptococcal	   mitochondrial	   genome	   information	   was	   annotated	   using	   the	   open	  reading	   frame	   finder	   from	   the	   National	   Centre	   for	   Biotechnology	   Information	  (NCBI)	  and	  the	  basic	  local	  alignment	  search	  tools	  (Blast)	  available	  from	  the	  Broad	  Institute	  of	  MIT	  and	  Harvard	  and	  NCBI.	  Multiple	  alignments	  were	  created	  with	  the	  software	  Mauve	  2.0	  (Darling	  et	  al.,	  2010).	   Information	  from	  sequencing	  reactions	  was	   analysed	   using	   the	   sequence	  Mac	   Sequence	   View	   software	   and	   blast	   search	  engines.	  	  	  
2.6.2	   STATISTICAL	  ANALYSIS	  At	   least	   three	   individual	   experiments	  were	  performed	   for	   each	   assay.	  Data	  were	  tested	   for	   normality	   using	   the	  Kolmogorov-­‐Smirnov	   test	   and	   for	   homogeneity	   of	  variances	  using	  the	  Levene	  statistic.	  If	  data	  were	  normally	  distributed	  and	  showed	  homogeneity	  of	  variance,	  statistically	  significant	  differences	  among	  the	  mean	  data	  were	   analysed	   using	   a	   One-­‐Way	   ANOVA.	   Multi-­‐comparisons	   (Tukey	   Honestly	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Significant	   Differences	   (HSD)	   tests)	   were	   performed	   to	   identify	   statistically	  significant	   differences	   between	   pairs.	   A	   p-­‐value	   of	   p	   <	   0.05	   after	   controlling	   for	  multiplicity	  was	  considered	  to	  be	  statistically	  significant.	  	  Different	  cryptococcal	  genotypes	  were	  compared	  for	  their	  median	  IPR	  values	  using	  the	  non-­‐parametric	  Mann-­‐Whitney	  U-­‐test	  and	  values	  of	  p<0.025,	  after	  controlling	  for	   multiplicity,	   were	   accepted	   as	   statistically	   significant	  (http://elegans.swmed.edu/~leon/stats/utest.cgi).	  For	   assessment	   of	   data	   from	   expulsion	   assays	   and	   from	  mitochondrial	   staining,	  results	  from	  at	  least	  three	  individual	  assays	  were	  tested	  for	  statistically	  significant	  differences	  using	  a	  χ2-­‐	   test.	  P-­‐values	  of	  <	  0.05	  were	  considered	   to	  be	  statistically	  significant.	  Furthermore,	  Pearson	  correlation	  was	  used	  to	  measure	  the	  correlation	  between	  tubular	  mitochondrial	  morphology	  and	  IPR	  values;	  an	  F-­‐value	  of	  P<0.05	  was	  considered	  to	  be	  a	  significant	  correlation	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In	  healthy	  hosts,	  cryptococcal	  infection	  is	  usually	  self-­‐limiting,	  suggesting	  effective	  clearance	   or	   maintenance	   in	   a	   latent	   state	   by	   phagocytic	   cells.	   The	   outcome	   of	  cryptococcosis	   depends	   on	   the	   immune	   status	   of	   the	   infected	   individual	   and	   the	  cytokine	   pattern	   generated	   in	   response	   to	   the	   pathogen.	   Although	   it	   is	   well	  established	   that	   the	   host’s	   cytokine	   profile	   dramatically	   affects	   the	   outcome	   of	  cryptococcal	  disease,	   the	  molecular	  basis	   for	   this	   effect	   is	  unclear.	  Both	  Th1	  and	  Th2	  cytokines	  are	   involved	   in	  protection	  against	  C.	  neoformans,	  but	  whereas	  Th1	  associated	  cytokines	  are	  essential	  for	  natural	  immunity,	  Th2	  associated	  immunity	  is	   not	   protective	   in	  mice	   (Beenhouwer	   et	   al.,	   2001,	   Hoag	   et	   al.,	   1997,	   Huffnagle,	  1996).	   Increased	  expression	  of	  Th1	  cytokines,	  such	  as	  TNF-­‐α	  and	  IFN-­‐γ,	  result	   in	  improved	   fungal	   control	   (Flesch	   et	  al.,	   1989,	  Kawakami	   et	  al.,	   1995,	  Milam	   et	  al.,	  2007,	  Wormley	   et	   al.,	   2007)	   whilst	   IFN-­‐γ	   knockout	  mice	   show	   increased	   fungal	  burden	  (Arora	  et	  al.,	  2005).	  Recently,	  Müller	  et	  al.	  (2007)	  showed	  a	  significant	  role	  for	  Th17	  response	  and	  the	  pro-­‐inflammatory	  cytokine	  IL-­‐17	  in	  modulating	  survival	  of	  Cryptococcus–infected	  mice.	   In	   contrast,	   Th2	   cytokines	   such	   as	   IL-­‐4	   and	   IL-­‐13	  reduce	  the	  host’s	  ability	  to	  deal	  with	  C.	  neoformans	  in	  vivo	  (Blackstock	  et	  al.,	  2004,	  Decken	  et	  al.,	  1998,	  Muller	  et	  al.,	  2007,	  Kawakami	  et	  al.,	  1999).	  	  Despite	  these	  observations	  from	  animal	  models,	   little	  work	  has	  been	  done	  on	  the	  
in	   vitro	   effect	   of	   Th1,	   Th17	   and	   Th2	   cytokines	   on	   the	   interaction	   between	  macrophages	  and	  Cryptococcus.	  This	  section	  reports	  a	  systematic	  study	  of	  cytokine	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influence	  on	  macrophage-­‐Cryptococcus	  interactions	  in	  a	  representative	  selection	  of	  
Cryptococcus	   strains.	   The	   results	   demonstrate	   that	   Th1	   and	   Th17-­‐stimulated	  macrophages	   are	   significantly	   better	   at	   phagocytosing	   cryptococci	   and	   at	  controlling	   intracellular	   proliferation	   of	   this	   pathogen	   than	   Th2-­‐stimulated	   cells.	  	  In	   contrast,	   Th2-­‐activated	   macrophages	   show	   a	   significantly	   lower	   rate	   of	  cryptococcal	  expulsion	  than	  Th1	  or	  Th17-­‐activated	  cells.	  	  Together,	  these	  data	  help	  explain	  the	  susceptibility	  phenotype	  associated	  with	  Th2	  cytokine	  profiles	  in	  vivo.	  	  	  
3.1	   MACROPHAGE	  ACTIVATION	  
Macrophages	  were	   treated	  with	  different	   cytokines	   to	  mimic	  Th1,	  Th17	  and	  Th2	  activation.	   It	  was	  chosen	  to	   investigate	  the	  Th1	  cytokines	  IFN-­‐γ,	  TNF-­‐α,	   the	  Th17	  cytokine	   IL-­‐17	   and	   the	   Th2	   cytokines	   IL-­‐4	   and	   IL-­‐13	   as	   there	   is	   already	  considerable	   in	   vivo	   information	   available	   describing	   the	   influence	   of	   these	  cytokines	  on	  cryptococcosis.	  To	  avoid	  artifacts	  due	  to	  over-­‐stimulation,	  the	  lowest	  cytokine	   concentrations	   previously	   demonstrated	   to	   induce	   Th1,	   Th2	   or	   Th17	  phenotypes	  were	  used,	  as	  follows:	  10	  units/ml	  IFN-­‐γ	  (Murray	  et	  al.,	  1985),	  1	  ng/ml	  TNF-­‐α	  (Roilides	  et	  al.,	  1998),	  10	  ng/ml	  IL-­‐17	  (Higgins	  et	  al.,	  2006),	  10	  ng/ml	  IL-­‐4	  (Weiss	   et	  al.,	  1997)	  and	  10	  ng/ml	   IL-­‐13	  (Weiss	   et	  al.,	  1997).	  To	  confirm	  that	   the	  cytokines	   were	   nonetheless	   functional	   at	   these	   concentrations,	   macrophage	  morphology	  and	  phagocytic	  capacity	  after	  cytokine	  exposure	  was	  monitored.	  	  Untreated	  J774	  and	  primary	  macrophages	  appeared	  mainly	  round	  or	  occasionally	  slightly	   spread.	   However,	   following	   exposure	   of	   J774	   cells	   to	  mouse	   or	   primary	  macrophages	   to	   human	   recombinant	   cytokines,	   most	   cells	   were	   extensively	  elongated	   and	   spread,	   demonstrating	   that	   cells	   are	   effectively	   activated	   by	  cytokines	   at	   these	   concentrations	   (Figure	   15	   A).	   To	   detect	   any	   cytokine-­‐evoked	  cytotoxic	  effects	  on	  macrophages,	  growth	  was	  monitored	  over	  72	  hours.	   	  Neither	  J774	   (Figure	   15	   B)	   nor	   human	   monocyte-­‐derive	   macrophages	   (Figure	   15	   B)	  exhibited	  any	  cytokine-­‐induced	  cytotoxicity.	  	  Given	   the	   well-­‐established	   role	   of	   pro-­‐inflammatory	   cytokines	   in	   enhancing	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phagocytosis	   (Kawakami	   et	   al.,	   1995)	   the	   ability	   of	   macrophage-­‐like	   cells	   and	  human	  primary	  macrophages	  to	  phagocytose	  Cryptococcus	  when	  treated	  with	  Th1,	  Th17	  and	  Th2	  cytokines	  was	  used	  as	  a	  second	  parameter	   to	  show	  the	  efficacy	  of	  cytokine	   treatment.	   Untreated	   or	   cytokine	   treated	   macrophages	   were	   infected	  with	  C.	  neoformans	   strain	  ATCC90112,	  H99	  or	  C.	  gattii	  strain	  R265	  and	  analyzed	  for	   uptake	   rates	   (percentage	   phagocytosis).	  Whilst	   Th1/Th17	   cytokines	   induced	  an	   increase	   in	   cryptococcal	   phagocytosis,	   neither	   IL-­‐4	   nor	   IL-­‐13	   treatment	  significantly	  altered	  uptake	  rates	  (Figure	  16	  A).	  Similar	  results	  were	  obtained	  for	  all	   three	   cryptococcal	   strains	   in	   both	   mouse	   and	   human	   macrophages	  (Figure	  16	  A	  &	   B),	   suggesting	   that	   Th1/Th17-­‐dependent	   enhancement	   of	  phagocytosis	   is	   not	   strain-­‐specific.	   It	   is	   noted	   that	  most	   of	   the	   increases	   are	   not	  statistically	   significant,	   most	   likely	   because	   of	   experimental	   error	   and	   variation.	  However,	  given	  that	  the	  results	  agree	  with	  those	  previously	  published	  (Kawakami	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Figure	   15:	   Assessment	   of	   cytokine	   efficacy.	   Treatment	   with	   cytokines	   at	   the	   chosen	  concentrations	   results	   in	   morphological	   changes	   in	   both	   J774	   and	   human	   primary	  monocyte-­‐derived	   macrophages	   but	   does	   not	   influence	   macrophage	   survival.	   J774	   and	  human	  primary	  monocyte-­‐derived	  macrophages	  were	  treated	  with	  Th1	  (10	  units/ml	  IFN-­‐
γ,	   1	   ng/ml	   TNF-­‐α),	   Th17	   (10	   ng/ml	   IL-­‐17)	   or	   Th2	   (10	   ng/ml	   IL-­‐4	   or	   10	   ng/ml	   IL-­‐13)	  cytokines	   and	   then	   monitored	   to	   assess	   cytokine	   efficacy	   at	   the	   chosen	   cytokine	  concentrations.	   (A)	  Representative	   images	   of	   cytokine-­‐treated	   J774	   and	   human	  primary	  macrophage	  cells.	  Note	  the	  polarized	  and	  spread	  morphology	  of	  activated,	  but	  not	  control,	  cells	   (B)	   Cytokine	   treatment	   does	   not	   significantly	   influence	   human	   primary	   or	   J774	  macrophage	   survival.	   The	   data	   are	   presented	   as	   the	   mean	   of	   at	   least	   three	   individual	  experiments	  ±	  2	  x	  standard	  error	  of	  the	  mean.	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Figure	   16:	   Cryptococcus	   uptake	   after	   cytokine	   treatment.	   Cryptococcus	   uptake	   is	  increased	  in	  a	  Th1	  and	  Th17	  cytokine,	  but	  not	  altered	  in	  Th2	  cytokine,	  treated	  J774	  cells	  and	  human	  macrophages.	  Untreated	  and	  Th1	   (10	  units/ml	   IFN-­‐γ,	   1	  ng/ml	  TNF-­‐α),	  Th17	  (10	  ng/ml	   IL-­‐17)	   or	   Th2	   (10	  ng/ml	   IL-­‐4	   or	   10	   ng/ml	   IL-­‐13)	   cytokine	   treated	   J774	   cells	  were	  infected	  with	  C.	  neoformans	  strains	  ATCC90112	  and	  H99	  or	  C.	  gattii	  strain	  R265	  and	  then	   assessed	   for	   cryptococcal	   uptake.	   (A)	   Percentage	   phagocytosis	   of	   C.	   neoformans	  ATCC90112.	  There	  is	  a	  trend	  for	  increased	  uptake	  after	  Th1/Th17	  cytokine	  treatment	  but	  no	  influence	  on	  yeast	  uptake	  after	  treatment	  with	  Th2	  cytokines.	  (B)	  Similar	  trends	  can	  be	  found	  in	  all	  three	  selected	  Cryptococcus	  strains.	  The	  data	  are	  presented	  as	  the	  mean	  of	  at	  least	   three	   individual	   experiments	   ±	   2	   x	   standard	   error	   of	   the	   mean.	   The	   means	   were	  tested	   for	   statistical	   significance	   using	   Tukey	   HSD	   test	   assuming	   equal	   variances.	  Statistically	   significant	   differences	   compared	   to	   the	   control	   are	   indicated	   by	   asterisks	  (*	  P	  <	  0.05,	  **	  P	  ≤	  0.01).	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3.2	   INTRACELLULAR	  PROLIFERATION	  IN	  J774	  MACROPHAGES	  
Cryptococcus	  is	  known	  to	  survive	  and	  proliferate	  within	  macrophages.	  A	  method	  to	  monitor	   intracellular	   Cryptococcus	   proliferation	   in	   cell	   culture	   systems	   that	   has	  recently	   been	   developed	   was	   used	   (Ma	   et	   al.,	   2009a).	   In	   vitro,	   the	   intracellular	  yeast	  cell	  number	  increases	  steadily	  for	  the	  first	  18	  to	  24	  hours	  before	  the	  number	  starts	   to	   decline	   due	   to	   host	   cell	   lysis.	   Maximal	   Intracellular	   Proliferation	   Rate	  (IPR)	  was	  used	  as	  a	  measure	  of	  proliferative	  capacity	  that	  enables	  easy	  comparison	  of	  intracellular	  proliferation	  between	  different	  conditions	  (Figure	  17	  A).	  	  To	   analyze	   if	   Th1,	   Th17	   or	   Th2	   cytokines	   influence	   intracellular	   cryptococcal	  proliferation,	  untreated	  or	   cytokine	  pre-­‐treated	   J774	  macrophages	  were	   infected	  with	  the	  C.	  neoformans	  strains	  ATCC90112	  or	  H99	  or	  the	  C.	  gattii	  strain	  R265	  and	  monitored	   for	   intracellular	   proliferation	   over	   72	   hours.	   In	   all	   three	   strains,	  treatment	   with	   the	   Th1	   cytokine	   IFN-­‐γ	   did	   not	   alter	   IPR	   whereas	   IPR	   was	  significantly	  increased	  in	  macrophages	  treated	  with	  the	  Th2	  cytokine	  IL-­‐4	  (Figure	  17	  B).	  To	  confirm	  that	  these	  findings	  were	  not	  specific	  to	  these	  two	  cytokines,	  IPR	  following	   J774	   macrophage	   pre-­‐treatment	   with	   TNF-­‐α	   (Th1	   cytokine),	   IL-­‐17	  (Th17	  cytokine)	   or	   IL-­‐13	   (Th2	   cytokine)	   was	   measured.	   All	   three	   cryptococcal	  strains	  showed	  similar	  trends	  in	  this	  experimental	  analysis	  and	  so,	  for	  simplicity,	  representative	   data	   for	   only	   one	   strain	   is	   presented.	   In	   all	   cases,	   Th1/Th17	  cytokines	  did	  not	  alter	  IPR	  whilst	  Th2	  activation	  increased	  it	  (Figure	  17	  C).	  None	  of	  the	   cytokine	   treatments	   altered	   the	   timing	   of	   the	   maximal	   IPR,	   which	   always	  occurred	  at	  either	  18	  or	  24	  hours	  post	  infection.	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Figure	   17:	   Intracellular	   Cryptococcus	   proliferation	   in	   J774	   macrophages	   after	  
cytokine	  treatment.	  Intracellular	  Cryptococcus	  proliferation	  is	  increased	  in	  Th2	  cytokine,	  but	  not	  altered	  in	  Th1/Th17	  cytokine,	  treated	  J774	  cells.	  Untreated	  and	  Th1	  (10	  units/ml	  IFN-­‐γ,	  1	  ng/ml	  TNF-­‐α),	  Th17	  (10	  ng/ml	  IL-­‐17)	  or	  Th2	  (10	  ng/ml	  IL-­‐4	  or	  10	  ng/ml	  IL-­‐13)	  cytokine	  treated	  J774	  cells	  were	  infected	  with	  C.	  neoformans	  strains	  ATCC90112	  and	  H99	  or	  C.	  gattii	  strain	  R265	  and	  then	  further	  incubated	  under	  the	  same	  conditions	  to	  monitor	  intracellular	  yeast	  proliferation.	  (A)	  Schematic	  graph	  illustrating	  how	  IPR	  was	  derived.	  (B)	  IPR	   is	  not	  altered	  under	   the	   influence	  of	   the	  Th1	  cytokine	   IFN-­‐γ	  but	   increases	  under	   the	  influence	  of	   the	  Th2	  cytokine	  IL-­‐4	   for	  all	   three	  selected	  strains.	  (C)	   IPR	  of	  ATCC90112	  is	  unaltered	  following	  treatment	  with	  the	  Th1	  cytokines	  IFN-­‐γ,	  TNF-­‐α	  and	  the	  Th17	  cytokine	  IL-­‐17	  but	  increases	  significantly	  following	  treatment	  with	  the	  Th2	  cytokines	  IL-­‐4	  or	  IL-­‐13.	  The	  data	  are	  presented	  as	  the	  mean	  of	  at	  least	  three	  individual	  experiments	  ±	  2	  x	  standard	  error	  of	  the	  mean.	  The	  means	  were	  tested	  for	  statistical	  significance	  using	  Tukey	  HSD	  test	  assuming	  equal	  variances.	  Statistically	  significant	  differences	  compared	  to	  the	  control	  are	  indicated	  by	  asterisks	  (*	  P	  <	  0.05,	  **	  P	  ≤	  0.01).	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3.3	   INTRACELLULAR	   PROLFERATION	   IN	   PRIMARY	   HUMAN	  
MACROPHAGES	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Figure	   18:	   Intracellular	   Cryptococcus	   proliferation	   in	   human	   macrophages	   after	  
cytokine	  treatment.	  Intracellular	  Cryptococcus	  proliferation	  is	  increased	  in	  Th2	  cytokine	  but	   not	   altered	   in	   TNF-­‐α	   and	   IL-­‐17	   cytokine	   treated	   human	   primary	   macrophages.	  Untreated	   and	   Th1	   (10	   units/ml	   IFN-­‐γ,	   1	   ng/ml	   TNF-­‐α),	   Th17	   (10	   ng/ml	   IL-­‐17)	   or	   Th2	  (10	  ng/ml	   IL-­‐4	   or	   10	   ng/ml	   IL-­‐13)	   cytokine	   treated	   human	   primary	  macrophages	  were	  infected	  with	  C.	  neoformans	  strains	  ATCC90112	  and	  H99	  or	  C.	  gattii	  strain	  R265	  and	  then	  further	   incubated	  under	  the	  same	  conditions	  to	  monitor	   intracellular	  yeast	  proliferation.	  IPR	  is	  low	  following	  treatment	  with	  the	  Th1	  cytokine	  TNF-­‐α	  and	  the	  Th17	  cytokine	  IL-­‐17	  but	  higher	  following	  treatment	  with	  the	  Th2	  cytokines	  IL-­‐4	  or	  IL-­‐13,	  although	  due	  to	  high	  donor	   variability	   and	   multiplicity	   of	   testing,	   not	   all	   comparisons	   are	   significant	   at	   the	  5	  %	  level.	   The	   data	   are	   presented	   as	   the	  mean	   of	   at	   least	   three	   individual	   experiments	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3.4	   THE	   INFLUENCE	   OF	   CYTOKINE	   SIGNALING	   ON	   EXPULSION	  
EVENTS	  IN	  J774	  MACROPHAGES	  
Expulsion	  is	  believed	  to	  be	  a	  possible	  trafficking	  mechanism	  by	  which	  Cryptococcus	  disseminates	  within	  the	   infected	  individual	  without	  triggering	   local	   inflammation	  (Ma	  et	  al.,	  2006,	  Alvarez	  et	  al.,	  2006).	  Thus,	  the	  influence	  of	  the	  selected	  Th1,	  Th17	  and	  Th2	  cytokines	  on	  the	  occurrence	  of	  cryptococcal	  expulsion	  was	  analysed	  using	  live	   cell	   imaging.	   A	   total	   of	   10,031	   J774	   macrophages	   (of	   which	   1208	   showed	  internalized	   yeast	   cells)	   and	   115	   expulsion	   events	   were	   observed.	   All	   three	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Figure	  20:	  Occurrence	  of	  cryptococcal	  expulsion	  in	  J774	  macrophages	  after	  cytokine	  
treatment.	   Occurrence	   of	   cryptococcal	   expulsion	   is	   reduced	   in	   Th2	   cytokine	   but	   not	  altered	   in	   TNF-­‐α	   and	   IL-­‐17	   cytokine	   treated	   J774	   macrophages.	   Untreated	   and	   Th1	  (10	  units/ml	   IFN-­‐γ,	   1	   ng/ml	   TNF-­‐α),	   Th17	   (10	   ng/ml	   IL-­‐17)	   or	   Th2	   (10	   ng/ml	   IL-­‐4	   or	  10	  ng/ml	   IL-­‐13)	   cytokine	   treated	   J774	   cells	   were	   infected	   with	   C.	   neoformans	   strains	  ATCC90112	   and	   H99	   or	   C.	   gattii	   strain	   R265,	   then	   further	   incubated	   under	   the	   same	  conditions	   whilst	   monitoring	   for	   cryptococcal	   expulsion.	   Occurrence	   of	   expulsion	   is	  significantly	   reduced	   following	   treatment	  with	  Th2	   cytokines	   IL-­‐4	  or	   IL-­‐13	   compared	   to	  untreated	   or	   Th1/Th17	   treated	   cells.	   The	   presented	   data	   were	   obtained	   from	   at	   least	  three	   individual	   experiments	   and	   analysed	   for	   statistical	   significance	   using	   χ2	   tests.	  Statistically	  significant	  differences	  are	  indicated	  by	  asterisks	  (**	  P	  ≤	  0.01).	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3.5	   THE	   INFLUENCE	   OF	   CYTOKINE	   SIGNALING	   ON	   EXPULSION	  
EVENTS	  IN	  HUMAN	  PRIMARY	  MONOCYTE-­DERIVED	  MACROPHAGES	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Figure	   21:	   Occurrence	   of	   cryptococcal	   expulsion	   in	   human	   macrophages	   after	  
cytokine	  treatment.	  Occurrence	  of	  cryptococcal	  expulsion	  is	  reduced	  in	  Th2	  cytokine	  but	  not	  altered	  in	  TNF-­‐α	  and	  IL-­‐17	  cytokine	  treated	  human	  primary	  macrophages.	  Untreated	  and	  Th1	  (10	  units/ml	  IFN-­‐γ,	  1	  ng/ml	  TNF-­‐α),	  Th17	  (10	  ng/ml	  IL-­‐17)	  or	  Th2	  (10	  ng/ml	  IL-­‐4	   or	   10	  ng/ml	   IL-­‐13)	   cytokine	   treated	  human	  primary	  macrophages	  were	   infected	  with	  
C.	  neoformans	  strains	  ATCC90112	  and	  H99	  or	  C.	  gattii	  strain	  R265,	  then	  further	  incubated	  under	   the	   same	   conditions	   whilst	   monitoring	   for	   cryptococcal	   expulsion	   by	   live	   cell	  imaging.	   Occurrence	   of	   expulsion	   is	   significantly	   reduced	   following	   treatment	  with	   Th2	  cytokines	  IL-­‐4	  or	  IL-­‐13	  compared	  to	  untreated	  or	  Th1/Th17	  treated	  cells.	  The	  presented	  data	  were	  obtained	  from	  at	  least	  three	  individual	  experiments	  and	  analysed	  for	  statistical	  significance	   using	  χ2	   tests.	   Statistically	   significant	   differences	   are	   indicated	   by	   asterisks	  (**	  P	  ≤	  0.01).	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3.6	   INTRACELLULAR	   PROLIFERATION	   RATE	   AND	   EXPULSION	   OF	  
COMPLEMENT	   OPSONIZED	   CRYPTOCOCCUS	   IN	   CYTOKINE	   TREATED	  
J774	  MACROPHAGES	  
While	  opsonising	  antibodies	  to	  Cryptococcus	  may	  or	  may	  not	  be	  present	  during	  an	  infection,	   complement	   opsonization	   should	   occur	   in	   all	   healthy	   individuals.	   To	  determine	   the	   effect	   of	   Th1,	   Th17	   and	   Th2	   cytokines	   on	   complement-­‐opsonized	  yeast,	   intracellular	   proliferation	   and	   occurrence	   of	   expulsion	   were	   assessed	   in	  cytokine	   treated	   J774	   cells	   infected	   with	   serum-­‐opsonized	   C.	   neoformans	   strain	  ATCC90112	  cells.	  As	  with	  antibody-­‐opsonized	  yeast,	  complement-­‐opsonized	  yeast	  proliferated	  more	  readily	  in,	  but	  was	  expelled	  less	  frequently	  from,	  Th2-­‐stimulated	  macrophages	   than	   from	  Th1	  or	  Th17	   stimulated	  macrophages	   (Figure	  22).	   Thus	  the	  effects	  of	  cytokine	  activation	  appear	  to	  be	  largely	  independent	  of	  the	  opsonin	  present	  on	  the	  cryptococcal	  surface.	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Figure	   22:	   Effect	   of	   cytokine	   treatment	   after	   complement-­mediated	   opsonisation.	  Complement-­‐mediated	  opsonization	  does	  not	  change	  the	  effect	  of	  cytokine	  stimulation	  on	  cryptococcal	  behaviour.	  Untreated	  and	  Th1	  (10	  units/ml	  IFN-­‐γ,	  1	  ng/ml	  TNF-­‐α),	  Th17	  (10	  ng/ml	  IL-­‐17)	  or	  Th2	  (10	  ng/ml	  IL-­‐4	  or	  10	  ng/ml	  IL-­‐13)	  cytokine	  treated	  human	  primary	  macrophages	   were	   infected	   with	   C.	   neoformans	   strain	   ATCC90112,	   opsonized	   in	   fresh	  human	   serum,	   and	   then	   further	   incubated	   under	   the	   same	   conditions	   to	   monitor	  intracellular	  yeast	  proliferation	  or	  to	  monitor	  cryptococcal	  expulsion	  by	  live	  cell	  imaging.	  (A)	   IPR	   is	   significantly	   lower	   following	   treatment	  with	   the	  Th1	   cytokine	  TNF-­‐α	   and	   the	  Th17	  cytokine	  IL-­‐17	  in	  comparison	  with	  both	  of	  the	  Th2	  cytokines.	  The	  data	  are	  presented	  as	  the	  mean	  of	  at	  least	  three	  individual	  experiments	  ±	  2	  x	  standard	  error	  of	  the	  mean.	  (B)	  Occurrence	  of	  expulsion	  is	  reduced	  following	  treatment	  with	  Th2	  cytokines	  IL-­‐4	  or	  IL-­‐13	  compared	  to	  untreated	  cells	  or	  cells	  treated	  with	  IFN-­‐γ.	  Data	  were	  obtained	  from	  at	  least	  three	  individual	  experiments.	  Statistically	  significant	  differences	  are	  indicated	  by	  asterisks	  (*	  P	  <	  0.05).	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3.7	   DISCUSSION	  
The	  importance	  of	  a	  Th1	  immune	  response	  for	  controlling	  cryptococcal	  burden	  is	  evident	   from	   the	   high	   incidence	   of	   severe	  Cryptococcus	   neoformans	   infections	   in	  HIV	  patients	   (Wadhwa	   et	   al.,	   2008)	   and	   from	  data	   obtained	   in	  numerous	  mouse	  models	  (Flesch	  et	  al.,	  1989,	  Kawakami	  et	  al.,	  1995,	  Milam	  et	  al.,	  2007,	  Wormley	  et	  
al.,	  2007).	  Here,	  a	  molecular	  explanation	  for	  these	  in	  vivo	  observations	  is	  provided.	  The	  results	  strongly	  suggest	   inhibition	  of	  anticryptococcal	  macrophage	  functions,	  such	  as	  phagocytosis	  and	  intracellular	  clearance,	  by	  Th2	  cytokines,	  which	  would	  be	  likely	   to	   lead	   to	   a	   higher	   fungal	   burden	   in	   hosts	   showing	   a	   Th2-­‐dominated	  response,	   as	   previously	   reported	   (Blackstock	   et	   al.,	   2004,	   Decken	   et	   al.,	   1998,	  Muller	  et	  al.,	  2007).	  Three	   different	   Cryptococcus	   strains	   were	   selected	   to	   represent	   the	   two	   most	  important	   serotypes.	  The	  C.	  neoformans	   serotype	  A	  strains	  ATCC90112	  and	  H99,	  both	  clinical	  isolates	  from	  patient	  cerebrospinal	  fluid,	  represent	  the	  serotype	  most	  commonly	   isolated	   from	  immunocompromised	  patients	  and	  which	   is	  responsible	  for	  95	  %	  of	  all	  C.	  neoformans	  infections	  (Hull	  et	  al.,	  2002).	  The	  C.	  gattii	  serotype	  B	  strain	   R265	   is	   a	   clinical	   isolate	   from	   the	   ongoing	   cryptococcosis	   outbreak	   in	  immunocompetent	   individuals	   in	   British	   Columbia,	   Canada,	   an	   outbreak	   that	  highlights	   the	   potential	   of	   Cryptococcus	   as	   an	   emerging	   pathogen	   (Fraser	   et	   al.,	  2003,	   MacDougall	   et	   al.,	   2007).	   Trends	   were	   similar	   for	   all	   three	   strains	  throughout	  the	  study	  and	  thus	  the	  influence	  of	  cytokine	  signaling	  on	  cryptococcal	  pathogenesis	   is	   likely	   to	   be	   common	   to	   both	   Cryptococcus	   species,	   despite	   the	  different	  disease	  etiology	  between	  them.	  	  The	   lowest	   possible	   cytokine	   concentrations	   were	   deliberately	   selected	   for	   this	  study	  in	  order	  to	  minimize	  the	  risk	  of	  artifacts.	  Given	  this,	  it	  needs	  to	  be	  recognized	  that	   there	   might	   be	   more	   dramatic	   effects	   on	   cryptococcal	   behavior	   at	   higher	  concentrations	   and	   thus	   that	   Th1/Th17/Th2	   balance	   may	   profoundly	   affect	   the	  path	  of	  disease	  progression	  in	  infected	  patients.	  	  	  The	  data	  demonstrates	  that	  intracellular	  yeast	  proliferation	  is	  increased	  after	  Th2	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activation	  of	  macrophages.	  These	  findings	  provide	  a	  molecular	  explanation	  for	  the	  protective	  effect	  of	  Th1	  cytokines	  such	  as	  IFN-­‐γ	  and	  TNF-­‐α	  (Kawakami	  et	  al.,	  1995,	  Milam	  et	  al.,	  2007,	  Wormley	  et	  al.,	  2007)	  and	  Th17	  cytokines	  such	  as	  IL-­‐17	  (Muller	  
et	  al.,	  2007),	  and	  the	  non-­‐protective	  effect	  of	  Th2	  cytokines	  such	  as	  IL-­‐4	  and	  IL-­‐13	  (Blackstock	  et	  al.,	  2004,	  Decken	  et	  al.,	  1998,	  Muller	  et	  al.,	  2007),	   in	  mouse	  model	  systems.	  	  Two	  additional	  interesting	  observations	  can	  be	  made	  from	  the	  IPR	  dataset.	  Firstly,	  it	  is	  intriguing	  that	  IFN-­‐γ	  suppresses	  cryptococcal	  IPR	  far	  more	  effectively	  in	  J774	  cells	  than	  in	  human	  primary	  macrophages.	  This	  observation	  is	  in	  agreement	  with	  previous	   reports	   demonstrating	   a	   reduction	   in	   the	   inhibition	   of	   cryptococcal	  growth	   in	   human	   alveolar	   and	   monocyte-­‐derived	   macrophages	   after	   IFN-­‐γ	  treatment	   (Levitz	   et	   al.,	   1990,	  Reardon	   et	   al.,	   1996).	   	   Such	   findings	  may	   indicate	  differences	  in	  IFN-­‐γ	  related	  regulation	  of	  anticryptococcal	  functions	  in	  mouse	  and	  human	   macrophages.	   Secondly,	   in	   J774	   cells	   treatment	   with	   pro-­‐inflammatory	  cytokines	   did	   not	   alter	   cryptococcal	   proliferation	   as	   compared	   with	   untreated	  controls.	   	   This	   is	   suggestive	   of	   the	   fact	   that	   J774	   macrophages	   may	   already	   be	  partially	   activated	   by	   the	   presence	   of	   opsonized	   cryptococci	   and/or	   the	   tissue	  culture	  environment.	  	  It	   is	  also	  demonstrated	  for	  the	  first	   time	  that	  Th2,	  but	  not	  Th1	  or	  Th17,	  cytokine	  treatment	   leads	   to	   a	   significant	   reduction	   in	   the	   occurrence	   of	   cryptococcal	  expulsion,	   a	   recently-­‐described	   phenomenon	   that	   appears	   to	   be	   unique	   to	   this	  pathogen	   (Alvarez	   et	   al.,	   2006,	   Ma	   et	   al.,	   2006).	   The	   relevance	   of	   expulsion	   for	  disease	   progression	   is,	   as	   yet,	   unclear.	   However,	   cryptococci	   expelled	   from	  circulating	  monocytes	  will	   likely	  be	  exposed	   to	  a	   far	  greater	   immune	  attack	   than	  those	   that	   remain	   intracellular.	   In	   addition,	   reduced	   expulsion	   might	   favor	   the	  dissemination	   of	   Cryptococcus	   to	   the	   central	   nervous	   system	   in	   parasitized	  macrophages	  via	  a	  ‘Trojan	  Horse’	  mechanism	  (Charlier	  et	  al.,	  2009,	  Luberto	  et	  al.,	  2003).	   Thus,	   suppression	   of	   cryptococcal	   expulsion	   by	   a	   dominant	   Th2	   cytokine	  profile	  may	  benefit	   the	  pathogen	  and	  reduce	  the	  host’s	   likelihood	  of	  surviving	  an	  infection.	   It	   is	   important	   to	   note	   that	   reduced	   expulsion	   alone	   is	   insufficient	   to	  account	   for	   the	   increased	   IPR	  observed	   in	  Th2-­‐stimulated	  macrophages;	   even	   in	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Th1-­‐stimulated	  cells,	   expulsion	   is	   a	  very	   rare	  effect	   (Ma	   et	  al.,	   2006)	   that	   cannot	  account	  for	  the	  differences	  observed	  in	  IPR.	  Thus,	  cytokine	  signaling	  operates	  in	  at	  least	   two	   ways;	   firstly,	   to	   modify	   intracellular	   proliferation	   and	   secondly	   to	  influence	  the	  likelihood	  of	  expulsion.	  	  How	  might	  cytokine-­‐signaling	  impact	  on	  intracellular	  cryptococcal	  behavior?	  	  The	  most	  likely	  scenario	  is	  that	  cytokine	  activation	  triggers	  changes	  in	  the	  composition	  of	   the	  phagosome	   that	   favor	  either	  expulsion	   (Th1/Th17)	  or	  proliferation	   (Th2).	  	  Recent	   data	   suggest	   that	   one	   such	   change	  may	   be	   the	   availability	   of	  metal	   ions.	  Many	   cryptococcal	   virulence	   factors	   such	   as	   laccase,	   SOD,	   catalase	   and	   urease	  depend	   upon	   metal	   ions	   and	   thus	   cation	   homeostasis.	   Interestingly,	   the	   anti-­‐inflammatory	   cytokines	   IL-­‐4	   and	   IL-­‐13	   have	   been	   suggested	   to	   enhance	   iron	  uptake	  and	  storage	  by	  macrophages	  by	  suppression	  of	  activation	  of	  iron	  regulatory	  protein-­‐1	   and	   -­‐2,	   leading	   to	   translational	   repression	   of	   the	   iron	   storage	   protein	  ferritin	   or	   transcriptional	   activation	   of	   the	   membrane	   receptor	   for	   iron	   uptake	  (Weiss	  et	  al.,	  1997).	  Thus,	  higher	  metal	  ion	  availability	  might	  increase	  the	  activity	  of	   cryptococcal	   virulence	   factors	   and	   could	   lead	   to	   increased	   intracellular	  proliferation	  in	  Th2-­‐stimulated	  cells.	   	   In	  this	  regard,	   it	   is	   intriguing	  that	  urease,	  a	  cryptococcal	   virulence	   factor	   (Cox	   et	   al.,	   2000),	   promotes	   a	   non-­‐protective	   Th2	  immune	   response	   within	   the	   lung	   (Osterholzer	   et	   al.,	   2009b),	   suggesting	   that	  
Cryptococcus	  may	  actively	  bias	  the	  host’s	  cytokine	  profile	  to	  its	  own	  advantage.	  	  Cryptococcosis	   incidence	   increases	   throughout	   the	  course	  of	  AIDS	  and	  correlates	  with	  the	  loss	  of	  Th1	  response	  in	  AIDS	  patients	  (Altfeld	  et	  al.,	  2000)	  and	  with	  a	  Th2-­‐type	   cytokine	   profile	   in	   transplant	   recipients	   (Singh	   et	   al.,	   2008).	   The	   presented	  data	   indicate	   that	   the	   loss	   of	   Th1	   cytokines	   significantly	   reduces	   the	   ability	   of	  macrophages	   to	   deal	   with	   Cryptococcus	   and	   prevents	   efficient	   cryptococcal	  clearance	  in	  HIV	  patients	  and,	  therefore,	  that	  pro-­‐inflammatory	  cytokines	  may	  be	  a	  useful	   therapeutic	   agent	   for	   the	   treatment	   of	   this	   disease.	   IFN-­‐γ	   has	   been	  successfully	   applied	   to	   enhance	   chemotherapy	   of	   systemic	   cryptococcosis	   in	  BALB/c	  mice	  (Lutz	  et	  al.,	  2000)	  and	  in	  immunocompromised	  SCID	  mice	  (Clemons	  
et	   al.,	   2001)	   and	   thus,	   has	   been	   suggested	   as	   a	   potential	   therapeutic	   regime	   in	  humans.	  However,	  there	  seem	  to	  be	  differences	  in	  IFN-­‐γ	  related	  signaling	  in	  mice	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and	   humans.	   IFN-­‐γ	   has	   clearly	   been	   demonstrated	   to	   have	   a	   protective	   role	   in	  mouse	  model	  systems	  of	  cryptococcosis	  (Hoag	  et	  al.,	  1997,	  Bava	  et	  al.,	  1995)	  and	  to	  increase	  fungicidal	  activity	  of	  murine	  macrophages	  (Flesch	  et	  al.,	  1989).	  However,	  in	   human	   cells,	   IFN-­‐γ	   treatment	   reduces	   the	   capacity	   of	   human	   alveolar	  macrophages	   (Reardon	   et	   al.,	   1996)	   and	   human	  monocyte-­‐derived	  macrophages	  (Levitz	  et	  al.,	  1990)	  to	  inhibit	  cryptococcal	  growth,	  a	  finding	  that	   is	  supported	  by	  the	   presented	   data.	   Although	   IFN-­‐γ	   levels	   at	   the	   site	   of	   infection	   have	   been	  negatively	   correlated	   with	   cryptococcal	   CFU	   (Siddiqui	   et	   al.,	   2005)	   and	   IFN-­‐γ	  therapy	  has	  proved	  successful	  in	  one	  patient	  (Netea	  et	  al.,	  2004),	  these	  in	  vitro	  data	  suggest	   that	   IFN-­‐γ	   treatment	   may	   not	   always	   be	   an	   appropriate	   therapeutic	  approach.	  	  Taken	   together,	   these	   data	   suggest	   that	   the	   poor	   prognosis	   of	   Th2-­‐cytokine	  profiles	   in	   cryptococcal	   infection	   may	   in	   part	   result	   from	   a	   combination	   of	  increased	  intracellular	  proliferation	  and	  reduced	  expulsion	  of	  the	  pathogen.	  	  These	  effects	   are	   independent	   of	   cryptococcal	   strain	   or	   phagocytic	   opsonin	   and	   may	  therefore	   represent	   a	   general	   phenomenon	   associated	   with	   intracellular	  pathogens.	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Research	   into	   the	   interaction	   between	   Cryptococcus	   and	   macrophages	   in	   recent	  years	   has	   established	   this	   as	   a	   model	   system	   for	   investigation	   of	   cryptococcal	  virulence,	   since	   intracellular	   yeast	   proliferation	   in	   macrophages	   correlates	   well	  with	   virulence	   data	   from	  mice	   (Ma	   et	   al.,	   2009a,	   Byrnes	   et	   al.,	   2010).	   However,	  experimental	   approaches	   to	   quantify	   macrophage	   parasitism	   rely	   on	   time-­‐lapse	  imaging	   and/or	   manual	   colony	   counts	   of	   isolated	   yeast,	   both	   of	   which	   are	   low	  throughput,	  time-­‐consuming	  methods.	  To	  facilitate	  faster	  analysis	  of	  cryptococcal	  intracellular	   parasitism,	   the	   use	   of	   fluorescently	   tagged	   yeast	   together	  with	   flow	  cytometry	   was	   investigated.	   This	   section	   reports	   the	   production	   of	   two	  cryptococcal	   strains	   that	   show	   strong,	   stable	   GFP	   expression:	   a	   GFP-­‐positive	   C.	  
neoformans	  serotype	  A	  type	  strain	  H99	  and	  a	  GFP-­‐positive	  C.	  gattii	  serotype	  B	  type	  strain	  R265	  (an	   isolate	   from	  the	  ongoing	  Vancouver	   Island	  Outbreak	  (Kidd	  et	  al.,	  2004)).	   Both	   strains	   were	   extensively	   characterised	   and	   their	   responses	   to	  environmental	   and	  host	   stress	   conditions	   and	   their	   virulence	   in	   the	  macrophage	  model	   system	   remain	   unaltered.	   Using	   these	   strains,	   a	   flow	   cytometry-­‐based	  approach	   for	   accurate,	   high	   throughput	   quantification	   of	  macrophage	   parasitism	  was	  developed.	  Taken	   together,	   these	   findings	  represent	  a	  powerful	   resource	   for	  the	  cryptococcosis	  research	  community	  and	  should	  facilitate	  rapid	  advances	  in	  our	  understanding	  of	  cryptococcal	  virulence.	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4.1	   RANDOM	   GENOMIC	   INTEGRATION	   AND	   EXPRESSION	   OF	   A	   GFP	  
CONSTRUCT	  IN	  C.	  NEOFORMANS	  H99	  AND	  C.	  GATTII	  R265	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4.2	   IDENTIFICATION	  OF	  GFP	  INTERGATION	  SITE	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Table	  6:	  Primer	  used	  for	  Single	  PCR	  procedure	  and	  following	  sequencing.	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The	   initial	   PCR	  products	   contained	  mixtures	   of	   different	   fragments	   –	   integration	  specific	   fragments	   and	   random	   fragments	   from	   other	   genomic	   regions	   (Figure	  24	  A).	  The	  mixtures	  were	  subjected	  to	  sequencing	  with	  an	  integration	  site	  specific	  primer	   located	  downstream	  of	   the	  original	  PCR	  primer	  and	  sequences	  were	  then	  analysed	   with	   the	   basic	   local	   alignment	   search	   tools	   (Blast)	   available	   from	   the	  Broad	   Institute	  of	  MIT	  and	  Harvard	  and	  NCBI.	  Analysis	  was	   concentrated	  on	   the	  GFP-­‐positive	   strain	   R265_GFP6.	   Sequences	   from	   reactions	   using	   the	   primer	   sets	  pAG32-­‐1	   to	   pAG32-­‐7	   did	   not	   return	   any	   significant	   matches	   within	   the	   R265	  genome.	   However,	   a	   129	   bp	   long	   fragment	   within	   the	   sequence	   data	   from	  reactions	   with	   the	   primer	   sets	   GFP,	   pAG32-­‐8	   and	   pAG32-­‐9	   could	   be	   identified	  within	  the	  genome	  and	  aligns	  with	  the	  locus	  for	  anthranilate	  synthase	  component	  2	   (Figure	  24	  B).	  A	   literature	   search	   suggested	   that	   this	   component	   is	  part	  of	   the	  tryptophan	  operon	  in	  Salmonella	  typhimurium	  and	  E.	  coli	  (Horowitz	  et	  al.,	  1982,	  La	  Scolea	  et	  al.,	  1972).	  With	  trp1	  supplying	  the	  terminator	  in	  the	  GFP	  construct,	  this	  observation	  prompted	  further	  analysis	  of	  the	  129	  bp	  fragment.	  Closer	  examination	  of	   the	  matches	  with	   the	  R265	  genome	   revealed	   that	   all	   three	   localize	  within	   the	  same	  area	  of	  the	  R265	  genome	  (228852-­‐228980)	  and	  an	  alignment	  of	  the	  129	  bp	  section	  with	  the	  trp1	  terminator	  sequence	  from	  C.	  neoformans	  JEC21	  (AY483215)	  showed	  88	  %	  sequence	  identity	  (Figure	  24	  C).	  This	  indicates	  that	  the	  129	  bp	  match	  the	   terminator	   region	   of	   the	   GFP	   construct	   and/or	   terminator	   regions	   of	   genes	  involved	   in	   tryptophan	   synthesis	   within	   the	   R265	   genome.	   Furthermore,	   the	  chromatogram	  of	   the	  region	  downstream	  of	   the	  129	  bp	   fragment	  seems	   to	  show	  more	  than	  one	  sequence	  being	  overlaid	  (Figure	  24	  D).	  Taken	  together,	  no	  definite	  statement	  about	  the	  integration	  site	  can	  be	  made.	  However,	  an	  observation	  made	  after	   DNA	  microinjection	   into	   nuclei	   of	  mammalian	   cultured	   cells	  might	   help	   to	  explain	   this	   phenomenon.	   Multiple	   copies	   of	   the	   transforming	   gene	   were,	  dependent	  on	  the	  DNA	  concentration,	  integrated	  as	  concatemer	  at	  one	  or	  few	  sites	  in	   the	   host	   genome	   (Folger	   et	   al.,	   1982).	   Thus,	   adjustment	   of	   plasmid	   DNA	  concentration	   for	  biolistic	   transformation	  might	  reduce	  or	  prevent	   the	   formation	  of	  concatemer	  and	  enable	  identification	  of	  the	  DNA	  integration	  site	  in	  the	  future.	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Figure	  24:	   Identification	  of	  GFP	   integration	  site.	   (A)	  The	  single	  primer	  PCR	  approach	  resulted	  in	  a	  mixture	  of	  PCR	  products.	  (B)	  Analysis	  of	  sequence	  data	  from	  primer	  sets	  GFP,	  pAG32-­‐8	  and	  pAG32-­‐9	  resulted	  in	  matches	  within	  the	  anthranilate	  synthase	  component	  2	  within	   the	   R265	   genome	   (alignment	   shown	   for	   GFP	   sequence	   data).	   (C)	   Closer	  examination	   revealed	   that	   this	  match	   is	   against	   the	   trp1	   terminator	   of	   either	   the	   GFP	   a	  construct	   or	   terminator	   region	   of	   genes	   involved	   in	   tryptophan	   synthesis	   in	   R265.	   (D)	  Furthermore,	   the	   chromatogram	   downstream	   of	   the	   129	   bp	   match	   shows	   the	   clear	  sequence	  trace	  of	  the	  fragment	  turning	  into	  multiple	  overlapping	  traces.	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4.3	   GFP	   EXPRESSING	   STRAINS	   SHOW	   NO	   ALTERED	   RESPONSE	   TO	  
STRESS	  CONDITIONS	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Figure	  25:	  Response	  of	  GFP	   expressing	   strains	   to	   stress.	   The	   stress	   tolerance	   of	   the	  GFP-­‐expressing	   isolates	   was	   tested	   by	   incubation	   under	   stress	   conditions	   for	   24	   hours	  followed	   by	   relative	   CFU	   analysis.	   Neither	   high	   temperature	   (A),	   hypoxia	   (B),	   oxidative	  stress	   (C),	   nitrosative	   stress	   (D),	   SDS	   exposure	   (E)	   or	   high	   salt	   (F)	   resulted	   in	   any	  significant	   differences	   in	   survival	   relative	   to	   non-­‐GFP	   expressing	   parental	   strains	  (Table	  7).	   Data	   are	   presented	   as	   means	   of	   at	   least	   three	   independent	   repeats	   with	  2	  x	  standard	  error.	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Table	  7:	  P-­values	  of	  statistical	  analysis.	  Results	  from	  CFU	  counts	  from	  stress	  treatments	  and	   intracellular	   virulence	   assays	   of	   GFP-­‐positive	   strains	   were	   compared	   to	   parental	  strains.	  	  
R265	   H99	  Strain	  
Condition	   GFP6	   GFP13	   GFP14	   GFP15	   GFP	  	   25°C	   0.975	   0.861	   1.000	   0.994	   0.623	  	   37°C	   0.999	   1.000	   0.984	   1.000	   0.996	  	   3	  %	  O2	   0.937	   1.000	   0.996	   1.000	   1.000	  
0.05	  mM	  	   0.999	   0.919	   0.999	   1.000	   0.871	  
0.1	  mM	   0.857	   0.908	   0.993	   0.724	   1.000	  CoCl2	  
0.3	  mM	   0.697	   0.697	   0.973	   0.614	   0.614	  
0.25	  mM	   0.988	   1.000	   1.000	   1.000	   0.899	  
0.5	  mM	   0.602	   1.000	   0.984	   0.988	   0.211	  H2O2	  
1	  mM	  	   0.887	   1.000	   0.999	   1.000	   0.930	  
1	  mM	   0.790	   0.996	   0.613	   0.989	   0.490	  
5	  mM	   1.000	   0.883	   1.000	   1.000	   0.523	  NaNO2	  
20	  mM	   0.998	   0.954	   0.924	   1.000	   0.301	  
0.005	  %	   0.484	   0.995	   1.000	   0.095	   1.000	  
0.01	  %	   0.797	   0.923	   1.000	   0.535	   0.999	  SDS	  
0.05	  %	   1.000	   1.000	   0.748	   1.000	   1.000	  
0.05	  mM	   1.000	   1.000	   0.970	   1.000	   1.000	  
0.1	  mM	   0.998	   0.980	   1.000	   1.000	   0.984	  NaCl	  	  
0.3	  mM	   0.976	   1.000	   0.999	   1.000	   0.998	  
Percentage	  Phagocytosis	   0.877	   0.969	   0.794	   0.918	   0.851	  
IPR	   0.972	   0.916	   1.000	   0.989	   0.989	  
Occurrence	  of	  Expulsion	   0.934	   0.718	   0.904	   0.433	   0.264	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4.4	   GFP	   EXPRESSING	   STRAINS	   SHOW	   NO	   ALTERATION	   IN	  
VIRULENCE	  IN	  MACROPHAGES	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4.5	   GFP	   EXPRESSING	   STRAINS	   CAN	   BE	   USED	   FOR	   AUTOMATED	  
ANALYSIS	  OF	  CRYPTOCOCCAL	  INTERACTION	  WITH	  MACROPHAGES	  
To	   date,	   analysis	   of	   cryptococcal	   interactions	   with	   macrophages	   has	   required	  elaborate	   and	   time-­‐consuming	   experimental	   approaches.	   Potentially,	   flow	  cytometry-­‐based	   systems	   offer	   an	   accurate	   but	   high-­‐throughput	   alternative	  strategy	   for	   analysing	   intracellular	   proliferation.	   Since	   the	   GFP-­‐positive	   strains	  described	   above	   are	   unaltered	   in	   their	   behaviour	   in	  macrophages,	   these	   strains	  were	   used	   to	   develop	   a	   flow	   cytometry-­‐based	   methodology	   for	   quantifying	  intracellular	  proliferation	  of	  cryptococci	  in	  collaboration	  with	  Dr.	  S.	  A.	  Johnston.	  By	  microscopy,	  all	  five	  GFP	  positive	  strains	  showed	  evenly	  distributed	  GFP	  expression	  within	   the	   cytoplasm	   (Figure	   27	   A).	   Furthermore,	   analysis	   of	   fluorescence	   and	  forward	   scatter	   by	   flow	   cytometry	   showed	   all	   five	   GFP	   expressing	   strains	   were	  clearly	   distinct	   from	   both	   the	   non-­‐GFP	   expressing	   parental	   strains	   and	   from	  uninfected	   macrophages	   (Figure	   27	   B).	   The	   previously	   published	   method	   for	  assaying	  proliferation	  within	  macrophages	  requires	  lysis	  of	  macrophages	  followed	  by	  manual	  counting	  of	  numerous	  replicate	  samples	  using	  either	  a	  haemocytometer	  or	  by	  plating	  on	  YPD	  plates	  and	  counting	  colony	  forming	  units	  (CFU)	  (Voelz	  et	  al.,	  2009;	   Ma	   et	   al.,	   2009).	   To	   validate	   the	   flow	   cytometry	   based	   method,	   replicate	  samples	   were	   taken	   from	  macrophage	   infections	   with	   the	   same	   GFP-­‐expressing	  strain	   and	   compared	   proliferation	   quantification	   by	   flow	   cytometry,	   CFU	   and	  haemocytometer	   count.	   Comparison	   of	   Cryptococcus	   proliferation	   from	   all	   three	  counting	  methods	  showed	  no	  significant	  differences.	  Thus,	  flow	  cytometry	  offers	  a	  reliable	   and	   rapid	   alternative	   to	   manual	   count-­‐based	   methods	   of	   analysis	  (Figure	  27	  C).	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Figure	   27:	   Automated	   counting	   of	   intracellular	   Cryptococcus	   proliferation	   within	  
macrophages.	   (A)	   GFP	   expression	   in	   GFP-­‐positive	   strains	   selected	   for	   analysis	   in	   this	  study.	   (B)	   GFP-­‐tagged	   strains	  were	   first	   analysed	   for	   their	   expression	   profile.	   	   All	   GFP-­‐expressing	   strains	   are	   clearly	   discernable	   from	   GFP-­‐negative	   cryptococci	   or	   cell	   debris.	  	  (C)	   Replicate	   samples	   were	   used	   for	   quantifying	   intracellular	   yeast	   cell	   numbers	   after	  macrophage	   infection	   via	   haemocytometer	   (black	   bars),	   CFU	   count	   (grey	   bars)	   or	   flow	  cytometry	   (white	   bars).	   	   For	   all	   of	   the	   strains,	   there	   was	   no	   statistically	   significant	  difference	  between	  any	  of	  the	  three	  counting	  methods.	  Data	  are	  presented	  as	  means	  with	  2	  x	  standard	  error	  from	  at	  least	  three	  independent	  repeats.	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4.6	   A	   NON-­LYTIC	   METHOD	   OF	   QUANTIFIYNG	   MACROPHAGE-­
CRYPTOCOCCUS	  INTERACTION	  BY	  FLOW	  CYTOMETRY	  
To	  date,	  all	  methods	  for	  quantifying	  intracellular	  cryptococcal	  proliferation	  involve	  a	   lysis	   step	   to	   free	   any	   intracellular	   yeast	   cells	   for	   counting.	   Lysis	   is	  methodologically	  undesirable	  since	  it	  increases	  processing	  time,	  increases	  the	  risk	  of	  sample	   loss	  and	  may	  potentially	  damage	   intracellular	  cryptococci.	   	  Accutase,	  a	  proteolytic	  and	  collagenolytic	  enzyme	  mix,	  allows	  detachment	  and	  dissociation	  of	  mammalian	   cells	   without	   significantly	   influencing	   viability	   (Bajpai	   et	   al.,	   2008),	  potentially	  enabling	  quantification	  of	   fungal	  burden	  within	   infected	  macrophages	  without	   lysis.	   J774	  macrophage	   cultures	  were	   infected	  with	  H99_GFP,	   incubated	  according	   to	   the	   protocol	   for	   IPR	   assays	   and	   then	   treated	  with	   the	   enzyme	  mix	  instead	  of	  being	  lysed.	  Flow	  cytometry	  demonstrated	  that	  extracellular	  yeast	  cells,	  macrophages	  and	  macrophages	  with	  intracellular	  yeast	  cells	  formed	  three	  distinct	  regions	   based	   upon	   their	   size	   (forward	   scatter,	   FSC)	   and	   GFP	   fluorescence	  intensity	   (Figure	   28	   A).	   By	   comparing	   events	   counted	   for	   macrophages	   versus	  events	   counted	   for	   macrophages	   with	   intracellular	   cryptococci	   percentage	  phagocytosis	   could	   by	   accurately	   quantified	   (Figure	   28	   B).	   In	   addition,	   by	  calculating	  fluorescence	  intensity,	  intracellular	  cryptococcal	  proliferation	  could	  be	  quantified	  without	  the	  need	  to	  lyse	  the	  macrophage	  culture	  (Figure	  28	  C).	  	  	  	  	  	  	  	  	  	  	  	  	  
Chapter	  4:	  Automated	  analysis	  of	  cryptococcal	  macrophage	  parasitism	  using	  GFP-­tagged	  
cryptococci.	  	  
	   141	  
	  
Figure	   28:	   Assessment	   of	   virulence	   parameters	   in	   the	  macrophage	  model	   system	  
after	   treatment	  with	  Accutase.	  Macrophages	  were	   infected	  with	   the	  GFP-­‐positive	  H99	  strain	   H99_GFP	   and	   cultured	   in	   the	   same	  way	   as	   for	   a	   normal	   infection	   assay.	   Samples	  were	  taken	  at	  standard	  time	  points	  but	  instead	  of	  cell	  lysis,	  the	  cultures	  were	  treated	  with	  Accutase	   to	   detach	   and	  dissociate	   cells.	   (A)	   Extracellular	   yeast,	   uninfected	  macrophages	  and	  macrophages	  with	  intracellular	  yeast	  cells	  show	  three	  distinct	  populations	  in	  a	  scatter	  plot.	   (B)	   Phagocytic	   uptake	   can	   be	   quantified	   by	   comparing	   the	   proportions	   of	   infected	  and	  uninfected	  macrophages	  using	   flow	  cytometry.	  Results	   are	  not	   statistically	  different	  between	  the	   two	  approaches.	   (C)	   Intracellular	  proliferation	  can	  also	  be	  determined	  with	  this	   approach	  by	   calculating	   fluorescence	   intensity.	  Results	   are	  not	   statistically	  different	  from	  IPR	  measurements	  with	  a	  hemocytometer,	  by	  CFU	  counts	  or	  flow	  cytometry	  counting	  after	  macrophage	  lysis.	  Data	  are	  presented	  as	  means	  with	  2	  x	  standard	  error	  from	  at	  least	  three	  independent	  repeats.	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4.7	   DISCUSSION	  
The	  generation	  of	  Cryptococcus	  type	  strains	  expressing	  GFP;	  C.	  gattii	  GFP-­‐positive	  serotype	  B	  R265	  strains	  and	  a	  C.	  neoformans	  GFP-­‐positive	  serotype	  A	  H99	  strain	  was	  described.	  	  Transformation	  of	  Cryptococcus	  with	  plasmid	  DNA	  can	  result	   in	  non-­‐homologous	  integration	   into	   the	   genome	   or	   extrachromosomal	   integration	   of	   the	   target	  sequence;	   the	   former	   being	   mitotically	   stable,	   the	   latter	   unstable	   (Varma	   et	   al.,	  1992a).	  All	  mutants	  analysed	  in	  this	  study	  show	  stable	  GFP	  expression	  indicating	  stable	   ectopic	   integration	   within	   the	   genome.	   The	   one	   H99	   transformant	   with	  unstable	   GFP	   expression	   is	   thus	   very	   likely	   a	   mutant	   that	   harboured	   the	   GFP	  containing	  plasmid	  extrachromosomal	  (Varma	  et	  al.,	  1992a,	  Toffaletti	  et	  al.,	  1993).	  Unfortunately,	   it	   was	   not	   possible	   to	   identify	   the	   GFP	   integration	   site	   following	  PCR	   and	   sequencing.	   Analysis	   of	   the	   sequence	   chromatograms	   revealed	   the	  presence	  of	  overlaying	  sequences	  indicating	  potential	  multiple	   integration	  events	  within	  the	  Cryptococcus	  genome	  and/or	  the	   integration	  of	   transgene	  concatemer.	  An	  observation	  made	  after	  DNA	  microinjection	  into	  nuclei	  of	  mammalian	  cultured	  cells	  might	  help	   to	  explain	   this	  phenomenon.	  Multiple	  copies	  of	   the	   transforming	  gene	  were,	  depending	  on	  the	  DNA	  concentration,	  integrated	  as	  concatemer	  at	  one	  or	  few	  sites	  in	  the	  host	  genome	  (Folger	  et	  al.,	  1982).	  Thus,	  adjustment	  of	  plasmid	  DNA	   concentration	   for	   biolistic	   transformation	   might	   reduce	   or	   prevent	   the	  formation	  of	   concatemer	   and	  enable	   identification	  of	   the	  DNA	   integration	   site	   in	  the	  future.	  	  However,	  all	  characterised	  strains	  show	  strong	  and	  stable	  GFP	  expression	  and	  are	  indistinguishable	   from	  non-­‐fluorescent	  parental	   isolates	   in	   terms	  of	   growth	   rate,	  stress	  tolerance	  or	  their	  ability	  to	  parasitize	  macrophages.	  These	  strains	  were	  then	  used	   to	   develop	   and	   validate	   a	   flow	   cytometry	   based	   assay	   for	   quantifying	  intracellular	  cryptococcal	  proliferation.	  	  Endogenous	   GFP	   expression	   has	   substantial	   advantages	   over	   exogenous	  fluorescent	   labels	   since	   it	  does	  not	   require	  any	  secondary	  manipulations	  such	  as	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staining	   or	   treatment	   with	   a	   probe	   and	   thus	   can	   be	   directly	   used	   for	   analysis.	  	  Although	  GFP	   is	   generally	   regarded	   as	   a	   protein	   that	   does	   not	   influence	   cellular	  processes,	   it	   is	   known	   that	   in	   Salmonella	   enterica	   expression	   of	   GFP	   alters	  establishment	   of	   the	   intracellular	   niche	   in	   epithelial	   cells	   and	   macrophages	  (Knodler	  et	  al.,	  2005).	  However,	  careful	  analysis	  indicates	  that	  the	  GFP	  expressing	  cryptococci	  reported	  here	  show	  no	  significant	  differences	  in	  their	  stress	  responses	  or	  behaviour	  within	  macrophages.	  	  GFP	   and	   its	  molecular	   cousins	   (Shaner	   et	   al.,	   2005)	   offer	  many	   advantages	   over	  dye	  labelling	  previously	  used	  to	  track	  Cryptococcus	  in	  vivo	  and	  in	  vitro	  (Charlier	  et	  
al.,	   2009,	  Chretien	   et	   al.,	   2002,	   Santangelo	   et	   al.,	   2004,	   Shi	   et	   al.).	   Such	  dyes	   (for	  example	  fluorescein	  isothiocyanate)	  are	  significantly	  phototoxic	   in	  comparison	  to	  GFP,	  a	  major	  impediment	  to	  live	  imaging.	  GFP	  is	  stably	  expressed	  and	  is	  not	  diluted	  by	   proliferation,	  making	   long	   term	   study	   in	   vivo	   a	   possibility.	   In	   addition,	  multi-­‐colour	  expression	  systems	  have	  been	  established	   that	   could	  be	  easily	  adapted	   to	  allow	   the	   tracking	   of	   many	   members	   of	   an	   infective	   population	   simultaneously	  (Livet	  et	  al.,	  2007).	  The	  interaction	  with	  macrophages	  plays	  a	  key	  role	  in	  the	  outcome	  of	  cryptococcal	  infections.	   After	   phagocytosis,	   Cryptococcus	   manipulates	   host	   macrophages	   to	  establish	  itself	  as	  an	  intracellular	  parasite	  that	  can	  survive	  and	  proliferate	  within	  the	  macrophage	  phagolysosome	  (Feldmesser	  et	  al.,	  2000).	  This	  intracellular	  niche	  might	  help	  to	  explain	  how	  Cryptococcus	  stays	  latent	  within	  infected	  individuals	  and	  also	   how	   the	   yeast	   disseminates	   within	   the	   host.	   Phagocytosis,	   intracellular	  proliferation	  and	  the	  ability	  to	  exit	  macrophages	  in	  a	  non-­‐lytic	  manner	  (expulsion)	  are	  important	  parameters	  in	  understanding	  Cryptococcus-­‐macrophage	  interactions	  (Ma	  et	  al.,	  2006,	  Ma	  et	  al.,	  2009a,	  Voelz	  et	  al.,	  2009,	  Goldman	  et	  al.,	  2001,	  Idnurm	  et	  
al.,	   2005,	  Hu	   et	   al.,	  Alvarez	   et	   al.,	   2009,	  Alvarez	   et	   al.,	   2006,	  Alvarez	   et	   al.,	   2007,	  Alvarez	  et	  al.,	  2008,	  Geunes-­‐Boyer	  et	  al.,	  2009,	  Oliveira	  et	  al.,	  Goldman	  et	  al.,	  2000,	  Bobak	  et	  al.,	  1988,	  Bolanos	  et	  al.,	  1989,	  Brummer	  et	  al.,	  1994,	  Bulmer	  et	  al.,	  1967,	  Bulmer	   et	   al.,	   1975,	   Cross	   et	   al.,	   1997,	   Del	   Poeta,	   2004,	   Diamond	   et	   al.,	   1973a,	  Griffin,	  1981,	  Kozel	  et	  al.,	  1988,	  Levitz	  et	  al.,	  1997a,	  Luberto	  et	  al.,	  2003,	  Miller	  et	  
al.,	   1991,	   Mitchell	   et	   al.,	   1972,	   Monari	   et	   al.,	   2003).	   In	   particular,	   the	   ability	   to	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proliferate	   within	   these	   host	   cells	   is	   an	   important	   pathogenesis	   feature	   as	   it	  correlates	  with	   in	   vivo	  virulence	   data	   from	  mice	   (Ma	   et	   al.,	   2009a).	   However,	   to	  date	  the	  analysis	  of	  intracellular	  proliferation	  and	  yeast	  uptake	  by	  phagocytes	  has	  required	  time	  consuming	  methods,	  thus	  preventing	  high	  throughput	  screening	  or	  related	  experimental	  approaches.	  The	  data	  presented	  here	  describe	  GFP-­‐positive	  derivatives	   of	   widely	   used	   Cryptococcus	   strains	   coupled	   with	   a	   flow	   cytometry	  approach	   that	   enables	   efficient	   and	   high-­‐throughput	   analysis	   of	   virulence	  parameters	  in	  the	  macrophage	  model	  system.	  Flow	  cytometry	  allows	  the	  absolute	  analytical	  separation	  of	  infected	  macrophages	  and	  therefore	  this	  population	  can	  be	  separately	   assessed	   for	   immune	   regulatory	   changes.	   Furthermore	   this	  methodology	   potentially	   permits	   high	   throughput	   examination	   of	   drugs	   and	  antifungal	   components	   from	   both	   new	   and	   existing	   libraries,	   and,	   critically,	   the	  ability	  to	  analyse	  within	  the	  host	  macrophage	  environment.	  	  	  	  Furthermore,	   it	   will	   also	   allow	   for	   assessment	   of	   cryptococcal	   interaction	   with	  other	  model	   systems.	   Some	   cell	   lines	   such	   as	   HD11	   chicken	  macrophages	   show	  only	   very	   low	   cryptococcal	   uptake	   (S.A.	   Johnston,	   personal	   communication).	  However,	  as	  pigeons	  have	  been	  described	  as	  a	  carrier	  of	  Cryptococcus	  and	  pigeon	  guano	   as	   an	   infection	   source	   (Ellis	   et	   al.,	   1990a,	   Emmons,	   1960),	   a	   deeper	  understanding	   of	   how	   the	   yeast	   acts	   within	   this	   environment	   might	   help	   to	  develop	  prophylactic	  measures	  to	  prevent	  infections.	  The	  ‘Trojan	  Horse’	  model	  for	  dissemination	   implicates	  macrophages	  as	  vehicle	   for	  cryptococcal	  crossing	  of	   the	  epithelial	   layer	   of	   the	   blood-­‐brain	   barrier.	   GFP	   expressing	   Cryptococcus	   in	  combination	   with	   a	   secondary	   stain	   (e.g.	   red	   fluorescent	   tagged	   macrophages)	  might	  be	  an	  easy	  tool	  to	  trace	  yeast	  cells	  within	  the	  host	  and	  during	  passage	  of	  the	  blood-­‐brain	   barrier.	   Similarly,	   the	  GFP-­‐positive	   yeast	   could	   easily	   be	   followed	   in	  transparent	  model	  systems	  such	  as	  the	  zebra	  fish	  or	  amoeba.	  	  	  In	   summary,	   a	   reliable	   tool	   for	   rapid	   and	   simple	   quantification	   of	   cryptococcal	  macrophage	  parasitism	  is	  reported,	  which	  can	  easily	  be	  transferred	  to	  other	  in	  vivo	  and	  in	  vitro	  model	  systems.	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In	   1999,	   an	   ongoing	   and	   spreading	   outbreak	   of	   cryptococcosis	   in	   healthy	  individuals	   caused	   by	   unusual	   C.	   gattii	   strains	   of	   the	   genotype	   VGIIa	   started	   on	  Vancouver	   Island,	  Canada	   (Kidd	   et	  al.,	   2004).	  To	  date,	  deciphering	   the	  molecular	  mechanisms	   underlying	   this	   hypervirulence	   has	   still	   proven	   to	   be	   a	   scientific	  challenge.	   Recent	   advances	   correlated	   an	   enhanced	   ability	   of	   Vancouver	   Island	  Outbreak	  (VIO)	  isolates	  to	  proliferate	  within	  macrophages	  with	  virulence	  in	  mice	  (Ma	   et	   al.,	   2009a),	   suggesting	   that	   the	   increased	  virulence	  of	   the	  VIO	  population	  might	   result	   from	   a	   greater	   capability	   to	   parasite	   macrophages.	   The	   search	   for	  candidate	   genes	   influencing	   this	   proliferative	   capacity	   by	   whole-­‐genome	  microarray	   analysis	   identified	   an	   unexpected	   role	   of	   mitochondrial	   genes	   and	  tubular	   mitochondrial	   morphology	   in	   regulating	   macrophage	   parasitism	   by	   VIO	  isolates	  (Ma	  et	  al.,	  2009a).	  The	   following	   sections	   try	   to	   further	   understand	   how	   these	   VIO	  C.	   gattii	   strains	  have	   acquired	   a	   hypervirulent	   phenotype	   that	   causes	   disease	   in	  immunocompetent	  individuals.	  It	  focuses	  on	  the	  role	  of	  mitochondria	  in	  adaptation	  to	   the	   intracellular	   environment	  within	  macrophages	   and	   examines	   the	   effect	   of	  different	   host	   cell	   stresses	   on	   the	   morphology	   of	   yeast	   mitochondria	   and	   the	  behavior	   of	   cryptococcal	   mitochondria	   within	   host	   cells	   over	   time.	   In	   addition,	  available	   mitochondrial	   genomes	   are	   studied	   and	   the	   first	   steps	   towards	   a	  comparative	  mitochondrial	  genome	  analysis	  undertaken.	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5.1	   INCREASED	  IPR	  AND	  TUBULAR	  MITOCHONDRIAL	  MORPHOLOGY	  
AS	   GENERAL	   CHARACTERISTICS	   OF	   HYPERVIRULENCE	   IN	   VGII	  
SUBGROUPS	  	  	  
The	  original	  outbreak	  on	  Vancouver	   Island	  has	  predominantly	  been	  caused	  by	  C.	  
gattii	  strains	  of	  the	  VGII	  subtype	  a	  (Kidd	  et	  al.,	  2004).	  However,	  the	  genotype	  VGIIc	  has	   recently	   emerged	   as	   another	   hypervirulent	   cluster	   causing	   an	   outbreak	   in	  Oregon,	  USA	   (Byrnes	   et	   al.,	   2009c).	   The	  outbreak	   lineages	  VGIIa	   and	  VGIIc	  were	  evaluated	  against	  the	  non-­‐outbreak	  subgroup	  VGIIb	  in	  regard	  to	  their	  proliferative	  potential	   in	   macrophages	   and	   mitochondrial	   morphology	   after	   passage	   through	  macrophages.	   IPR	   data	   for	   eight	   VGIIc,	   20	   VGIIa	   and	   three	   VGIIb	   isolates	   were	  obtained	  from	  a	  previous	  study	  (Ma,	  2009,	  Ma	  et	  al.,	  2009a)	  and	  median	  values	  for	  each	  genotype	  compared.	  The	  median	  IPR	  value	  of	  VGIIc	   is	  statistically	  similar	  to	  the	  median	  VGIIa	  IPR	  value	  (P	  =	  0.862),	  however,	  significantly	  different	   from	  the	  median	   IPR	   value	   of	   VGIIb	   (P	   =	   0.024)	   (Figure	   29	   A).	   High	   IPR	   values	   in	   VGIIa	  isolates	   correlate	   with	   the	   ability	   to	   form	   highly	   tubular	   mitochondria	   after	  encounter	  of	   the	   intracellular	  conditions	   in	  macrophages	  (Ma	  et	  al.,	  2009a).	  Four	  VGIIc	  isolates	  (EJB12,	  EJB18,	  EJB52	  and	  A6M-­‐R38)	  and	  two	  environmental	  control	  isolates	   (CBS8684	  and	  CBS7750)	  were	  explored	   in	   regard	   to	   their	  mitochondrial	  morphology	  after	  macrophage	  exposure	  in	  this	  context.	  Three	  of	  the	  VGIIc	  isolates	  showed	   significantly	   higher	   percentages	   of	   tubular	   mitochondria	   after	   passage	  through	  macrophages	   than	   the	   environmental	   control	   strains	  whilst	  maintaining	  low	   level	   of	   tubular	   mitochondria	   after	   incubation	   in	   macrophage-­‐free	   culture	  medium	   (DMEM)	   (Figure	   29	   B).	   EJB52	   seemed	   to	   be	   an	   exception	   and	   did	   not	  follow	   the	   trend	   of	   increased	   tubular	   mitochondria	   morphology.	   However,	  inspection	  of	  the	  IPR	  value	  revealed	  this	  isolate	  as	  an	  outlier	  with	  a	  low	  IPR	  value	  of	   0.97.	   A	   subsequent	   regression	   analysis	   of	   IPR	   versus	   percentage	   of	   cells	  with	  tubular	   mitochondria	   showed	   a	   significant	   correlation	   between	   the	   two	  parameters	   with	   an	   R2-­‐value	   of	   0.85	   and	   F-­‐value	   of	   22.686	   (P	   =	   0.009)	  (Figure	  29	  C).	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Figure	   29:	   Increased	   IPR	   and	   tubular	   mitochondria	   morphology	   as	   general	  
characteristics	   of	   hypervirulence	   in	   VGII	   subgroups.	   (A)	   Median	   IPR	   values	   of	   each	  population	  were	  compared	  with	  the	  non-­‐parametric	  Mann-­‐Whitney	  U-­‐test	  and	  values	  of	  p	  <	   0.025,	   after	   controlling	   for	   multiplicity,	   and	   were	   accepted	   as	   statistically	   significant	  (http://elegans.swmed.edu/~leon/stats/utest.cgi).	  IPR	  rates	  for	  VGII	  are	  similar	  to	  VGIIa	  IPR	  data,	  however,	  statistically	  significantly	  different	  from	  VGIIb	  IPR	  rates.	  (B)	  Similar	  to	  VGIIa	  isolates,	  VGIIc	  isolates	  form	  highly	  tubular	  mitochondria	  following	  encounter	  of	  the	  intracellular	   niche	  within	  macrophages.	   The	   data	   are	   presented	   as	   the	  mean	   of	   at	   least	  three	  individual	  experiments	  ±	  2	  x	  standard	  error	  of	  the	  mean.	  The	  means	  were	  tested	  for	  statistical	   significance	   using	   Student’s	   T-­‐test	   assuming	   equal	   variances.	   Statistically	  significant	   differences	   compared	   to	   the	   control	   are	   indicated	   by	   asterisks	   (*	   P	   <	   0.05,	  **	  P	  ≤	  0.01,	  ***	  P	  ≤	  0.001).	   (C)	  As	  shown	  before	   for	   the	  VGIIa	  subgroup,	  VGIIc	   IPR	  values	  correlate	  with	  the	  percentage	  of	  tubular	  mitochondria	  due	  to	  macrophage	  exposure.	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5.2	   TEMPORAL	   MITOCHONDRIAL	   MORPHOLOGY	   IN	   VIO	   AND	   NON-­
VIO	  STRAINS	  UPON	  EXPOSURE	  TO	  THE	  INTRACELLULAR	  NICHE	  
The	  ability	   to	  proliferate	  within	  macrophages	   correlates	   in	  C.	   gattii	   isolates	  with	  the	  formation	  of	  tubular	  mitochondria:	   isolates	  with	  high	  IPR	  values	  show	  a	  high	  percentage,	  isolates	  with	  low	  IPR	  a	  low	  proportion	  of	  tubular	  mitochondrial	  after	  exposure	   to	   macrophages	   (Ma	   et	   al.,	   2009a,	   Byrnes	   et	   al.,	   2010).	   However,	  assessment	   of	   mitochondrial	   morphology	   has	   only	   been	   performed	   at	   24	   hours	  post	   infection,	   usually	   the	   time	  point	   of	  maximal	   intracellular	   yeast	   cell	   number.	  This	   approach,	   however,	   does	   not	   offer	   insight	   into	   whether	   mitochondria	   in	  strains	   with	   high	   proliferative	   capacity	   tubularise	   faster	   than	   mitochondria	   in	  strains	   with	   low	   IPR	   or	   if	   the	   latter	   generally	   lacks	   the	   ability	   for	   formation	   of	  tubular	  mitochondria.	  To	  address	  this	  question,	  the	  VIO	  strain	  CDCF2932	  and	  the	  environmental	   isolate	   CBS8684	   were	   chosen	   as	   high	   and	   low	   proliferators,	  respectively,	  and	  mitochondrial	  morphology	  within	  macrophages	  monitored	  after	  0,	  2,	  6,	  12,	  18	  and	  24	  hours	  post	  infection.	  The	  VIO	  strain	  CDCF2932	  shows	  the	  first	  signs	   of	   tubularisation	   after	   two	  hours	  within	   the	   intracellular	   environment	   and	  continues	   to	   increase	   the	  percentage	  of	   tubular	  mitochondria	  up	   to	  24	  hours.	   In	  contrast,	  the	  proportion	  of	  tubular	  mitochondria	  stays	  consistently	  low	  over	  time	  in	   the	   environmental	   isolate	   (Figure	   30	   A).	   It	   seems	   likely	   that	   globular	  morphology	  is	  the	  precursor	  for	  formation	  of	  tubular	  mitochondria.	  Interestingly,	  the	   amount	   of	   mitochondria	   with	   globular	   morphology	   also	   seems	   to	   follow	   a	  certain	  pattern:	  whereas	  the	  VIO	  strain	  already	  shows	  a	  high	  percentage	  after	  two	  hours	   of	   infection	   that	   drops	   with	   onset	   of	   tubularisation,	   the	   control	   strain	  initially	  shows	  low	  levels	  of	  globular	  mitochondria	  that	  slowly	  increase	  over	  time	  but	  don’t	  fully	  tubularise	  in	  the	  non-­‐VIO	  strain	  (Figure	  30	  B).	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Figure	   30:	   Temporal	   pattern	   of	   yeast	   mitochondrial	   morphology.	   Mitochondrial	  morphologies	  were	   analysed	   at	   different	   time	   points	   after	   exposure	   to	   the	   intracellular	  environment	  of	  macrophages.	  J774	  macrophages	  were	  infected	  with	  either	  C.	  gattii	  strain	  CDCF2932	  or	  CBS8684	  for	  2	  hr	  and	  then	  further	  incubated.	  Samples	  were	  taken	  at	  0,	  2,	  6,	  12,	  18	  and	  24	  hr,	  mitochondria	  stained	  and	  cells	  analysed	  for	  the	  proportions	  of	   tubular	  and	   globular	   mitochondria.	   (A)	   The	   VIO	   strain	   CDCF2932	   shows	   first	   signs	   of	  tubularisation	   after	   two	   hours	   within	   the	   intracellular	   environment	   and	   continues	   to	  increase	   the	   percentage	   of	   tubular	   mitochondria	   up	   to	   24	   hours.	   In	   contrast,	   the	  proportion	  of	  tubular	  mitochondria	  stays	  consistently	  low	  over	  time	  in	  the	  environmental	  isolate	  CBS8684.	  (B)	  The	  amount	  of	  mitochondria	  with	  globular	  morphology	  also	  seems	  to	  follow	  a	  certain	  pattern:	  whereas	  the	  VIO	  strain	  already	  shows	  a	  high	  percentage	  after	  two	  hours	  of	  infection	  that	  drops	  with	  onset	  of	  tubularisation,	  the	  control	  strain	  initially	  shows	  low	   levels	   of	   globular	  mitochondria	   that	   slowly	   increase	   over	   time.	   Data	  were	   obtained	  from	   at	   least	   three	   individual	   experimental	   repeats	   and	   analysed	   for	   statistically	  significant	  differences	  using	  χ2	   tests.	   Statistically	   significant	  differences	   are	   indicated	  by	  asterisks	  (**	  P	  ≤	  0.01,	  ***	  P	  ≤	  0.001).	  AB	  –	  antibody.	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5.3	   MITOCHONDRIAL	   FUNCTIONS	   AND	   THE	   SEARCH	   FOR	   THE	  
MOLECULAR	  MECHANISM	  UNDERLYING	  HYPERVIRULENCE	  
Mitochondria	   seem	   to	  be	   the	  key	   to	  understanding	   the	  enhanced	  ability	  of	  VGIIa	  and	  VGIIc	  strains	  to	  parasitise	  macrophages	  and	  in	  the	  long	  run	  to	  understand	  the	  hypervirulence	   phenotypes	   of	   these	   subgroups.	   Mitochondria	   fulfill	   a	   variety	   of	  essential	  cell	  functions:	  oxidative	  respiration,	  resistance	  to	  oxidative	  stress	  (Grant	  
et	   al.,	   1997),	   certain	   heme	   synthesis	   reactions	   (Oh-­‐hama,	   1997)	   and	   sterol	  synthesis	   (Rossier,	   2006).	   To	   assess	   potential	   mechanisms	   underlying	  hypervirulence	  it	  is	  necessary	  to	  understand	  the	  influence	  of	  these	  features	  in	  the	  adaptation	   to	   the	   intracellular	   environment.	   The	   following	   section	   therefore	  investigates	   the	   influence	   of	   hypoxic	   conditions	   on	   macrophage-­‐Cryptococcus	  interaction	  and	  tests	  the	  stress	  susceptibility	  of	  VIO	  strains.	  	  
5.3.1	   MACROPHAGE-­CRYPTOCOCCUS	  INTERACTION	  UNDER	  HYPOXIC	  CONDITIONS	  	  Most	   tissue	   culture	   is	   done	   at	   atmospheric	   oxygen	   concentration.	   However,	   the	  oxygen	   concentrations	   within	   the	   human	   body	   differ	   significantly,	   ranging	   from	  21	  %	  in	  the	  lungs,	  12	  %	  in	  the	  blood	  stream	  and	  down	  to	  3-­‐6	  %	  in	  tissues	  and	  the	  brain.	  Cryptococcus	  encounters	  all	   these	  different	  oxygen	  concentrations	  within	  a	  host	   and	   has	   to	   adapt	   to	   them	   in	   order	   to	   colonize	   successfully.	   The	   research	  presented	   so	   far	   indicates	   that	  mitochondria	   play	   an	   important	   role	   in	   enabling	  infections.	   Hence,	   the	   interaction	   between	   macrophages	   and	   the	   yeast	   was	  analysed	   under	   hypoxic	   conditions	   (3	   %	   O2	   or	   following	   treatment	   with	   the	  hypoxia	   mimicking	   agent	   cobalt	   chloride	   (Lee	   et	   al.,	   2007)).	   The	   macrophage	  ability	  to	  internalize	  Cryptococcus	  was	  not	  significantly	  changed	  when	  cultured	  at	  3	  %	   O2	   but	   significantly	   increased	   upon	   treatment	   with	   0.1	   mM	   CoCl2	  (Figure	  31	  A).	   Cryptococcus	   was	   not	   able	   to	   proliferate	   in	   macrophages	   when	  cultured	  at	  3	  %	  oxygen	  or	  treated	  with	  0.1	  mM	  CoCl2	  (Figure	  31	  B).	  Extracellular	  proliferation	   and	   yeast	   control	   growth	   under	   hypoxic	   conditions	   were	   also	  reduced.	   However,	   Cryptococcus	   was	   still	   able	   to	   proliferate	   at	   low	   oxygen	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concentrations	   when	   grown	   in	   the	   absence	   of	   macrophages	   (Figure	   31	   C	   &	   D).	  Macrophage	  growth	  was	  similar	  to	  the	  control	  in	  the	  first	  24	  hours	  but	  the	  relative	  macrophage	  number	  was	  reduced	  afterwards	  (Figure	  31	  E).	  Thus,	  there	  seems	  to	  be	   a	   clear	   inhibitory	   effect	   of	   hypoxia	   on	   intracellular	   yeast	   proliferation	   and,	   in	  fact,	  Cryptococcus	  does	  not	  establish	  within	   the	   intracellular	  niche.	  However,	   this	  effect	  might	  be	  slightly	  overestimated	  due	  to	  generally	  reduced	  yeast	  cell	  growth	  within	   hypoxic	   conditions.	   Furthermore,	   Cryptococcus	   leaves	   the	   intracellular	  niche	   significantly	   more	   often,	   as	   shown	   by	   an	   increased	   number	   of	   expulsion	  events	  under	  hypoxic	  conditions	  (Figure	  31	  F).	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Figure	   31:	   Macrophage-­Cryptococcus	   interaction	   under	   hypoxic	   conditions.	   The	  effect	   of	   hypoxia	   on	   yeast	   uptake,	   intracellular	   and	   extracellular	   proliferation,	   yeast	  growth,	   macrophage	   growth	   and	   yeast	   expulsion	   was	   analysed.	   J774	   macrophages	  infected	   with	   C.	   neoformans	   strains	   ATCC90112	   or	   H99	   or	   C.	   gattii	   strain	   R265,	   yeast	  control	   and	  macrophages	   alone	  were	   incubated	   at	   atmospheric	  O2	   (control),	   3	  %	  O2	  or	  0.1	  mM	   CoCl2.	   Phagocytosis	   was	   analysed	   after	   2	   hr	   infection	   as	   proportion	   of	  macrophages	  with	  internalized	  cryptococci.	  The	  number	  of	  intra-­‐	  and	  extracellular,	  yeast	  control	  and	  macrophages	  were	  counted	  at	  0,	  18,	  24,	  48	  and	  72	  hr	  and	  is	  expressed	  relative	  to	   the	  number	  at	  T=0.	  Expulsion	  events	  were	  monitored	  over	  20	  hr	  by	   live-­‐cell	   imaging.	  (A)	  Phagocytosis	   of	  Cryptococcus	   is	   not	   altered	  by	   culture	   in	  3	  %	  O2	  but	   is	   significantly	  enhanced	   by	   treatment	   with	   0.1	   mM	   CoCl2.	   (B)	   Cryptococcus	   fails	   to	   proliferate	   within	  macrophages	   under	   hypoxic	   conditions.	   (C)	   Extracellular	   proliferation	   rate	   is	   decrease	  (ATCC90112	   shown	   as	   example).	   (D)	   The	   yeast	   control	   also	   shows	   reduced	   growth	  (ATCC90112	   shown	   as	   example).	   (E)	   Macrophage	   growth	   was	   not	   altered	   in	   the	   first	  24	  hr,	  macrophages	  died	  quicker	  afterwards.	   (F)	  Occurrence	  of	  expulsion	   is	   significantly	  increased	   under	   hypoxic	   conditions.	   Data	   were	   obtained	   from	   at	   least	   three	   individual	  experiments	  and	  are	  presented	  as	  means	  with	  2	  x	  standard	  error	  of	  the	  mean.	  Statistically	  significant	  differences	  are	  indicated	  by	  asterisks	  (*	  p	  <	  0.05,	  ***	  p	  <	  0.001).	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5.3.2	   SUSCEPTIBILITY	  PHENOTYPES	  OF	  C.	  GATTII	  IN	  VIO	  AND	  NON-­VIO	  STRAINS	  Important	   features	   of	   mitochondria	   are	   resistance	   mechanisms	   to	   withstand	  damage	   caused	  by	   the	   host	   attack	  with	   oxidative	   and	  nitrosative	   stress,	   stresses	  that	   may	   otherwise	   severely	   limit	   cryptococcal	   growth	   within	   the	   macrophage	  phagosome.	  To	  explore	  the	  possibility	  that	  mitochondrial	   tubularisation	  provides	  cryptococci	   with	   an	   improved	   ability	   to	   handle	   different	   stress	   conditions,	   four	  
C.	  gattii	  strains	  with	  high	  IPR	  and	  four	  C.	  gattii	  strains	  with	  low	  IPR	  (Table	  8)	  (Ma	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Table	   8:	  C.	   gattii	   strains	   chosen	   for	   phenotypic	   analysis.	   Analysis	   included	   different	  host	  and	  environmental	  stress	  conditions.	  The	  selection	  was	  made	  to	  cover	  a	  range	  of	  IPR	  values.	  
Strain	   IPR	   Source/Feature	  CBS7229	   0.56	   Meningitis,	  China	  CBS8684	   0.90	   Wasp	  nest.	  Uruguay	  CBS7750	   0.93	   E.	  camaldulensis,	  USA	  CBS1930	   1.14	   Sick	  goat,	  Aruba	  R265	   1.74	   Clinical	  isolate,	  British	  Columbia	  CDCR271	   2.04	   Clinical	  isolate,	  British	  Columbia	  ENV152	   2.28	   Alder	  tree,	  Vancouver	  Island	  CDCF2932	   2.98	   Clinical	  isolate,	  British	  Columbia	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Figure	   32:	   Stress	   susceptibility	   of	   C.	   gattii	   strains.	   Four	   strains	   with	   low	  	  	  	  	  	  	  (columns	  1-­‐4)	   and	   four	   strains	  with	   high	   (column	  5-­‐8)	   IPR	   values	  were	   assessed	   for	  growth	   after	   24	   hours	   after	   exposure	   to	   different	   stress	   conditions:	   (A)	   hypoxia	  mimicking	   agent	   CoCl2,	   (B)	   H2O2	   as	   oxidative	   stress,	   (C)	   NaNO2	   as	   nitrosative	   stress	  inducer	  with	  (D)	  a	  E.	  coli	  DH5α	  control,	  (E)	  SDS	  and	  (F)	  NaCl	  as	  cell	  wall	  stresses	  and	  (G)	   UV	   stress.	   CFU	   were	   counted	   after	   0	   and	   24	   hours	   treatment	   and	   the	   numbers	  analysed	  relative	  to	  time	  point	  0	  and	  untreated	  control.	  Data	  are	  obtained	  from	  at	  least	  three	  individual	  experimental	  repeats	  and	  presented	  as	  mean	  with	  2	  x	  standard	  error	  of	   the	  mean.	  The	  means	  were	  tested	   for	  statistical	  significant	  differences	  using	  Tukey	  HSD	  test	  assuming	  equal	  variances.	  Statistically	  significant	  differences	  are	  indicated	  by	  asterisks	  (*	  p	  <	  0.05).	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5.4	   MITOCHONDRIAL	   MORPHOLOGY	   IN	   THE	   RESPONSE	   TO	   HOST	  
AND	  ENVIRONMENTAL	  STRESS	  CONDITIONS	  
The	   analysis	   of	   mitochondrial	   functions	   in	   Cryptococcus	   and	   stress	   susceptibly	  phenotypes	  in	  C.	  gattii	  VIO	  and	  non-­‐VIO	  strains	  did	  not	  show	  any	  significant	  trends	  for	  either	  subgroup	  that	  might	  have	  helped	  to	  explain	  the	  increased	  ability	  to	  grow	  intracellularly	   in	   hypervirulent	   genotypes.	  However,	   as	   earlier	   data	   indicated	   an	  involvement	  of	  tubular	  mitochondria	  in	  hypervirulence	  (Byrnes	  et	  al.,	  2010,	  Ma	  et	  
al.,	  2009a),	  the	  response	  of	  cryptococcal	  mitochondria	  towards	  individual	  host	  and	  environmental	   stress	   conditions	   was	   analysed	   in	   an	   attempt	   to	   narrow	   down	  potential	   triggers	   responsible	   for	   tubularisation.	  Data	   from	   the	   stress	   treatments	  was	  used	  to	  determine	  stress	  doses	  of	  50	  %	  growth	  inhibition.	  These	  doses	  were	  then	   used	   to	   treat	   the	   selected	   cryptococcal	   strains	   and	   yeast	   were	   isolated	   for	  assessment	   of	  mitochondrial	  morphology.	   Interestingly,	   the	   formation	   of	   tubular	  mitochondria	   correlated	   positively	   with	   IPR	   values	   under	   several	   ‘host’	   stress	  situations	   (1	   mM	   H2O2,	   5	   mM	   NaNO2,	   3	   %	   O2	   and	   0.1	   mM	   CoCl2)	   and	   during	  exposure	   to	   UV.	   In	   contrast,	   however,	   IPR	   values	   correlate	   negatively	   with	  mitochondrial	  tubularisation	  following	  cell	  wall	  or	  osmotic	  stresses	  (0.005	  %	  SDS,	  0.05	  M	  NaCl)	  (Figure	  33	  A).	  To	  compare	  VIO	  strains	  with	  non-­‐VIO	  strains,	  the	  data	  for	   each	   subgroup	   were	   pooled	   and	   statistically	   analysed	   using	   a	   χ2-­‐test.	   This	  approach	  revealed	  a	  significantly	  higher	  percentage	  of	  tubular	  mitochondria	  in	  VIO	  strains	  after	  macrophage	  passage	  and	  under	  oxidative,	  nitrosative,	  hypoxic	  and	  UV	  stress.	   On	   the	   contrary,	   mitochondria	   of	   non-­‐VIO	   strains	   tubularised	   more	  frequently	  than	  mitochondria	  of	  VIO	  strains	  under	  cell	  wall	  stress	  (Figure	  33	  B).	  	  Taken	  together,	  VIO	  strains	  appear	  to	  respond	  better	  to	  certain	  stresses.	  However,	  this	  advantage	  seems	  to	  be	  at	  the	  cost	  to	  form	  tubular	  mitochondria	  under	  cell	  wall	  stress.	  This	  adaptation	  is	  somehow	  connected	  with	  mitochondria	  and	  in	  particular	  with	  the	  formation	  of	  tubular	  mitochondria.	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Figure	  33:	  Cryptococcal	  mitochondria	  morphology	  after	  stress	  treatment.	  To	  analyse	  the	   effect	   of	   host	   and	   environmental	   stresses	   on	   the	   morphology	   of	   cryptococcal	  mitochondria	   in	  VIO	  and	  non-­‐VIO	  strains,	   yeast	  were	  passaged	   through	  macrophages	  or	  incubated	   with	   1	   mM	   H2O2,	   5mM	   NaNO2,	   0.1	   mM	   CoCl2,	   3	   %	   O2,	   0.03	   J/cm2	   UV,	  0.005	  %	  SDS	  or	  0.05	  M	  NaCl	  for	  24	  hours	  and	  cells	  then	  counted	  for	  the	  number	  of	  yeast	  with	   tubular	  mitochondria.	   	   (A)	  Formation	  of	   tubular	  mitochondria	  correlated	  positively	  with	  IPR	  values	  under	  host	  stress	  situations	  and	  UV	  stress	  but	  correlated	  negatively	  with	  IPR	  values	  under	  cell	  wall	  stresses.	  (B)	  To	  compare	  VIO	  strains	  versus	  non-­‐VIO	  strains,	  the	  data	   for	   each	   subgroup	   were	   combined	   and	   statistically	   analysed	   using	   a	   χ2-­‐test.	   This	  approach	  revealed	  a	  significantly	  higher	  percentage	  of	  tubular	  mitochondria	  in	  VIO	  strains	  after	  macrophage	  passage	  and	  under	  oxidative,	  nitrosative,	  hypoxic	  and	  UV	  stress.	  On	  the	  contrary,	  mitochondria	  of	  non-­‐VIO	  strains	  tubularised	  more	  frequently	  than	  mitochondria	  of	   VIO	   strains	   under	   cell	   wall	   stress.	   Data	  were	   obtained	   from	   at	   least	   three	   individual	  experiments	  and	  are	  presented	  as	  accumulated	  data.	  Statistically	  significance	  was	   tested	  using	  χ2	  tests	  and	  significant	  differences	  are	  indicated	  by	  arrows	  (***	  p	  <	  0.0001).	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5.5	   	  GENETIC	   UNCOUPLING	   OF	   TUBULAR	   MITOCHONDRIAL	  
MORPHOLOGY	  AND	  IPR	  
A	   previous	   study	   analysed	   the	   mitochondrial	   contribution	   to	   the	   hypervirulent	  phenotype	   of	   VIO	   strains	   (Ma,	   2009).	   Due	   to	   the	   uniparental	   inheritance	   of	  mitochondria	  from	  MATa	  mating	  type	  (Xu	  et	  al.,	  2000),	  it	  is	  possible	  to	  explore	  the	  role	   of	   mitochondrially-­‐encoded	   control	   of	   virulence	   by	   replacing	   mitochondria	  from	   a	   ‘good’	   proliferator	   (high	   IPR	   strain)	  with	  mitochondria	   from	   a	   poor	   (low	  IPR)	   proliferator.	   In	   this	   case,	   good	   proliferating	  MATa	   and	  α	   VGII	   strains	  were	  mated	  with	  poorly	  proliferating	  MATα	  and	  a	  VGIII	  strains,	  respectively,	   to	  create	  progenies	   containing	   only	   mitochondria	   from	   a	   good	   or	   poor	   proliferator	  (Figure	  34	  A).	  Both	  parental	  strains,	  and	  randomly	  selected	  F1	  progeny,	  were	  then	  analysed	  for	  their	  IPR	  values	  (Ma,	  2009).	  Interestingly,	  possession	  of	  mitochondria	  from	  a	  high	  IPR	  parent	  did	  not	  result	  in	  high	  IRP	  values	  in	  all	  offspring	  suggesting	  that	  both	  the	  nuclear	  and	  the	  mitochondrial	  genome	  are	  involved	  in	  regulating	  the	  hypervirulence	   phenotype.	   Conversely,	   however,	   all	   offspring	   containing	  mitochondria	   from	   a	   parental	   strain	   with	   low	   IPR	   subsequently	   showed	   low	  potential	   to	  proliferate	  within	  macrophages.	   	  Thus,	  a	   ‘high	   IPR’	  mitochondrion	   is	  necessary,	  but	  not	  sufficient,	  for	  enhanced	  intracellular	  proliferation	  (Ma,	  2009).	  	  To	   establish	   whether	   the	   mechanism	   of	   virulence	   in	   progeny	   strains	   was	   also	  conserved,	  offspring	  from	  both	  crosses	  were	  tested	  for	  their	  ability	  to	  form	  tubular	  mitochondria	  upon	  exposure	  to	  macrophages.	  In	  cross	  1,	  in	  which	  progeny	  share	  a	  ‘low	  IPR’	  mitochondrial	  type,	  F1	  strains	  showed	  a	  significantly	  lower	  percentage	  of	  tubular	  mitochondria	  after	  macrophage	  passage	  than	  the	  high	  proliferating	  MATα	  parent	  R265	  (Figure	  34	  B).	  	  Thus,	  the	  mitochondrial	  genetic	  background	  from	  high	  proliferative	  strains	  is	  essential	  for	  increased	  tubularisation	  upon	  encounter	  of	  the	  intracellular	   niche.	   The	   second	   cross,	   in	   which	   all	   progeny	   share	   a	   ‘high	   IPR’	  mitochondrial	  type,	  results	  in	  a	  range	  of	  IPR	  values	  in	  the	  F1	  strains,	  from	  0.57	  to	  1.78	  (Ma,	  2009).	  	  However,	  in	  the	  progeny	  of	  this	  cross,	  the	  link	  between	  IPR	  and	  mitochondrial	  tubularisation	  appears	  to	  have	  been	  broken.	  	  There	  is	  no	  correlation	  between	  these	  two	  parameters	  for	  the	  strains	  tested,	  and	  most	  F1	  strains	  show	  an	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increased	  proportion	  of	   tubular	  mitochondria	  after	  macrophage	  passage	  but	  also	  when	  grown	   in	  DMEM	  (Figure	  34	  C	  &	  D).	  Taken	   together,	   this	   indicates	   that	   the	  mitochondrial	   genomic	   make	   up	   is	   essential	   for	   the	   formation	   of	   tubular	  mitochondria	   specifically	   within	   macrophages	   but	   that	   its	   interaction	   with	   the	  nuclear	   genomic	   background	   also	   plays	   an	   important	   role.	   Thus,	   in	   the	   second	  cross	   it	   appears	   as	   if	   the	   mitochondrial	   morphology	   has	   been	   uncoupled	   from	  intracellular	  proliferation,	   suggesting	   that	   the	   formation	  of	   tubular	  mitochondria	  might	   be	   negatively	   regulated	   by	   nuclear	   encoded	   genes	   and	   this	   link	   was	   lost	  following	   the	   change	   into	  a	  non-­‐hypervirulent	  VGIII	  background	  and	  hence	   from	  the	   inhibitory	   function	   of	   a	   nuclear	   regulated	   pathway	   normally	   preventing	  tubularisation.	  
Chapter	  5:	  The	  Vancouver	  Island	  Outbreak	  (VIO)	  and	  mitochondrial	  involvement	  in	  macrophage	  
parasitism	  	  
	   163	  
	  
Figure	   34:	   Genetic	   uncoupling	   of	   tubular	   mitochondria	   morphology	   and	   IPR.	  (A)	  Offspring	  from	  crosses	  that	  replaced	  mitochondria	  from	  a	  good	  proliferator	  into	  a	  poor	  proliferator	   nuclear	   background	   and	   vice	   versa	   were	   obtained	   (Ma,	   2009).	   Yeast	   were	  either	   grown	   in	   serum-­‐free	   DMEM	   (macrophage	   growth	   media)	   or	   used	   to	   infect	  macrophages.	  After	  24	  hours,	  yeast	  cells	  were	  harvested	  and	  stained	  for	  mitochondria	  and	  the	   percentage	   of	   cells	   with	   tubular	   mitochondria	   counted.	   (B)	   Formation	   of	   tubular	  mitochondria	   in	   offspring	   from	   both	   crosses.	   Offspring	   from	   cross	   I	   show	   low	  tubularisation	  both	  after	  macrophage	  passage	  and	  after	  growth	  in	  DMEM.	  However,	  most	  offspring	   from	   cross	   II	   show	   an	   increased	   proportion	   of	   tubular	   mitochondria	   in	   the	  DMEM	   control	   condition,	   indicating	   uncoupling	   from	   a	   nuclear	   regulated	   pathway	  normally	   inhibiting	   tubularisation.	   Data	   were	   obtained	   from	   at	   least	   three	   individual	  experiments	   and	   are	   presented	   as	   accumulated	   data.	   Statistical	   significance	   was	   tested	  using	  χ2	   tests	  and	  significant	  differences	   in	  tubularisation	  after	  macrophage	  passage	  and	  in	   DMEM	   are	   indicated	   by	   arrows	   (***	   p	   <	   0.0001).	   (C)	   This	   results	   in	   IPR	   not	   being	  correlated	   with	   the	   percentage	   of	   tubular	   mitochondria	   after	   macrophage	   exposure	  anymore.	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5.6	   ANALYSIS	   OF	   MITOCHONDRIAL	   GENOMIC	   FEATURES	   IN	   THE	  
SEARCH	   FOR	   THE	   MOLECULAR	   MECHANISM	   UNDERLYING	  
HYPERVIRULENCE	  
Data	  presented	  earlier	   in	   this	   thesis	  provides	  evidence	   that	  mitochondria	  and,	   in	  particular,	   the	   ability	   to	   form	   tubular	   mitochondria	   upon	   entry	   into	   the	  intracellular	  niche	  are	  important	  players	  in	  the	  regulation	  of	  hypervirulence	  in	  VIO	  strains.	  Research	  described	  in	  the	  next	  paragraphs	  will	  turn	  the	  focus	  to	  methods	  to	   uncover	   the	  underlying	  mechanisms	  by	   genomic	   approaches.	   It	  will	   analyse	   a	  set	   of	   microarray	   data	   and	   also	   describe	   the	   first	   steps	   towards	   a	   parallel	  sequencing	  strategy	  for	  comparative	  analysis	  of	  mitochondrial	  genomes.	  	  	  
5.6.1	   COMPARATIVE	  ANALYSIS	  OF	  MITOCHONDRIAL	  GENOMES	  	  Currently,	  seven	  cryptococcal	  isolates	  have	  been	  sequenced	  and	  the	  mitochondrial	  genome	   sequence	   of	   five	   strains	   could	   be	   obtained	   from	   online	   sources	   (Broad	  Institute	   of	   MIT	   and	   Harvard)	   or	   were	   kindly	   provided	   by	   collaborators	  (Prof.	  J.	  Heitman	   (Department	   of	   Molecular	   Genetics	   and	   Microbiology,	   Duke	  University),	  Prof.	  T.	  Boekhout	   (CBS	  Fungal	  Biodiversity	  Centre,	  The	  Netherlands)	  and	   Prof.	   J.	   Kronstad	   (Michael	   Smith	   Laboratories,	   The	   University	   of	   British	  Columbia)).	  The	  size	  of	  the	  mitochondrial	  genomes	  ranges	  from	  24,919	  bp	  in	  the	  C.	  
neoformans	  strain	  H99	  up	  to	  34,790	  bp	  in	  the	  C.	  gattii	  strain	  R265.	  The	  other	  three	  isolates	   C.	   neoformans	   JEC21,	   C.	   gattii	   CDCR272	   and	   C.	   gattii	   WM276	   have	  mitochondrial	  genomes	  of	  33,199	  bp,	  34,642	  bp	  and	  34,342	  bp	  size,	  respectively.	  Due	   to	   large	   gaps	   in	   the	   sequence,	   the	   data	   for	   CDCR272	   was	   excluded	   from	  further	  analysis;	  however,	  the	  other	  four	  strains	  were	  compared	  for	  open	  reading	  frames	   and	   the	   distribution	   of	   introns.	  With	   the	   help	   of	  Dr.	   A.	  Haines	   (School	   of	  Biosciences,	   University	   of	   Birmingham),	   the	  mitochondrial	   DNA	   sequences	  were	  rotated	   to	   enable	   alignment	   with	   the	   genome	   alignment	   visualization	   software	  Mauve	   2.3.1	   (Darling	   et	   al.,	   2010).	   Using	   the	   NCBI’s	   open	   reading	   frame	   (ORF)	  finder	  (http://www.ncbi.nlm.nih.gov.	  /gorf/gorf.html),	  ORFs	  encoding	  15	  different	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genes	   in	   a	   conserved	   order	   were	   identified	   in	   all	   four	   strains	   (Figure	   35	   A).	   A	  striking	   difference	   between	   strains	  was	   found	   in	   the	   number	   of	   introns.	   Introns	  within	  the	  mitochondrial	  genomes	  were	  identified	  with	  the	  online	  tool	  RNAweasel	  (http://megasun.bch.umontreal.ca/RNAweasel).	   Within	   the	   H99	   mitochondrial	  genome,	  the	  smallest	  of	  the	  four,	  only	  two	  introns	  were	  identified,	  whereas	  in	  the	  larger	  mitochondrial	  genomes	  up	  to	  16	  introns	  could	  be	  detected,	  all	  belonging	  to	  intron	   group	   I	   (Figure	   35	   B).	   Group	   I	   introns	   are	   self-­‐catalytic	   introns	   with	  maturase	   and	  homing	   endonucleases	   functions	   that	   are	   particularly	   abundant	   in	  fungal	  mitochondrial	   genes	   (Lang	   et	   al.,	   2007,	   Saldanha	   et	   al.,	   1993).	  Within	   the	  intronic	   regions	   of	   ORFs	   encoding	   cytochrome	   oxidase	   subunit	   1	   and	  apocytochrome	   B	   genes,	   several	   internal	   ORFs	   potentially	   encoding	   so-­‐called	  homing	  endonucleases	  containing	  a	  LAGLIDADG	  motif	  (Lang	  et	  al.,	  2007,	  Saldanha	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Figure	   35:	   Comparative	   alignment	   of	   cryptococcal	   mitochondrial	   genome	  
sequences.	   (A)	   Four	   cryptococcal	  mitochondrial	   genome	   sequences	   from	  C.	   neoformans	  strains	   H99	   and	   JEC21	   and	   C.	   gattii	   strains	   R265	   and	   WN276	   were	   aligned	   using	   the	  alignment	  visualization	  software	  Mauve	  2.3.1	  and	  annotated	  using	  the	  NCBI’s	  ORF	  finder.	  All	   four	  strains	  showed	   the	  same	  gene	  order.	  Similar	  colours	   in	   the	  alignment	  represent	  sequence	   similarity	   between	   strains.	   (B)	  Mitochondrial	   genomes	  were	   also	   analysed	   for	  introns	   using	   the	   intron	   search	   tool	   RNAweasel.	   Only	   a	   small	   number	   of	   introns	   were	  found	  in	  H99	  mitochondrial	  DNA,	  the	  smallest	  of	  the	  mitochondrial	  genomes,	  whereas	  the	  bigger	  genomes	  contain	  significantly	  more	  introns.	  All	  introns	  belong	  to	  group	  I.	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5.6.2	   MITOCHONDRIAL	  GENE	  EXPRESSION	  	  Phenotypic	   analysis	   of	   VIO	   strains	   has	   repeatedly	   shown	   an	   important	   role	   of	  mitochondria	   and	   tubular	   mitochondrial	   morphology	   in	   enhanced	   intracellular	  proliferation.	  However,	  the	  underlying	  mechanisms	  are	  still	  unknown.	  In	  a	  recent	  comparative	  whole-­‐genome	  microarray	  study	  RNA	  from	  C.	  gattii	  strains	  with	  IPR	  values	   from	   0.44	   and	   2.33	   was	   isolated	   after	   macrophage	   passage	   and	   then	  individually	  hybridized	  against	  a	  pooled	  RNA	  sample	  from	  all	  strains	  (Ma,	  2009).	  This	   analysis	   identified	   1,367	   probes	   with	   significantly	   correlation	   between	  expression	   and	   IPR	   values.	   These	   target	   loci	   were	   evenly	   distributed	   across	   the	  
C.	  gattii	   R265	   nuclear	   genome;	   however,	   the	   mitochondrial	   genome	   was	  significantly	  overrepresented	  despite	  no	  increase	  in	  DNA	  copy	  number	  (Ma	  et	  al.,	  2009a,	  Ma,	  2009).	  This	  prompted	  a	   closer	  examination	  of	   the	  microarray	   results	  from	  mitochondrial	   probes.	   The	   expression	   data	   from	   the	  mitochondrial	   probes	  seem	  to	  follow	  a	  trend	  where	  strains	  with	  low	  IPR	  values	  show	  generally	  negative	  expression	  levels	  of	  mitochondrial	  genes	  compared	  to	  the	  pooled	  sample	  and	  the	  expression	  levels	  increase	  with	  increasing	  IPR	  values	  (Figure	  36	  A).	  In	  fact,	  when	  the	  sum	  of	  expression	  data	  from	  all	  mitochondrial	  probes	  were	  plotted	  against	  IPR	  values,	   a	   statistically	   significant	  positive	   correlation	  was	  observed	   (Figure	  36	  B).	  However,	  no	  specific	  loci	  could	  be	  established	  that	  might	  regulate	  hypervirulence.	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Figure	   36:	   Mitochondrial	   expression	   data	   across	   a	   spectrum	   of	   IPR	   values.	  Microarray	   data	   from	   C.	   gattii	   strains	   with	   IPR	   values	   from	   0.44	   up	   to	   2.33	   where	  analysed.	   (A)	   The	   data	   of	   minus	   and	   plus	   DNA	   strand	   showed	   negative	   expression	   of	  mitochondrial	   genes	   in	   low	   IPR	   strains	   and	   expression	   levels	   increase	   with	   increase	   of	  ability	  to	  proliferate	  intracellularly.	  Green	  peaks	  represent	  positive	  expression,	  red	  peaks	  negative	   expression	   levels	   relative	   to	   expression	   level	   from	   a	   pooled	   RNA	   sample	   of	   all	  strains.	  The	  centre	  circle	  represents	  the	  annotated	  R265	  genome.	  The	  annotation	   legend	  can	   be	   found	   underneath	   the	   expression	   diagram.	   Figure	   30	   A	   was	   created	   with	   the	  program	   Circos	   (Krzywinski	   et	   al.,	   2009)	   and	   help	   from	   Dr.	   Anthony	   Haines.	   (B)	  When	  accumulated	  expression	  data	  of	  each	  DNA	  strand	  from	  all	  loci	  for	  each	  strain	  was	  plotted	  versus	   IPR	   values,	   a	   significant	   correlation	   between	   proliferative	   potential	   and	   overall	  gene	  expression	  was	  detected.	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5.6.3	   COMPARATIVE	  ANALYSIS	  OF	  MITOCHODNRIAL	  C.	  GATTII	  GENOMES	  	  It	   is	   very	   likely	   that	   changes	   in	   the	   genetic	   make	   up	   are	   directly	   or	   indirectly	  accountable	   for	   the	   increased	   ability	   to	   grow	   intracellularly	   in	   macrophages.	  Different	   potential	   scenarios	   are	   imaginable:	   Firstly,	   single	   nucleotide	  polymorphisms	  might	  have	  enabled	  the	  yeast	  to	  withstand	  the	  harsh	  environment	  caused	  by	  oxidative	  and	  nitrosative	   stress	  within	  macrophages	  and/or	  enhanced	  the	  functionality	  of	  virulence	  factors.	  Furthermore,	  it	  might	  be	  possible	  that	  strains	  from	  the	  outbreak	  lineage	  have	  gained	  additional	  coding	  regions	  and/or	  that	  gene	  duplications	   have	   occurred	   leading	   to	   increased	   virulence.	   Finally,	   nucleotide	  changes	  within	   regulatory	   regions	  could	  have	   increased	  or	  decreased	  expression	  levels	  of	  virulence-­‐related	  genes	  resulting	  in	  hypervirulence.	  Genomic	  comparison	  of	  strains	  from	  the	  outbreak	  lineage	  and	  phylogenetic	  reconstruction	  of	  sequences	  will	   enable	   the	   identification	   of	   possible	   genetic	   differences	   that	   are	   responsible	  for	  changes	  in	  mitochondrial	  functions	  and	  thus	  might	  be	  the	  genetic	  foundation	  of	  hypervirulence	  	  In	  cooperation	  with	  F.	  Hagen	  (CBS	  Fungal	  Biodiversity	  Centre,	  The	  Netherlands),	  existing	   nuclear	   and	   mitochondrial	   MLST	   datasets,	   phenotypic	   and	   virulence	  analyses,	   as	   well	   as	   intracellular	   proliferation	   assays,	   were	   used	   to	   create	  phylogenetic	  relationships	  between	  strains	  (Figure	  37	  A	  &	  B).	  The	  virulence	  assays	  had	  been	  performed	  in	  two	  different	  systems,	  an	  intranasal	  infection	  model	  using	  Balb/c	   mice	   (Ma	   et	   al.,	   2009a)	   and	   the	   intracellular	   proliferation	   rates	   (IPR)	   of	  
Cryptococcus	  cells	  in	  a	  J774	  macrophage	  cell	  line	  (Ma	  et	  al.,	  2009a).	  The	  three	  well-­‐known	  virulence	  factors	  of	  melanin,	  phospholipase	  and	  proteinase	  production,	  as	  well	   as	   19	   pathogenicity	   related	   enzymes	   had	   been	   tested	   at	   25ºC	   and	   37ºC,	   as	  described	  before	  (Ma	  et	  al.,	  2009).	  Neighbour-­‐Joining	  phylogenetic	  trees	  according	  to	   the	   four	  mitochondrial	   loci	  ATP6,	  mtlrRNA,	  NAD2	   and	  NAD4	   (3203nt)	  and	   the	  seven	  nuclear	   loci	  GPD1,	  IGS1,	  LAC1,	  MPD1,	  PLB1,	  SOD1	  and	  URA5	  (4607nt)	  were	  reconstructed	  by	  F.	  Hagen	  using	  the	  Pearson	  correlation	  coefficient	  in	  Bionumerics	  version	   4.61	   (Applied	   Maths,	   St.	   Martems-­‐Latem,	   Belgium)	   (Meyer	   et	   al.,	   2009,	  Bovers	  et	  al.,	  2008,	  Xu	  et	  al.,	  2009,	  Bovers	  et	  al.,	  2009).	  No	  major	  differences	  in	  the	  phylogenetic	   clustering	   were	   found	   when	   the	   mitochondrial	   (Figure	   37	   A)	   and	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Figure	   37:	   Phylogenetic	   constructions	   of	   C.	   gattii	   strains.	   MLST	   data,	   data	   from	  phenotypic	  analysis	  and	  virulence	  data	  were	  used	  to	  model	  the	  evolutionary	  relationship	  between	  C.	  gattii	  strains.	  The	  reconstructions	  were	  then	  used	  to	  select	  a	  wide	  range	  of	  C.	  
gattii	  strains	  for	  DNA	  isolation.	  Colour	  code:	  green	  low	  to	  red	  high.	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Table	   9:	   C.	   gattii	   strains	   selected	   for	   comparative	   analysis	   of	   mitochondrial	  
genomes.	  
Strain	   Genotype	   IPR	   Strain	  details	  CBS7229	   AFLP4	   0.56	   China,	  meningitis	  isolate	  CBS6955	   AFLP5	   	   Clinical	  isolate,	  USA	  CBS6993	   AFLP5	   1.45	   USA,	  California,	  CSF	  human	  CBS10485	   AFLP6A	   1.78	   Danish	  tourist	  visited	  Vancouver	  Island,	  Canada	  ENV152	   AFLP6A	   2.28	   Canada,	  Vancouver	  Island,	  Alder	  tree	  CBS10090	   AFLP6A	   1.71	   Greece,	  clinical	  A1M-­‐R271	   AFLP6A	   2.04	   Canada,	  British	  Columbia,	  clinical,	  immunocompetent	  male	  A1M-­‐F3016	   AFLP6A	   1.47	   Canada,	  dead	  wild	  Dall’s	  porpoise	  CBS8684	   AFLP6A	   0.90	   Uruguay,	  wasp	  nest	  A1M-­‐F2932	   AFLP6A	   2.98	   Canada,	  British	  Columbia,	  clinical,	  immunocompetent	  patient	  LA362	   AFLP6B	   1.36	   Brazil,	  parrot	  liver	  ICB180	   AFLP6B	   0.42	   Brazil,	  Eucalyptus	  sp.	  tree	  ICB184	   AFLP6B	   0.54	   Brazil,	  tree	  CBS1930	   AFLP6B	   1.14	   Aruba,	  sick	  goat	  CBS10089	   AFLP6B	   0.44	   Greece,	  clinical	  CCA242	   AFLP6B	   	   Spain	  LMM265	   AFLP6B	   	   Brazil	  EJB18	   AFLP6c	   1.73	   USA,	  Oregon,	  clinical	  CBS10101	   AFLP7	   1.00	   S.-­‐Africa,	  reference	  strain	  of	  Cryptococcus	  gattii	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Following	  the	  selection	  of	  C.	  gattii	  strains	  and	  confirmation	  of	  strain	   identity,	  we	  isolated	  high	  quality	   total	  DNA	   from	  each	   strain.	   	  To	  amplify	  mitochondrial	  DNA	  for	  parallel	  sequencing	  it	  was	  opted	  for	  a	  long-­‐range	  PCR	  approach	  (Hu	  et	  al.,	  2007,	  Jex	   et	   al.,	   2008).	   Together	  with	   Dr.	   A.	   Jex	   (Department	   of	   Vetenary	   Science,	   The	  University	   of	   Melbourne),	   PCR	   primers	   were	   designed	   to	   amplify	   the	   whole	  mitochondrial	   genome.	   With	   help	   of	   the	   previously	   described	   alignment	   of	  mitochondrial	   genomes,	   eight	   primers	   were	   created	   that	   localised	   in	   conserved	  regions	   of	   the	   genes	   encoding	   the	   large	   ribosomal	   subunit	   (rnl),	   NADH	  dehydrogenase	  subunit	  5	  (nad5),	  cytochrome	  oxidase	  subunit	  1	  (cox1)	  and	  NADH	  dehydrogenase	   subunit	   1	   (nad1)	   (Table	   10	   A).	   Primers	   were	   paired	   to	   produce	  four	  overlapping	  amplicons:	  three	  fragments	  of	  about	  6	  kb	  and	  one	  slightly	  larger	  fragment	  of	  ∼	  8	  kb	  (Table	  10	  B)	  and	  PCR	  reactions	  were	  performed	  with	  the	  Kapa	  HiFi	  HotStart	  DNA	  Polymerase	  kit	  for	  long-­‐range	  PCR	  (KapaBiosystems)	  according	  to	   the	   manufacturer’s	   instructions	   and	   an	   initial	   thermocycling	   profile	   of	   initial	  denaturation	  98°C	  for	  5	  minutes	  followed	  by	  30	  cycles	  of	  1	  minute	  denaturation	  at	  98°C,	  1	  minute	  annealing	  at	  53°C	  and	  10	  minutes	  extension	  at	  72°C	  together	  with	  a	  final	  extension	  of	  10	  minutes	  at	  72°C.	  This	  resulted	   in	  successful	  amplification	  of	  all	   four	  amplicons	   from	  the	   test	  strain	  CBS1930.	   	  However,	   the	  PCR	  product	  was	  contaminated	  by	  unspecific	  fragments	  (Figure	  39	  A).	  To	  improve	  specificity	  of	  the	  PCR	   reaction,	   the	   annealing	   temperature	   was	   increased	   to	   55°C	   and	   the	   cycle	  number	  reduced	   to	  25.	  This	  eliminated	  unspecific	  PCR	  products,	  however,	  at	   the	  cost	  of	  reduced	  yield	  for	  the	  three	  smaller	  amplicons	  and	  no	  product	  was	  obtained	  for	  the	  larger	  8	  kb	  amplicon	  (Figure	  39	  B).	  The	  optimization	  of	  this	  long-­‐range	  PCR	  protocol	   to	   achieve	   a	   specific	   PCR	   product	   for	   the	   8	   kb	   amplicon	   is	   currently	   in	  progress.	   In	   the	   next	   step,	   the	   cycle	   number	   will	   be	   increased	   to	   30	   and	   the	  annealing	   temperature	   reduced	   to	   54°C.	   Successfully	   amplified	   mitochondrial	  genomes	  will	  then	  be	  parallel	  sequenced	  with	  a	  454-­‐sequencer	  (Roche).	  Sequence 
data will be analysed for cryptic open reading frames present only in hypervirulent 
strains, for genomic rearrangements and single nucleotide polymorphisms. These data 
will then be compared with existing data on virulence and the ability to proliferate 
intracellularly/form tubular mitochondria to clarify the changes that have occurred and 
let to the increased virulence of strains in the Vancouver Island Outbreak. 	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Table	  10:	  Primer	  designed	  for	  amplification	  of	  the	  whole	  mitochondrial	  genome.	  (A)	  Primer	  sequence	  and	  additional	  information.	  (B)	  Primer	  pairs	  used	  in	  this	  study	  and	  their	  predicted	  amplicon	  size.	  	  
Primer	   Sequence	  





Rnl	  F	   CCATATAGCACTAGCGGATCA	   21	   52	  
Rnl	  R	   CCAATAAAGTATCGGAGGACC	   21	   52	  
Nad5	  F	   ATGCTACTACCTGTACTTATTGTA	   24	   51	  
Nad5	  R	   CCTTCCCAACCTACAAACATAATA	   24	   52	  
Cox1	  F	   CGACGAATTCCTGACTATCCT	   21	   52	  
Cox1	  R	   CCATTCTAGAGATGTACTGTATC	   23	   52	  
Nad1	  F	   CCAGAAGCAGAATCAGAACTAGT	   23	   53	  








Rnl	  F	   Nad5	  R	   ∼	  6	  
Nad5	  F	   Cox1	  R	   ∼	  8	  
Cox1	  F	   Nad1	  R	   ∼	  6	  
Nad1	  F	   Rnl	  R	   ∼	  5.5	  
	  
	  
Figure	  39:	  Optimization	  of	  long-­range	  PCR	  to	  amplify	  the	  mitochondrial	  genomes	  of	  
selected	  C.	  gattii	  strains.	   (A)	   Initial	  PCR	  reaction	  with	  a	   thermocycling	  profile	  of	   initial	  denaturation	  98°C	  for	  5	  minutes	  followed	  by	  30	  cycles	  of	  1	  minute	  denaturation	  at	  98°C,	  1	  minute	  annealing	  at	  53°C	  and	  10	  minutes	  extension	  at	  72°C	  with	   together	  with	  a	   final	  10	  minutes	   extension	   at	   72°C	   resulted	   in	   unspecific	   PCR	   products.	   (B)	   Specificity	   was	  improved	  by	  increasing	  the	  annealing	  temperature	  to	  55°C	  and	  reducing	  the	  cycle	  number	  to	   25.	   However,	   this	   was	   at	   a	   cost	   of	   lower	   yield	   and	   no	   product	   was	   obtained	   for	   the	  larger	  8	  kb	  amplicon.	  
A	  
B	  
Chapter	  5:	  The	  Vancouver	  Island	  Outbreak	  (VIO)	  and	  mitochondrial	  involvement	  in	  macrophage	  
parasitism	  	  
	   179	  
5.7	   DISCUSSION	  
Isolates	   involved	   in	   the	  VIO	   outbreak	  have	   been	   shown	   to	   belong	  primarily	   to	   a	  single,	   hypervirulent	   C.	   gattii	   genotype	   (Kidd	   et	   al.,	   2004).	   Interestingly,	   VIO	  isolates	   show	   a	   dramatically	   increased	   ability	   to	   replicate	   within	   macrophages	  (Ma,	  2009,	  Ma	  et	  al.,	  2009a).	  This	  intracellular	  proliferative	  ability	  correlates	  with	  virulence	   data	   obtained	   from	  mouse	  model	   systems	   and	   thus	   indicates	   that	   the	  hyper-­‐proliferative	   phenotype	  might	   be	   the	   cause	   of	   the	   outbreak.	   Furthermore,	  subsequent	  microarray	  analysis	  revealed	  a	  large	  number	  of	  up-­‐regulated	  genes	  in	  the	  highly	  proliferative	  strains,	  many	  of	  which	  are	  encoded	  by	   the	  mitochondrial	  genome	  or	  code	  for	  mitochondrial	  functions,	  and	  a	  correlation	  between	  increased	  intracellular	  proliferation	  and	  an	  unusual	  tubular	  mitochondria	  morphology	  of	  the	  outbreak	  strains	  after	  macrophage	  passage	  has	  been	  reported	  (Ma,	  2009,	  Ma	  et	  al.,	  2009a).	  However,	  the	  underlying	  molecular	  reasons	  for	  the	  hypervirulence	  of	  this	  particular	  lineage	  are	  not	  fully	  understood.	  	  The	   data	   presented	   in	   this	   study	   further	   strengthens	   the	   evidence	   that	  mitochondria	  or	  mitochondrial	  functions	  may	  regulate	  hypervirulence	  in	  C.	  gattii.	  The	   data	   show	   that	   enhanced	   intracellular	   proliferative	   capacity	   is	   a	   common	  characteristic	  of	  the	  VGIIa	  VIO	  lineage	  and	  the	  related	  VGIIc	  lineage	  that	  has	  been	  causing	  a	  cryptococcosis	  outbreak	  in	  healthy	  individuals	  in	  Oregon	  (Byrnes	  et	  al.,	  2010,	   Byrnes	   et	   al.,	   2009c).	   The	   increase	   in	   proliferation	   is	   connected	   with	  increased	   formation	   of	   tubular	   mitochondria	   after	   exposure	   to	   macrophages.	  Interestingly,	  this	  difference	  seems	  to	  be	  due	  to	  a	  difference	  in	  temporal	  formation	  of	  tubular	  mitochondria:	  a	  VIO	  strain	  starts	  to	  form	  tubules	  shortly	  after	  entry	  into	  the	   intracellular	   niche	   whereas	   a	   non-­‐VIO	   strain	   appears	   to	   fail	   to	   initiate	  tubularisation.	   This	   pattern	   is	   paralleled	   by	   the	   percentage	   of	   globular	  mitochondria;	   the	   VIO	   strain	   shows	   a	   high	   percentage	   of	   globular	  mitochondria	  before	   switching	   to	   the	   tubular	   morphology	   that	   drops	   after	   initiation	   of	  tubularisation.	  In	  contrast,	  the	  non-­‐VIO	  strain	  only	  slowly	  builds	  up	  the	  proportion	  of	   globular	   mitochondria.	   It	   almost	   seems	   as	   if	   a	   certain	   threshold	   of	   globular	  mitochondria	  has	  to	  be	  crossed	  before	  tubular	  mitochondria	  can	  be	  formed.	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To	   further	   investigate	   this	   behaviour,	   progeny	   from	   crosses	   between	   ‘good’	   and	  ‘poor’	   proliferators	   were	   analysed	   for	   their	   mitochondrial	   morphology.	   As	   the	  mitochondrial	  genome	  is	  inherited	  uniparentally	  from	  the	  MATa	  parent	  (Xu	  et	  al.,	  2000),	   a	   cross	   between	   a	   good	   proliferating	   VGIIa	   MATa	   parent	   and	   a	   poorly	  proliferating	   VGIII	   MATα	   parent	   should	   result	   in	   all	   progeny	   inheriting	   a	   ‘good	  proliferator’	  mitochondrial	  type	  and	  thus	  generating	  a	  high	  proportion	  of	  tubular	  mitochondria	  and	  high	  proliferation	  rate	  after	  macrophage	  exposure.	  	  In	  contrast,	  the	  opposite	  cross	  should	  produce	  progeny	  with	  the	  ‘poor’	  mitochondrial	  type,	  low	  mitochondrial	  tubularisation	  and	  poor	  intracellular	  growth.	  	  Indeed	  the	  latter	  case	  turns	   out	   to	   be	   true,	   with	   progeny	   that	   inherit	   a	   ‘poor’	   mitochondrial	   type	   all	  showing	  low	  IPR	  values	  (Ma,	  2009)	  and	  a	  low	  percentage	  of	  tubular	  mitochondria	  after	  macrophage	  exposure.	  However,	   in	  a	  cross	   in	  which	  all	  progeny	   inherited	  a	  ‘good’	   mitochondrial	   type,	   IPR	   values	   varied	   from	   0.57	   to	   1.78	   (Ma,	   2009).	   In	  addition,	   an	   assessment	   of	  mitochondrial	  morphology	   revealed	   that	  most	   of	   the	  isolates	  have	  an	  increased	  proportion	  of	  tubular	  mitochondria	  even	  in	  the	  control	  situation.	   This	   data	   suggests	   that	   a	   hypervirulent	   mitochondrial	   background	   is	  necessary	   for	   increased	   virulence,	   but	   that	   a	   compatible	   nuclear	   genome	   is	   also	  required	  for	  enhanced	  ability	  to	  parasitise	  phagocytes	  (Ma,	  2009).	  In	  addition,	  the	  constitutive	   production	   of	   tubular	   mitochondria	   in	   the	   progeny	   of	   this	   cross	  suggests	   the	  possible	   existence	  of	   a	  negative	   regulator	  of	   tubularisation	   that	  has	  been	  ‘uncoupled’	  in	  the	  progeny	  during	  the	  recombination	  of	  the	  nuclear	  VGII	  and	  VGIII	   genomes.	   Recently,	   incompatibility	   between	   nuclear	   and	   mitochondrial	  genomes	   has	   been	   described	   for	   the	   two	   closely	   related	   species	   S.	   bayanus	   and	  
S.	  cerevisiae.	   In	   particular	   one	   hybrid	   line	   with	   substitution	   of	   chromosome	  thirteen	   was	   completely	   sterile	   due	   to	   an	   inability	   of	   the	   S.	   bayanus	   nuclear	  encoded	   mitochondrial	   protein	   Aep2	   to	   regulate	   translation	   of	   the	   S.	  cerevisiae	  mitochondrial	  OLI1	  mRNA	  encoding	  a	  subunit	  of	  the	  ATP	  synthase	  complex	  (Lee	  et	  
al.,	  2008).	  Mitochondrial	  morphology	  is	  regulated	  by	  opposing	  pathways	  –	  fusion	  and	  fission	  (Sesaki	   et	   al.,	   1999,	   Bleazard	   et	   al.,	   1999).	   Fusion	   events	   in	   S.	   cerevisiae	   are	  controlled	  by	  a	  protein	  complex	  consisting	  of	  Fzo1p,	  Mgm1p	  and	  Ugo1p	  dependent	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on	  pH,	  GTP	  concentration	  and	  electrical	  membrane	  potential	   (Sesaki	   et	  al.,	  1999,	  Meeusen	   et	   al.,	   2003,	   Sesaki	   et	   al.,	   2003,	   Wong	   et	   al.,	   2000).	   Fzo1p	   in	   turn	   is	  regulated	  by	  the	  F-­‐box	  protein	  Mdm30p	  whose	  mutation	  blocks	  fission	  (Fritz	  et	  al.,	  2003).	   Furthermore,	   steady	   state	   levels	   of	   Fzo1p	   are	   increased	   in	   an	   mdm30	  mutant	  and	  decreased	  when	  mdm30	  is	  overexpressed	  (Fritz	  et	  al.,	  2003).	  As	  F-­‐box	  proteins	  are	   components	  of	   the	  E3	  ubiquitin	   ligase	   complex	  which	   catalyses	  26S	  proteasome-­‐mediated	   degradation,	   it	   has	   been	   proposed	   that	   Mdm30p	   might	  negatively	   regulate	   Fzo1p	   by	   labeling	   the	   protein	   as	   substrate	   for	   protein	  degradation	   (Patton	   et	   al.,	   1998).	   This	   hypothesis	   has	   been	   supported	   by	  observation	   of	   Fzo1p	   ubiquitination	   (Hitchcock	   et	   al.,	   2003)	   and	   increased	  mitochondrial	   fragmentation	   and	   aggregation	   after	   knockout	   of	   the	   two	   E2	  encoding	   enzymes	   UBC4	   and	   UCB5	   (Fisk	   et	   al.,	   1999).	   Hence,	   the	   Mdm30p	  homologue	   in	   C.	   gattii	   potentially	   might	   be	   a	   negative	   regulator	   of	   initiation	   of	  tubularisation	   and	   explain	   the	   ‘uncoupling’	   of	   tubularisation	   discussed	   above.	  Furthermore,	  maintenance	  of	  tubular	  morphology	  is	  controlled	  by	  a	  second	  set	  of	  proteins,	  Mmm1p,	  Mdm10p	  and	  Mdm12p,	  forming	  the	  MMM	  complex	  (Boldogh	  et	  
al.,	   2001)	   that	   connects	   mitochondrial	   tubules	   to	   other	   cellular	   structures	   or	  organizes	   scaffolding-­‐like	   proteins	   to	   maintain	   tubular	   shape	   (Okamoto	   et	   al.,	  2005).	   Weaker	   mitochondrial	   connection	   to	   this	   scaffold,	   or	   rearrangements	  within	  the	  backbone,	  might	  reduce	  stability	  of	  tubular	  morphology	  and	  thus	  result	  in	   failure	   to	   tubularise	   sufficiently.	   Understanding	   the	   molecular	   mechanisms	  regulating	   tubularisation	   in	   C.	   gattii	  might	   provide	   new	   targets	   for	   therapeutic	  approaches.	  	  One	  hypothesis	   for	   the	   involvement	  of	  mitochondria	   in	   increased	  virulence	   is	   an	  enhancement	   of	   mitochondrial	   function	   during	   stress	   resistance.	   Mitochondrial	  functions	   include	   oxidative	   respiration	   and	   these	   organelles	   are	   important	   for	  handling	   low	   oxygen	   concentrations	   and	   oxidative	   or	   nitrosative	   stress.	  
C.	  neoformans	   mutants	   with	   impaired	   mitochondrial	   function	   show	   reduced	  oxidative	   respiration	   and	   higher	   sensitivity	   to	   reactive	   oxygen	   species	   under	  hypoxic	   condition	   (Ingavale	   et	   al.,	   2008).	   To	   address	   how	   mitochondria	   might	  regulate	  cryptococcal	  virulence,	  the	  influence	  of	  hypoxia	  and	  a	  signaling	  pathway	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involved	  in	  oxygen	  signaling	  on	  the	  interaction	  with	  macrophages	  was	  evaluated.	  	  Most	   cell	   and	   tissue	   culture	   treatments	   are	   done	   at	   atmospheric	   oxygen	  concentrations.	  Cryptococcus	  grows	  very	  well	  under	  atmospheric	  oxygen	  condition	  (21	  %	   O2)	   but	   has	   to	   face	   low	   oxygen	   concentrations	   in	   the	   host	   ranging	   from	  approximately	  21	  %	  in	  the	  lungs,	  12	  %	  in	  the	  blood	  to	  only	  3-­‐6	  %	  in	  tissues	  and	  the	  brain.	   Therefore,	   macrophage-­‐Cryptococcus	   interactions	   were	   analysed	   under	  hypoxic	  conditions.	  The	  occurrence	  of	  expulsion	  was	  significantly	  increased	  under	  hypoxic	   conditions.	   When	   macrophages	   were	   infected	   with	   Cryptococcus	   under	  3	  %	   O2,	   the	   macrophage’s	   ability	   to	   internalize	   yeast	   was	   not	   altered	   whereas	  treatment	   with	   0.1	   mM	   CoCl2	   significantly	   increases	   yeast	   uptake.	   The	   chosen	  CoCl2	  concentration	   is	  very	   likely	   to	  cause	  more	  severe	  hypoxia	  than	  3	  %	  O2	  and	  thus	  indicates	  that	  Cryptococcus	  can	  adapt	  to	  low	  oxygen	  until	  a	  certain	  threshold.	  Once	   this	   threshold	   is	   passed,	   the	   anti-­‐phagocytic	   properties	   of	   the	   yeast	   are	  restricted,	   allowing	   rapid	   uptake.	   Cryptococci	   were	   not	   able	   to	   proliferate	   in	  macrophages	   when	   kept	   in	   hypoxic	   conditions	   after	   infection.	   Cryptococcus	   is	  rarely	  found	  in	  solid	  tissues	  and,	  since	  the	  oxygen	  concentration	  can	  fall	  as	  low	  as	  3	  %	  in	  tissues,	  macrophages	  might	  be	  more	  effective	  in	  killing	  the	  yeast	  and	  thus	  in	  eliminating	  them	  from	  these	  locations.	  	  One	   possible	   explanation	   for	   the	   hypervirulence	   of	   the	   VIO	   lineage	   is	   that	   the	  mitochondria	   of	   the	   C.	   gattii	   VIO	   strains	   have	   polymorphisms	   that	   produce	   an	  advantage	  under	  oxidative	  and	  nitrosative	  stress	  or	  low	  oxygen	  conditions.	  To	  test	  this	   possibility,	   four	   C.	   gattii	   strains	   with	   high	   IPR	   and	   four	   strains	   with	   low	  intracellular	  proliferative	  potential	  were	   tested	  under	  different	  stress	  conditions.	  However,	   no	   trend	   towards	   enhanced	   proliferative	   capacity	   of	   the	   strains	   with	  increased	   intracellular	   proliferation	   was	   detected	   under	   any	   of	   the	   stresses.	  Although	   there	   was	   no	   direct	   influence	   of	   stress	   conditions	   on	   the	   growth	   rate	  between	  high	  and	  low	  proliferators,	  there	  might	  be	  an	  enhanced	  ability	  to	  adapt	  to	  the	   intracellular	   environment	   due	   to	   mitochondrial	   functions	   that	   are	   only	  activated	  upon	  entry	  into	  the	  intracellular	  niche.	  One	  possibility	  would	  be	  greater	  mitochondrial	   plasticity	   in	   number	   or	   morphology	   that	   changes	   rapidly	   in	  response	  to	  the	  intracellular	  niche.	  Indeed,	  VIO	  strains	  appear	  to	  have	  an	  enhanced	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ability	  to	  deal	  with	  certain	  stresses	  such	  as	  hypoxia,	  oxidative,	  nitrosative	  and	  UV	  stress	  by	  adapting	  a	   tubular	  mitochondrial	  morphology.	  Most	  of	   these	  conditions	  are	  encountered	  within	  the	  mature	  phagosome	  and	  might	  enable	  these	  strains	  to	  withstand	  the	  innate	  immune	  attack.	  Many	  mitochondrial	  functions	  are	  performed	  by	  reactions	  involving	  regulatory	  and	  enzymatic	  protein	  complexes	  or	  a	  cascade	  of	  different	   proteins.	   Damage	   to	   one	   of	   these	   proteins	   by	   host	   immune	   attack	  mechanisms	   could	   result	   in	   disruption	   of	   successive	   activation	   reactions	   and	  inhibition	   of	   mitochondrial	   functions	   ultimately	   leading	   to	   cell	   death.	   In	  mitochondria	  with	  tubular	  morphology,	  it	  is	  likely	  that	  multiple	  copies	  of	  the	  same	  protein	   are	   in	   close	   proximity	   and	   thus	   can	   replace	   damaged	   units;	   in	   essence,	  resulting	   in	   ‘cross-­‐complementation’.	  This	  would	  result	   in	  an	   increased	  tolerance	  to	  host	  stresses	  and	  an	  advantage	  in	  establishing	  within	  the	  intracellular	  niche.	  It	   is	   very	   likely	   that	   changes	   in	   the	   genetic	   make	   up	   are	   directly	   or	   indirectly	  accountable	   for	   the	   increased	   ability	   to	   grow	   intracellularly	   in	   macrophages.	  Different	   potential	   scenarios	   are	   imaginable:	   Firstly,	   single	   nucleotide	  polymorphisms	  might	  have	  enabled	  the	  yeast	  to	  withstand	  the	  harsh	  environment	  caused	   by	   oxidative	   and	   nitrosative	   stress	   within	   infected	   phagocytes	   and/or	  enhanced	  the	  functionality	  of	  virulence	  factors.	  Furthermore,	   it	  might	  be	  possible	  that	   strains	   from	   the	   outbreak	   lineage	   have	   gained	   additional	   coding	   regions	  and/or	   that	   gene	   duplications	   have	   occurred	   leading	   to	   increased	   virulence.	  Finally,	   nucleotide	   changes	   within	   regulatory	   regions	   could	   have	   increased	   or	  decreased	  expression	  levels	  of	  virulence-­‐related	  genes	  resulting	  in	  hypervirulence.	  	  Available	  cryptococcal	  genomes	  were	  aligned	  and	  analysed	  for	  their	  gene	  synteny.	  Similar	   to	   an	   earlier	   study	   showing	   no	   differences	   in	   the	   gene	   order	   of	  
C.	  neoformans	  strains	  IFO410	  (var.	  grubii)	  and	  IFM5944	  (var.	  neoformans),	   it	  was	  found	  that	  the	  mitochondrial	  gene	  arrangement	  is	  also	  conserved	  in	  C.	  neoformans	  strains	  H99	  and	  JEC21	  as	  well	  as	  in	  C.	  gattii	  strains	  R265	  and	  WM276.	  Generally,	  there	  seems	  to	  be	  high	  sequence	  similarity	  between	  the	  genomes.	  However,	  there	  are	   several	   intronic	   regions,	   especially	   within	   the	   ORFs	   coding	   for	   cytochrome	  oxidase	  c	  subunit	  1	   (cox1),	  present	   in	   the	  C.	  gattii	  strains.	   Indeed,	   the	  number	  of	  detected	   introns	   in	   the	  C.	   gattii	   strains	   is	  much	   higher	   than	   in	   the	  H99	   genome.	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Many	   of	   these	   intronic	   regions	   encode	   putative	   endonucleases	   containing	   a	  LAGLIDADG	   motif	   (Saldanha	   et	   al.,	   1993,	   Lang	   et	   al.,	   2007).	   	   LAGLIDADG	  endonucleases	   have	   been	   implicated	   as	   maturases	   in	   splicing	   and	   as	   homing	  endonucleases	  facilitating	  group	  I	  intron	  mobility	  and	  activation	  of	  the	  DNA	  repair	  machinery	  (Burke,	  1988,	  Lambowitz	  et	  al.,	  1990,	  Perlman	  et	  al.,	  1989,	  Lang	  et	  al.,	  2007).	   The	   high	   abundance	   of	   ORFs	   potentially	   coding	   for	   these	   endonucleases	  raises	   the	   potential	   of	   greater	   mitochondrial	   genome	   plasticity	   by	   enabling	  rearrangements	   and	   additional	   integration	   of	   mobile	   introns	   that	   might	   affect	  regulatory	   regions.	   Activation	   of	   the	   DNA	   repair	   machinery	   by	   homing	  endonucleases	  might	  be	  an	  advantage	  during	  attack	  by	  oxidative	   and	  nitrosative	  stresses	  in	  mending	  DNA	  damage.	  In	  addition,	  the	  expression	  of	  maturases	  might	  accelerate	   the	   splicing	   process	   and	   facilitate	   increased	   levels	   of	   mitochondrial	  proteins.	   Interestingly,	   it	   has	   been	   described	   that	   the	   mitochondrial	   gene	  expression	   profile	   of	   cox1	   can	   be	   altered	   by	   temperature	   changes	   or	   encounter	  with	   the	   host	   environment	   in	   C.	   neoformans	   (Toffaletti	   et	   al.,	   2003),	   whilst	   a	  subsequent	   study	   ruled	   out	   mitochondrial	   involvement	   in	   virulence	   in	   C	  	  
neoformans	  A	  and	  D	  strains	   (Toffaletti	   et	  al.,	  2004).	   In	   this	   context,	  data	  analysis	  from	  microarrays	  with	  a	   range	  of	  C.	  gattii	  strains	   revealed	  a	  positive	   correlation	  between	  mitochondrial	  expression	  level	  and	  IPR	  value.	  	  	  Indications	   that	  mitochondria	   regulate	   pathogen	   virulence	   have	   previously	   been	  noted	   in	   the	  plant	  pathogen	  Heterobasidion	  annosum	   (Olson	   et	   al.,	   2001).	   In	   this	  context,	   a	   comparative	   analysis	   of	  mitochondrial	   genomes	   of	   a	   range	   of	  C.	   gattii	  strains	   that	   have	   been	   selected	   based	   on	   data	   obtained	   from	  MLST,	   phenotypic	  analysis	   and	   IPR	   values	   and	   phylogenetic	   reconstruction	   of	   sequences	   will	  hopefully	   be	   the	   next	   step	   to	   the	   identification	   of	   the	   genetic	   basis	   of	  hypervirulence.	  Fortunately,	  much	  experimental	  progress	  has	  already	  been	  made	  to	   prepare	  mitochondrial	   DNA	   for	   a	   parallel	   sequencing	   approach	   and	   hopefully	  further	   insight	  will	  be	  obtained	   in	  the	  near	   future.	  With	  the	  current	  knowledge	  a	  particular	   focus	  will	   also	   be	   given	   to	   genes	   involved	   in	   regulating	  mitochondrial	  morphology.	   Directed	   knockout	   of	   these	   genes	  will	   help	   to	   understand	   how	   the	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formation	   of	   tubular	   mitochondria	   is	   regulated	   in	   C.	   gattii	   and	   potential	  polymorphisms	  in	  VIO	  and	  non-­‐VIO	  genes	  might	  reveal	  regulatory	  aspects.	  	  In	  summary,	  striking	  results	  regarding	  the	  involvement	  of	  mitochondria	  in	  C.	  gattii	  hypervirulence	   are	  presented	   in	   this	   thesis.	  Mitochondrial	   plasticity	   seems	   to	  be	  the	  key	  in	  understanding	  the	  molecular	  mechanisms	  underlying	  the	  VIO	  outbreak.	  The	  next	  challenge	  will	  be	  to	  determine	  the	  genetic	  basis	  for	  this	  plasticity,	  based	  both	  on	  the	  mitochondrial	  and	  nuclear	  genomes.	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6.1	   INVOLVEMENT	   OF	   THE	   STEROL	   RESPONSE	   ELEMENT	   BINDING	  
PROTEIN	  IN	  MACROPHAGE	  PARASITISM	  
Under	   low	  oxygen	   conditions,	  Cryptococcus	  cannot	  proliferate	   intracellularly	   and	  shows	  an	  increase	  in	  the	  number	  of	  expulsion	  events.	  However,	  within	  the	  human	  body,	   the	   yeast	   has	   to	   adapt	   to	   different	   oxygen	   conditions.	   The	   sterol	   response	  element	  binding	  protein	  1	  (Sre1p)	  is	  involved	  in	  oxygen	  signaling	  in	  Cryptococcus.	  Low	   oxygen	   leads	   to	   reduced	   sterol	   synthesis	   followed	   by	   Sre1p	   activation.	  Knockout	  mutants	   of	   sre1,	   obtained	   by	  Agrobacterium-­‐mediated	   transformation,	  fail	   to	   grow	   under	   low	   oxygen	   conditions	   and	   these	   mutants	   show	   decreased	  virulence	  in	  a	  mice	  model	  (Lee	  et	  al.,	  2007,	  Chun	  et	  al.,	  2007,	  Chang	  et	  al.,	  2007).	  	  The	   role	   of	   Sre1p	   in	   macrophage	   parasitism	   by	   Cryptococcus	   was	   examined.	   As	  
Agrobacterium-­‐mediated	   transformation	   does	   not	   allow	   for	   directed	   knockout,	  
sre1	   was	   disrupted	   by	   homologous	   recombination	   following	   biolistic	  bombardment.	   After	   transformation,	   potential	   sre1	   knockout	   colonies	   were	  screened	  for	  their	  ability	  to	  grow	  on	  media	  containing	  0.6	  mM	  CoCl2	  and	  growth-­‐negative	   colonies	   checked	   for	   correct	   integration	   of	   the	   knockout	   cassette	   by	  southern	   hybridization	   (Figure	   40	   A).	   Two	   individual	   mutants	   (5.52	   and	   6.15)	  were	   selected	   for	   further	   analysis	   of	   their	   behavior	   within	   macrophages.	   At	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Figure	  40:	  Analysis	  of	  sre1	  KO	  mutants.	   (A)	  Potential	  sre1	  KO	  colonies	  were	  screened	  for	  loss	  of	  ability	  to	  grow	  on	  0.6	  mM	  CoCl2	  containing	  YPD	  agar	  plates.	  A	  selection	  of	  four	  colonies	  was	   then	   subjected	   to	   Southern	  analysis	   to	   control	   for	   single	   integration	  of	   the	  knockout	   cassette	   and	   potential	   genomic	   rearrangements.	   (B)	   J774	   cells	   were	   infected	  with	  C.	  neoformans	  strains	  H99	  and	  the	  two	  independent	  sre1	  KO	  strains	  6.15	  and	  5.52	  at	  atmospheric	  oxygen	   levels	  and	   then	   further	   incubated	  under	   the	  same	  conditions	  whilst	  being	  monitored	   for	   intracellular	   proliferation.	   IPR	  was	   significantly	   reduced	   in	   both	   of	  the	   KO	   strains	   compared	   to	   the	   parental	   H99	   strain.	   (C)	   The	   sre1	   KO	   strains	   and	   the	  parental	  C.	  neoformans	  H99	  strain	  were	  subjected	  to	  oxidative	  (H2O2),	  nitrosative	  (NaNO2)	  and	   cell	   wall	   stress	   (SDS	   and	   NaCl)	   in	   DMEM	   assay	   medium	   and	   growth	   assessed	   by	  hemocytometer	   countings	  after	  48	  hr	   incubation	  at	  37°C.	  Both	  mutant	   strains	   showed	  a	  general	   growth	   defect	   revealed	   by	   significantly	   reduced	   yeast	   cell	   number	   after	   48	   hr	  incubation	   in	   the	   untreated	   control	   as	   well	   as	   under	   stress	   conditions.	   Data	   presented	  were	   obtained	   from	   at	   least	   three	   individual	   experiments	   and	   are	   shown	   as	  mean	  with	  2	  x	  standard	   error	   of	   the	   mean.	   The	   means	   were	   tested	   for	   statistical	   significant	  differences	   using	   Tukey	   HSD	   test	   assuming	   equal	   variances.	   Statistically	   significant	  differences	  are	  indicated	  by	  asterisks	  (***	  p	  <	  0.001).	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6.1.1	  DISCUSSION	  
Cryptococcus	   often	   invades	   the	   central	   nervous	   system	   where	   it	   faces	   O2	  concentrations	   of	   around	   3	   %	   thus	   indicating	   a	   mechanism	   that	   enables	  
Cryptococcus	  to	  adapt	  to	  low	  oxygen	  conditions.	  In	  fact,	  there	  have	  been	  reports	  on	  
Cryptococcus	  mutants	   defective	   in	   the	   sre1	   gene,	   that	   are	   unable	   to	   grow	   at	   low	  oxygen	  concentrations	  and	  show	  reduced	  virulence	   in	  mice	  models	  (Chang	   et	  al.,	  2007,	   Chun	   et	   al.,	   2007).	   In	   mammals,	   Sre1p	   functions	   as	   oxygen-­‐sensing	  component	   of	   the	   cholesterol	   biosynthesis	   pathway	   that	   is	   required	   for	   the	  induction	   of	   sterol	   synthesis	   genes	   under	   low	   oxygen	   concentrations	   (Lee	   et	   al.,	  2007,	  Chang	   et	  al.,	   2007).	  Hughes	  et	  al.	   (2005)	   (Hughes	   et	  al.,	   2005)	   identified	  a	  similar	   mechanism	   in	   Schizosaccharomyces	   pombe.	   Thus,	   an	   analogous	   pathway	  might	  also	  be	  involved	  in	  sensing	   low	  oxygen	  concentrations	  and	  be	  required	  for	  adaptation	   of	  Cryptococcus	   to	   the	   hypoxic	   environment	   in	   the	   brain	   to	  maintain	  sterols,	   a	   major	   component	   of	   the	   fungal	   cell	   membrane.	   To	   address	   the	  importance	  of	  this	  oxygen-­‐signaling	  pathway	  in	  adaptation	  to	  hypoxic	  conditions,	  a	  
sre1	  knockout	  mutant	  was	   created	   and	   tested	   during	  macrophage	   infection.	   The	  








	  The	  research	  presented	   in	   this	   thesis	  provides	   insight	   into	  several	  aspects	  of	   the	  interaction	   of	   Cryptococcus	   with	   phagocytic	   effector	   cells.	   It	   offers	   a	   potential	  explanation	   for	   the	   susceptibility	  phenotype	  of	   immunocompromised	   individuals	  that	   hopefully	   in	   the	   future	   will	   be	   applied	   in	   research	   and	   the	   design	   of	   novel	  anticryptococcal	   therapies.	   It	   also	   introduces	   an	   automatic	   approach	   using	   GFP-­‐tagged	  strains	  that	  simplifies	  and	  accelerates	  the	  so	  far	  time-­‐consuming	  analysis	  of	  parameters	   describing	  macrophage-­‐Cryptococcus	   interaction.	   Finally,	   it	   proposes	  concepts	   to	   explain	   the	   increased	   virulence	   in	   C.	   gattii	   strains	   that	   have	   been	  causing	  outbreaks	  on	  Vancouver	   Island,	  Canada	  and	   in	  Oregon,	  USA.	  These	   ideas	  are	  a	  starting	  point	  for	  the	  design	  of	  exciting	  experimental	  approaches.	  Together,	  these	  findings	  will	  hopefully	  help	  to	  widen	  our	  understanding	  of	  this	  pathogen	  and	  how	   it	   causes	   disease	   to	   ultimately	   improve	   therapy	   and/or	   preventative	  measures.	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